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Abstract 
Flap	 endonuclease	 1	 (FEN1)	 is	 a	 member	 of	 a	 5’	 nuclease	 superfamily	 involved	 in	 DNA	
replication	and	repair.	FEN1	hydrolyses	the	phosphodiester	bond	one	nucleotide	into	the	duplex	
region	of	bifurcated	double-flapped	structures	as	found	in	lagging-strand	DNA	synthesis.	These	
flap	structures	need	to	be	cut	in	a	very	specific	manner	on	the	order	of	around	106	times	per	cell	
cycle.	Therefore	FEN1	is	seen	as	an	essential	enzyme	that	maintains	genomic	integrity	across	all	
life	 forms.	 How	 FEN1	 achieves	 its	 molecular	 recognition	 for	 a	 chemically	 very	 similar	 but	
structurally	different	DNA	substrate	and	how	 it	 achieves	 catalysis	on	a	biochemically	 relevant	
timescale	are	key	questions	to	understand	the	protein	system.	This	thesis	describes	some	of	the	
mechanistic	studies	used	to	understand	how	the	structure	and	dynamics	of	hFEN1	relate	to	its	
function.	
It	 was	 proposed	 that	 T5	 bacteriophage	 FEN	 was	 a	 catalytically	 perfect,	 or	 diffusion-limited	
enzyme,	 yet	 its	main	 rate-limiting	 step	 after	 substrate	 binding	was	 non-chemistry	 related.	 To	
ascertain	whether	 this	was	 true	 for	 hFEN1,	 the	 effect	 of	 leaving	 group	pKa	 using	 2’	modified	
double	flapped	substrates	on	rates	of	catalysis	was	measured.	It	was	found	that	both	apparent	
second	order	rates	and	first	order	single	turnover	rates	of	catalysis	were	insensitive	to	 leaving	
group	 pKa.	 Furthermore	 by	 supplementing	 the	 reaction	 with	 glycerol,	 an	 unexpectedly	 high	
viscosity	dependence	was	observed.	The	explanation	 for	 this	 is	 likely	 the	presence	of	another	
physical	step	in	the	catalytic	cycle	affected	by	viscosity.	
Previous	structural	and	biophysical	studies	of	hFEN1	identified	a	helical	arch,	which	was	thought	
to	be	disordered	as	it	could	accommodate	bulky	5’	flaps	through	it.	Furthermore,	the	arch	is	key	
for	positioning	the	5’	flap	into	the	active	site.	Using	NMR	spectroscopic	techniques	the	solution	
state	conformation	of	apo-hFEN1	was	analysed.	The	arch	was	found	to	be	disordered,	but	the	C-
terminal	portion	of	it	was	transiently	sampling	α-helical	ϕ,ψ	space,	while	the	other	half	was	in	
an	extended	conformation.	Another	DNA	recognition	region,	the	α2-α3	loop	was	also	found	to	
be	disordered.		
Various	 ligands	and	 substrates	were	 found	 to	alter	 the	 structure	and	 the	dynamics	of	hFEN1.	
Addition	 of	 substrate	 DNA	 slowed	 the	 motion	 of	 the	 arch	 and	 α2-α3	 loop	 to	 a	 millisecond	
timescale.	 Equally	 addition	 of	 a	 single	 monophosphate	 nucleotide	 had	 an	 effect	 on	 the	
dynamics	 of	 the	 top	 of	 the	 arch,	 despite	 binding	 in	 the	 active	 site.	 Furthermore,	 titration	 of	
calcium	 ions	 into	 the	 active	 site	 when	 DNA	 was	 present	 on	 the	 enzyme	 resulted	 in	 large	
perturbations	 to	 substrate	 recognition	 sites	 distant	 from	 the	 active	 site.	 This	 potentially	 links	
the	specificity	of	these	regions	to	activity	within	the	active	site.	
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Chapter 1: Introduction 
1.1 Nucleases 
1.1a Background 
It	has	been	shown	 for	many	years	now	that	deoxyribonucleic	acid	 (DNA)	 is	 the	molecule	 that	
codes	for	genetic	information.1,2	However,	the	DNA	molecule	is	by	no	means	a	static	structure.	
DNA	is	like	a	book,	which	is	fragile	in	places	and	needs	constant	copying	and	repair.	Hydrolysis,	
oxidation	and	methylation	of	DNA	occur	endogenously,	at	high	frequency,	in	vivo,	which	require	
constant	 repair	 by	 enzymatic	 pathways.3	 Maintenance	 of	 the	 genome	 includes	 nucleobase	
oxidation	 removal,	 nucleobase	methylation	 removal	 and	 resolving	mismatches	 of	 base	 pairs.	
Furthermore,	DNA	needs	to	be	replicated	in	order	to	propagate	genetic	information,	requiring	
an	unwinding	of	the	double-helix.4	Therefore,	the	importance	of	maintaining	high	fidelity	during	
DNA	replication	and	repair	is	paramount.	
	
Nucleic	acids	achieve	these	chemical	processes	with	the	aid	of	a	plethora	of	highly	efficient	and	
specific	enzymes.	There	are	many	pathways	that	are	both	monitored	and	catalysed	by	nucleic	
acid-acting	 enzymes.	 A	 few	 examples	 of	 enzymes	 that	 work	 on	 nucleic	 acids	 include	
polymerases,	glycosylases	and	nucleases.	The	latter,	which	are	the	focus	of	this	thesis,	catalyse	
the	hydrolysis	 of	 a	 phosphodiester	 bond	 that	 links	 two	nucleotides	 together.	 The	diversity	 of	
nucleases	is	striking.	They	are	involved	in	a	wide	variety	of	very	important	cellular	DNA	and	RNA	
tasks,	 such	 as	 replication,	 repair,	 structural	 changes,	 mRNA	 splicing,	 RNA	 degradation,	 cell	
defense	and	apoptosis	to	name	a	few.	
	
Figure	1.i.	Phosphodiester	hydrolysis.	The	base	(B:)	activates	a	nucleophile	(in	this	case	H2O)	that	attacks	
the	 phosphodiester.	 This	 results	 in	 a	 penta-covalent	 intermediate,	with	 the	 leaving	 group	 on	 the	 axial	
position	 (usually	 the	 3’	 bridging	 oxygen).	 Finally	 the	 leaving	 group	 is	 ejected	 and	 the	 product	 is	 a	 5’	
phosphate	monoester.	 It	 should	be	noted	 that	metal	 ions	 could	help	with	 (1)	 creation	of	 the	base,	 (2)	
stabilisation	of	the	penta-covalent	intermediate	and	(3)	reduction	in	energy	of	the	product.	
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1.1b Chemistry of nucleases 
Chemically,	nucleases	catalyse	a	nucleophilic	substitution	reaction.	This	was	shown	to	be	mainly	
an	 associative	 nucleophilic	 substitution	 (SN2),	 due	 to	 its	 characteristic	 inversion	 of	
stereochemistry	of	the	product.5	A	phosphodiester	bond	by	 itself	 in	water	pH	7	at	37	°C	has	a	
rate	of	hydrolysis	of	10-22	s-1	(or	one	bond	broken	per	3x108	million	years).6	Nucleases	bring	the	
half-life	of	a	phosphodiester	bond	down	to	hundreds	of	seconds,	a	rate	increase	of	19	orders	of	
magnitude.	Nucleases	achieve	this	by	bringing	all	the	required	components	in	close	proximity	to	
each	other	to	make	the	reaction	favourable.	The	phosphodiester	bond	is	positioned	for	attack	
by	an	activated	nucleophile	 (Fig.	 1.i).	Nucleophiles	 include	water,	 tyrosine,	 serine	or	histidine	
residues,	 and	 the	 2’-OH	 group	 in	 RNA.	 Furthermore	 the	 penta-covalent	 intermediate	 or	
transition	 state	 is	 usually	 stabilised	 by	 some	 external	 positive	 charge,	 like	 that	 from	 divalent	
metal	 ions.	 It	 might	 seem	 that	 such	 a	 simple	methodology	 would	 produce	 a	 very	 conserved	
pattern	of	active	sites	and	enzyme	structures.	The	chemistry	is	deceiving	however,	as	the	range	
of	nuclease	enzyme	structures	is	vast.	
	
1.1c Substrate specificity 
In	 order	 for	 a	 nuclease	 to	 function	 properly	 it	 needs	 to	 have	 a	 substrate	 to	 act	 on.	 This	 is	
especially	important	for	a	nuclease,	as	the	substrate	is	the	genetic	material	that	codes	for	life,	
errors	 or	 inactivity	 could	 result	 in	 cancer	 or	 other	 serious	 genetic	 illnesses.	 This	 regulatory	
problem	 could	 be	 solved	 by	 two	 distinct	 molecular	 mechanisms.	 Firstly	 the	 nuclease	 could	
interact	with	a	protein	partner,	receive	post-translational	modifications	or	bind	with	a	co-factor,	
such	as	a	metal	ion.	These	processes	either	inhibit	or	stimulate	the	nuclease’s	activity	or	ability	
to	bind	to	a	substrate,	thereby	allowing	the	cell	to	keep	its	nuclease	activity	in	check.	Secondly,	
by	having	a	nuclease	exhibit	a	high	degree	of	specificity	for	their	DNA	substrates,	thereby	only	
hydrolysing	DNA	or	RNA	that	needs	to	be	cut.	This	thesis	will	predominately	look	at	the	second	
mechanism,	focusing	on	how	nucleases	exhibit	an	inherent	specificity	for	their	substrates.	
	
Nucleases	have	traditionally	been	categorized	by	looking	at	how	they	achieve	their	nucleophilic	
substitution	 and	 what	 substrates	 they	 act	 upon.7	 Metal	 ions	 (as	 mentioned	 above)	 are	
predominately	 used	 in	 a	 wide	 range	 of	 nucleases	 to	 a)	 deprotonate	 water	 (activate	 a	
nucleophile),	b)	stabilise	the	negatively	charged	penta-covalent	intermediate	or	transition	state	
and	 c)	 lower	 the	 free	energy	of	 the	product.	Magnesium	 ions	 (Mg2+)	 are	 the	most	 frequently	
used	ions	due	to	their	unique	coordination	geometry	and	ubiquity	within	the	cell.	Nucleases	are	
categorised	as	one-,	two-	or	three-metal-ion	dependent,	or	may	be	metal-independent.		
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In	 terms	 of	 substrate	 specificity,	 broadly	 speaking	 there	 are	 two	 categories	 of	 nucleases:	
sequence-specific	 (restriction	 enzymes),	 or	 structure-specific.	 The	 former	 recognises	 a	 very	
select	 sequence	 of	 DNA	 or	 RNA	 and	 hydrolyses	 endo-nucleolytically,	 either	 double	 strand	 or	
single	 strand.	 The	 mechanism	 by	 which	 selection	 happens	 is	 in	 part	 by	 recognition	 of	 the	
chemistry	of	the	DNA	base	pairs.	The	latter	type	of	nuclease,	which	this	thesis	will	focus	on,	is	
the	 structure-specific	 type.	 These	 enzymes	 do	 not	 primarily	 discriminate	 catalytic	 activity	 by	
base-sequences,	but	rather	discriminate	based	on	the	secondary	structure	of	DNA.	
	
1.2 The Flap Endonuclease Superfamily 
1.2a Summary of the superfamily 
One	 such	 superfamily	 of	 structure-specific	 nucleases	 involved	 in	DNA	metabolism,	 replication	
and	repair	is	the	flap	endonuclease	superfamily.	This	includes	the	enzymes	exonuclease	(EXO1),	
gap	endonuclease	(GEN1),	exoribonuclease	(XRN1),	xeroderma	pigmentosum-G	(XPG)	and	flap	
endonuclease	 (FEN1).	The	 family	members	are	all	 linked	by	 their	 similar	protein	 fold	and	 two	
metal	ion-dependency.	These	enzymes	highlight	the	diversity	in	activity	and	cellular	function	of	
nucleases,	 even	 within	 one	 family.	 Each	 protein	 still	 performs	 a	 simple	 5’	 phosphodiester	
hydrolysis	with	remarkably	similar	active	sites,	but	each	one	has	its	preferred	substrate.	
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Figure	 1.ii.	 Superfamily	 substrates	 and	 their	 sites	 of	 activity.	 Sites	 of	 phosphodiester	 hydrolysis	 are	
denoted	in	red	arrows,	DNA	has	a	black	backbone	and	RNA	has	an	orange	backbone.	(A)	FEN1	hydrolyses	
double-flapped	 DNA,	 with	 an	 endonucleolytic	 reaction	 occurring	 one	 nucleotide	 into	 the	 dupliex.	 (B)	
EXO1	hydrolyses	a	nicked	DNA	exonucleolytically	with	slight	processivity.	(C)	GEN1	homodimer	hydrolyses	
two	mirrored	 sites	 on	 a	Holliday	 junction	 to	 resolve	 it.	 (D)	 XPG	hydrolyses	 large	 bubble	 like	 structures	
(dotted	 line)	 on	 one	 side	 of	 the	 bubble.	 (E)	 XRN1	 hydrolyses	 RNA	 bases	 in	 a	 5’	 to	 3’	 direction	 highly	
processively.	
	
FEN1	hydrolyses,	very	specifically,	one	nucleotide	into	the	duplex	of	flap-like	structures	found	in	
replication	and	repair	pathways	(Fig.1.ii.a).8	EXO1	is	involved	in	double-strand	break	repair	and	
mismatch	repair.9,10	Furthermore	it	is	only	found	in	eukaryotes.	Its	primary	substrate	is	that	of	a	
5’	 blunt	 end,	 or	 a	 nicked	 piece	 of	 DNA	 (Fig.	 1.ii.b).	 There	 is	 some	 evidence	 of	 limited	
processivity,	as	it	can	cleave	roughly	6-7	nucleotides	exonucleolytically	before	stopping.	GEN1	is	
the	 main	 holliday	 junction	 (HJ)	 ‘resolvase’,	 allowing	 for	 these	 potentially	 dangerous	 DNA	
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structures	to	be	removed	from	the	cell.	It	is	the	only	superfamily	member	that	is	confirmed	as	a	
dimer,	 and	uses	 the	mirrored	phosphodiester	hydrolysis	 activity	 to	 cut	each	 side	of	 the	HJ	 to	
achieve	 two	double-stranded	products	 (Fig.	 1.ii.c).	 XPG	 cuts	 open	 large	 ‘bubble’	 structures	 in	
DNA	found	during	nucleotide	excision	repair	(Fig.	1.ii.d),	and	works	as	part	of	the	XP	pathway.11	
Finally,	XRN1	cuts	very	precessively	ribonucleotides,	and	is	involved	in	mRNA	degredation	(Fig.	
1.ii.e).11	
	
1.2b The role of FEN1 in DNA replication 
FEN1	 is	 involved	 in	 many	 processes,	 including	 long-patch	 base	 excision	 repair	 and	
ribonucleotide	 excision	 repair,	 but	 it	 is	most	 vitally	 involved	 in	 replication.8,12	 The	 process	 of	
DNA	replication	uses	a	 large	host	of	proteins	 to	regulate	the	entire	process.	Most	are	outside	
the	scope	of	this	thesis.	To	understand	why	FEN1	is	so	vital	it	is	necessary	to	look	at	eukaryotic	
replication.	 It	 starts	 at	 specific	 sites	 on	 eukaryotic	 chromosomes	 called	origin	 sites.13	 In	 brief,	
origins	 are	 regulated	 by	 various	 replication	 initiation	 factors,	 which	 have	 to	 form	 a	 pre-
replicative	complex	on	the	DNA	before	the	origin	can	‘fire’	and	hence	replication	can	proceed.	
The	 regulation	of	 these	pre-replicative	 complexes	 is	 known	as	 ‘licensing’	 of	 replication	 and	 is	
essential	to	ensure	only	one	set	of	replication	is	carried	out	in	one	cell	growth	cycle.14	
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Figure	1.iii.	Cartoon	representation	of	a	replication	fork.	(A)	DNA	is	unpaired	by	helicase	and	splits	into	a	
leading	 strand	 and	 a	 lagging	 strand.	 On	 the	 leading	 strand	 Pol-ε	 polymerises	 new	 DNA	 continuously	
towards	the	replication	fork.	On	the	lagging	strand	Primase	binds	a	few	RNA	primers	before	Pol-α	extends	
them	a	bit	more.	(B)	Pol-δ	takes	over	from	Pol-α	and	polymerises	until	 it	runs	into	the	previously	made	
Okazaki	fragment,	whereby	strand	displacement	synthesis	occurs,	creating	a	5’	flap	like	structure,	which	
is	the	main	substrate	for	FEN1.	
	
Once	 the	 origin	 fires,	 it	 is	 aided	 by	 a	 trimeric	 protein	 scaffold,	 the	 proliferating	 cell	 nuclear	
antigen	(PCNA),	which	guides	other	proteins	on	and	off	the	replication	site.15	The	DNA	helix	 is	
unwound	 and	 unzipped	 by	 a	 helicase,	 which	 forms	 a	 replication	 fork	 (Fig.	 1.iii.a).	 Synthesis	
starts	 with	 a	 Polymerase-α	 Primase	 hetero-tetramer	 complex	 (Pol-α	 Primase).16	 The	 Primase	
segment	 can	 synthesise	 de	 novo	 RNA	 primers	 (about	 5-7)	 from	 the	 ribonucleotides	 in	 the	
nucleus	 on	 the	 replication	 site.	 The	 Pol-α	 segment	 of	 the	 complex	 is	 proficient	 at	 extending	
already	synthesised	strands,	so	it	uses	the	RNA	primer	as	a	scaffold	to	extend	a	small	number	of	
DNA	 nucleotides	 (about	 7-14).	 The	 Pol-α	 Primase	 complex	 is	 then	mediated	 off	 the	 site	 and	
Polymerase-δ	(Pol-δ)	takes	over	long	strand	DNA	synthesis	(Fig.	1.iii.b).	
	
Polymerases	 are	 another	 metal-dependent	 enzyme	 involved	 with	 phosphodiester	 formation	
and	 hydrolysis.	 However,	 Pol-δ	 can	 only	 synthesise	 DNA	 precessively	 in	 a	 5’	 to	 3’	 direction,	
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which	presents	a	problem.	On	the	template	strand	the	DNA	is	synthesised	continuously	towards	
the	replication	fork	 in	a	5’	to	3’	direction.	The	 lagging	strand	however	 is	going	 in	the	opposite	
direction,	which	means	 that	 the	 polymerase	 can	 only	 synthesise	 in	 a	 5’	 to	 3’	 direction	away	
from	 the	 fork,	 resulting	 in	 discontinuous	 polymerisation.	 Pol-δ	 latches	 on	 to	 a	 small	 Pol-α	
synthesised	DNA	strand	near	the	fork	and	synthesises	as	far	as	 it	can	forming	small	strands	of	
DNA	called	Okazaki	fragments.	Crucially,	when	a	Pol-δ	from	the	preceding	fragment	runs	 in	to	
the	 5’	 end	 of	 the	 former	 fragment	 strand	 displacement	 synthesis	 occurs	 (Fig.	 1.iii.b).	 This	 is	
where	 the	 polymerase	 displaces	 the	 preceding	 RNA/DNA	 strand	 resulting	 in	 a	 RNA/DNA	 flap	
structure.17	These	flap	structures	need	to	be	removed	and	the	double	strand	product	ligated	in	
order	for	the	lagging	strands	to	form	an	identical	replicate	of	the	original	DNA.	The	DNA	needs	
to	be	cleaved	in	a	structure-specific	manner,	without	regard	to	the	sequence	of	the	DNA	and	it	
needs	to	occur	roughly	50	million	times	per	cell	cycle.17	This	is	why	FEN1	is	a	crucial	enzyme	for	
most	life	on	earth.	
	
In	fact,	FENs	are	found	in	all	organisms	from	early	phage	through	to	mammals.	Older	FENs	such	
as	bacteriophage	T5	FEN	have	a	preference	for	a	different	5’	exonucleolytic	activity	that	trims	
flaps	rather	than	cutting	them.18	The	sheer	ubiquity	of	FENs	would	suggest	that	the	protein	is	of	
significant	importance	to	maintaining	the	integrity	of	the	genetic	code	across	all	life	forms.	This	
has	 been	 demonstrated	 in	 mammals	 where	 a	 FEN1	 knock	 out	 in	 the	 mouse	 genome	 is	
embryonically	 lethal.19	 Studies	 have	 also	 been	 carried	 on	 the	 yeast	 Saccharomyces	 cerevisiae	
where	 a	 null	 mutation	 of	 Rad27	 (a	 FEN	 homologue	 in	 yeast)	 display	 increased	 genomic	
instability,	 with	 a	 strong	 mutator	 phenotype.20	 On	 the	 other	 hand	 if	 mammalian	 FEN1	 is	
overexpressed	 in	 the	 genome	 it	 leads	 to	 an	 increase	 in	 tumor	 aggressiveness,	 perhaps	
increasing	the	stability	or	turnover	of	the	DNA	in	cancerous	cells.21	
	
1.3 FEN1: structure and function 
1.3a A review of the function of hFEN1 
FEN1	is	a	DNA-structure	specific	nuclease,	therefore	it	catalyses	the	endonucleolytic	removal	of	
5’	 flaps	by	hydrolysing	one	nucleotide	 (1nt)	 into	 the	synthesised	double	strand	region	of	DNA	
with	 a	 high	 degree	 of	 specificity.	 The	 preferred	 substrate	 structure	 is	 a	 double-flapped	 DNA	
molecule	with	any	length	of	5’	flap	on	the	downstream	duplex	and	a	1nt	3’	flap	on	the	upstream	
double	 strand	 (Fig.	 1.ii.a).22	 This	 structure	 is	 present	 at	 the	 junction	 of	 the	 two	 Okazaki	
fragments	 in	 vivo.	 Using	 two	 Mg2+	 ions	 as	 catalysts,	 FEN1	 hydrolyses	 the	 DNA	 1nt	 into	 the	
downstream	region	via	a	penta-covalent	phosphate	 intermediate	or	 transition	state,	 leaving	a	
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5’-phosphate	at	the	end	of	the	reaction.23	This	generates	a	nicked	DNA	because	the	upstream	
3’-flap	is	complementary	to	the	template	DNA.	This	final	structure	is	a	substrate	for	DNA	ligase	
and	 can	 immediately	be	processed	 to	 complete	 replication,	 thus	minimising	extra	DNA	 repair	
steps.	
	
The	 main	 questions	 are	 therefore,	 how	 does	 FEN1	 achieve	 this	 molecular	 recognition	 for	 a	
chemically	very	similar	but	structurally	different	DNA	substrate,	and	how	does	 it	catalyse	on	a	
biochemically	 relevant	 timescale?	 To	 answer	 these	 questions	 there	 have	 been	 numerous	
structural,	kinetic	and	biophysical	analyses	done	on	FEN1.	The	detailed	focus	of	this	thesis	will	
cover	mainly	human	FEN1	or	hFEN1,	but	some	insights	can	be	gained	from	looking	across	phyla	
at	the	wide	variety	of	FENs	and	how	they	compare	to	each	other.	
	
1.3b Structures of FEN1 with DNA 
The	 sequence	of	hFEN1	has	been	well	 characterized,	 there	are	 two	domains:	 a	nuclease-core	
domain	present	from	residues	1-336,	and	a	protein-binding	domain	from	residues	337-380.	The	
protein-binding	 domain	 links	 to	 many	 other	 proteins	 (including	 PCNA)	 that	 mediate	 FEN1’s	
activity	in	vivo	and	are	important	in	its	overall	cellular	function.24,25	The	protein	however,	retains	
its	 catalytic	 function	 and	DNA-binding	 capabilities	 in	 the	 absence	 of	 these	 43	 residues,	 albeit	
with	a	slightly	higher	Michaelis	constant	(KM).26	FENs	across	phyla	share	a	similar	primary	amino	
acid	sequence	to	hFEN1	as	well	as	similar	structural	motifs.	
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Figure	 1.iv.	 DNA	 recognition	 sites	 on	 hFEN1.	 The	 two	 figures	 are	 from	 a	 product-bound	 hFEN1-DNA	
crystal	 structure	 complex	 (3Q8K).27	 The	 right	 hand	 side	 figure	 has	 the	 DNA	 hidden	 for	 clarity.	 The	
highlighted	 cyan	 residues	 are	 basic	 residues,	 which	 lie	 along	 a	 positive	 charge	 groove	 on	 the	 protein.	
There	 is	 also	 a	 Helix-two-turn-Helix	 motif	 (H2tH)	 with	 a	 K+	 ion	 coordinated	 in	 it	 for	 additional	 DNA	
binding.	The	DNA	when	bound	forms	a	100°	bend	by	having	two	juxtaposed	binding	sites,	and	by	wedging	
the	top	of	α2	into	the	junction,	forcing	the	nicked	DNA	into	this	conformation.	The	α4-α5	archway	houses	
the	active	site	at	its	base	with	two	Mg2+	metal	ions	(black	spheres),	but	also	houses	many	basic	residues	
that	contact	the	5’	flap	and	the	template.	
	
Across	all	FENs	the	nuclease-core	structure	consists	of	a	7-stranded	β-sheet	platform,	which	is	
surrounded	 by	 15	 α-helices.	 There	 is	 a	 long	 positively	 charged	 groove	 down	 the	 center	 for	
general	 dsDNA	 binding	 (Fig.	 1.iv).	 A	 potassium	 ion	 is	 coordinated	 via	 peptide	 carbonyls	 in	 a	
helix-two-turn-helix	motif	 (H2tH),	 a	 double-stranded	 DNA	 binding	motif	 that	 binds	 backbone	
DNA	at	the	downstream	region	of	the	template	strand.	At	the	junction	of	the	duplex	DNA,	the	
nucleic	 acid	 is	 forced	 into	 a	 bent	 configuration	 by	 approximately	 100°	 around	 one	
phosphodiester	bond	by	 the	positioning	of	 the	protein	helix	α2,	as	a	hydrophobic	wedge	 into	
the	junction	(Fig.	1.iv).	The	DNA	is	further	held	in	place	by	a	second	site	upstream.	Contacts	in	
α3	 and	 the	α14-α15	 loop	help	 anchor	 the	 upstream	DNA	helping	 adopt	 the	DNA	 into	 a	 bent	
conformation.	This	provides	specificity	towards	a	dsDNA	that	can	easily	bend	at	that	particular	
phosphodiester	 bond.	 A	 weaker	 and	 broader	 specificity	 towards	 B-DNA	 is	 seen,	 as	 the	 H2tH	
motif	is	roughly	one	pitch	length	(34	Å)	away	from	the	bent	flap	structure.	In	this	way	most	of	
the	 initial	 substrate	 recognition	 is	 done	 by	 interactions	 between	 the	 template	 strand	 of	DNA	
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and	 the	 protein	 and,	 as	 is	 to	 be	 expected	 for	 a	 sequence	 independent	 nuclease,	 its	 main	
recognition	sites	are	on	the	phosphate	backbone,	not	the	base	pairs.	
	
	
Figure	1.v.	A	close	view	of	the	active	site	of	hFEN1.	(A)	Overview	of	the	hFEN1	crystal	3Q8K	(as	seen	in	
Fig	1.iv),27	showing	the	3’	binding	pocket	(blue),	arch	(red)	and	K+	ion	(purple).	The	crystal	structure	uses	
Sm3+	ions	(black	spheres)	to	aid	crystal	packing	and	inhibit	activity	but	in	vivo	this	would	be	the	location	of	
two	Mg2+	 ions.	 DNA	 is	 hidden	 for	 clarity.	 (B)	 Close-up	 of	 the	 active	 site	 showing	more	 of	 the	 specific	
interactions.	 Y40	 (magenta)	 stacks	 with	 the	 terminal	 5’	 nucleotide	 base	 of	 the	 cleaved	 product.	
Carboxylates	(green)	coordinate	with	the	Mg2+	ions	to	hold	them	in	the	ideal	coordination	to	stabilise	the	
negative	5’	monophosphate.	Basic	residues	in	the	arch	(in	cyan,	R100	and	K93)	hold	the	5’	flap	down	in	
position.	There	is	a	visible	deformation	of	the	two	bases	going	into	the	active	site.	
	
A	look	at	the	active	site	of	hFEN1	in	more	detail	shows	it	is	located	at	the	base	of	a	‘helical	arch’	
(α4-α5),	 with	 two	 Mg2+	 ions	 held	 in	 place	 with	 four	 inner-sphere	 and	 three	 outer-sphere	
carboxylic	 groups	 (Fig.	 1.v.b).	 The	 presence	 of	 Mg2+	 ions	 has	 been	 shown	 to	 be	 crucial	 for	
catalysis,	due	to	reasons	listed	above	(Section	1.1c).	It	should	be	noted	however	that	the	active	
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site	of	hFEN1	can	accommodate	a	wide	range	of	multi-valent	metal	ions.	In	the	crystal	structure	
above	 (3Q8K)	 Sm3+	 ions	 are	 used	 for	 crystallisation	 and	 allow	 for	 DNA	 binding.	 Furthermore,	
Ca2+	ions	allow	for	a	binding	and	bending	of	the	DNA.28	However,	Ca2+	and	Sm3+	do	not	facilitate	
catalysis.	 It	 is	 not	 quite	 understood	why,	 but	 it	 is	 likely	 to	 do	with	 the	 size	 and	 coordination	
geometry	of	the	ions,	which	do	not	coordinate	correctly	with	the	phosphodiester.	
	
In	X-ray	crystal	structures	of	both	product	(3Q8K)27	and	substrate	(5UM9)29	bound	hFEN1	there	
is	 a	high	degree	of	 secondary	 structure	ordered	around	 the	 5’	 terminus,	with	 it	 snugly	 fitting	
between	 the	helical	 arch.	 The	 flap	 is	 held	 in	 place	by	 several	 basic	 residues	 in	 the	 arch	 (K93,	
R100	and	R104)	and	a	conserved	nucleobase-stacking	residue	(Y40)	(Fig.	1.v.b).	In	this	way	the	
helical	 arch	 and	 other	 residues	 deliver	 the	 hydrolytic	 phosphodiester	 into	 the	 correct	
coordination	between	the	two	Mg2+	ions	allowing	chemistry	to	occur.	
	
A	further	structural	recognition	domain	of	hFEN1	is	the	3’	flap-binding	pocket,	which	consists	of	
the	α2-	α3	 loop	and	α14-α15	 loop.	These	protein	sequences	associate	with	a	1nt	 long	3’	DNA	
flap.	 This	not	only	allows	 for	an	enhanced	 specificity	 for	 the	preferred	dsDNA	double-flapped	
structures,	but	also	allows	 specific	hydrolysis	of	 the	phosphodiester	1nt	 into	 the	downstream	
dsDNA	 region.	 There	 is	 structural	 evidence	 of	 connectivity	 between	 the	 α2-α3	 loop	 and	 the	
helical	 arch	 as	 several	 important	 sidechains	 of	 residues	 from	 the	 top	 of	 α2	 are	 very	 close	 in	
space	 to	 the	bottom	of	α5	 (i.e.,	R47	and	 I44	and	V131).	Therefore	 it	has	been	suggested	 that	
allostery	 between	 the	 α2-α3	 loop	 and	 the	 helical	 arch	 play	 an	 important	 role	 in	 substrate	
recognition.	
	
In	 summary,	 substrate	 recognition	 and	 DNA	 binding	 have	 been	 associated	 with	 these	 three	
regions:	
1) Juxtaposed	DNA	binding	between	downstream	binding	sites	and	upstream	binding	sites,	
which	confer	specificity	for	dsDNA	able	to	bend.	
2) The	 helical	 arch	which	 accommodates	 and	 delivers	 the	 single	 stranded	 5’	 flap	 to	 the	
metal	ions	for	chemistry	to	occur.	
3) The	recognition	of	 the	3’	 flap	 in	 the	α2-α3	 loop	and	a14-a15	pocket	causing	potential	
allosteric	changes	elsewhere	in	the	protein	and	DNA.	
There	is	however	a	discrepancy	between	X-ray	crystal	structures	of	a	wide	variety	FENs.	So	far	
only	 structures	 crystallized	 with	 DNA	 have	 been	 examined.	 There	 are	 important	 structural	
changes	in	X-ray	crystal	structures	without	DNA.		
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1.3c Protein Dynamics 
In	a	crystal	structure	of	hFEN1	without	DNA	(1UL1)	we	see	that	portions	of	the	arch	region,	α2-
α3	 loop	 and	 the	 hitherto	 unmentioned	 region	 of	 the	 β-pin	 (β6-β7)	 are	 unobservable.24	 This	
could	be	for	many	crystallographic	reasons	such	as	a	high	B-Factor,	which	indicates	the	amount	
of	static	or	mobile	dynamics	of	a	region	or	just	simply	a	result	of	refinement	errors.	In	a	field	of	
phyla	we	actually	observe	the	arch	region	and	α2-α3	loop	in	a	range	of	frozen	conformations,	
sometimes	missing,	sometimes	in	a	random	coil,	sometimes	in	discernable	secondary	structure,	
or	a	mix	between	all	three	(Fig.	1.vi).	Whether	the	range	of	structures	arises	due	to	differences	
in	 the	 crystal	 lattice	 or	 crystallization	 conditions	 rather	 than	 a	 dynamic	 property	 of	 the	 FEN	
protein	is	unknown.	
	
	
Figure	1.vi.	 The	arch	 regions	 and	α2-α3	 loops	of	 FENs	 from	other	organisms.	Crystal	structures	of	 (A)	
Desulfurococcus	 solfataricus	 (3ORY)30	 and	 (B)	 T5	 bacteriophage	 FEN	 (1EXN)18	 show	 an	 α-helical	 arch	
region.	Crystal	structures	from	(C)	Pyrococcus	furiosus	(1B43)31	and	(D)	T5	FEN	(5HML	and	5HMM)32	show	
an	arch	region	with	a	degree	of	secondary	structure,	and	in	(C)	it	is	collapsed.	Equally	in	the	structure	of	
(E)	Pyrococcus	horikoshii	(1MC8)33	there	is	an	arch	region	with	very	limited	secondary	structure	and	it	is	
collapsed	over	 the	active	 site.	 In	 (F)	Methanococcus	 jannaschii	 (1A76	and	1A77)34	 there	 is	an	extended	
conformation	of	arch	with	very	limited	α-helical	nature.	Finally	for	(G)	Methanopyrus	kandleri	(4WA8)35,	
(H)	hFEN1	in	complex	with	an	inhibitor	(5FV7)26	and	(I)	T5	FEN	(1XO1)36,	there	is	a	lack	of	electron	density	
in	the	arch	region.	Furthermore	in	the	case	of	(H),	the	α2-α3	loop	is	missing.	
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The	supposed	dynamics	 in	these	regions	has	been	a	focus	of	study	for	some	time.	Kinetic	and	
fluorescence	anisotropy	studies	coupled	with	site-directed	mutagenesis	have	shed	much	insight	
into	the	link	between	dynamics	and	catalysis.	In	particular	the	role	of	the	arch	and	its	ability	to	
pass	the	5’	flap	through	it,	or	in	other	words	‘thread’	the	flap.	Proline	mutations	were	made	in	
the	 arch,	 whereby	 flexible	 leucine	 residues	 (L97,	 L111	 and	 L130)	 were	 mutated	 to	 equally	
hydrophobic,	but	rigid	prolines.	These	mutants	have	relatively	unaffected	binding	affinities	(KD),	
whereas	 their	 single-turnover	 rates	 of	 reaction	 (kST)	 were	 affected	 greatly.	 L97P	 showed	 the	
greatest	 reduction	 (>100,000-fold	 reduction),	 possibly	 because	 it	 may	 have	 disrupted	 other	
basic	residue	contacts	(K93,	R100).37	L111P	and	L130P	showed	reductions	in	rate	of	15,000-fold	
and	3,000-fold	respectively.	These	residues	were	at	the	top	of	the	arch,	far	away	from	the	active	
site	but	still	affected	the	single-turnover	rate	significantly.	The	question	of	how	these	mutations	
cause	such	catastrophic	reductions	in	rate	in	a	region	far	away	from	the	active	site	is	difficult	to	
explain	using	static	structural	models.	
	
More	 experiments	 done	with	 a	 bulky	 5’	 streptavidin	 tetramer	 linked	 to	 substrate	 DNA	 show	
further	 facts	 regarding	 the	 dynamics	 of	 the	 arch	 region.	 If	 streptavidin	 is	 added	 before	 any	
protein	 or	 catalytically	 activating	Mg2+	 ions	 are	 added	 it	 creates	 a	 ‘blocked’	 substrate,	 which	
slows	 catalysis	 considerably	 (15,000-fold	 decrease	 in	 kST)	 (Fig.	 1.vii.a).38	 If	 however,	 the	
streptavidin	is	added	after	pre-mixing	protein	in	the	solution	and	then	activating	with	Mg2+	ions,	
the	 catalysis	 is	 not	 changed	 considerably	 at	 all,	 hence	 illustrating	 a	 ‘trapped’	 complex	 (Fig.	
1.vii.b).	The	results	show	that	a	blocked	substrate	cannot	react	while	a	trapped	substrate	can.	
Therefore	 the	 DNA	 must	 thread	 through	 the	 arch	 during	 catalysis,	 which	 was	 subsequently	
confirmed	by	the	substrate	structure	of	hFEN1	(5UM9)29	and	T5	bacteriophage	FEN1	(5HNK).32	
Furthermore,	it	was	also	shown	that	a	short	5’	dsDNA	as	well	as	ssDNA	(gapped	substrate)	can	
also	 be	 threaded	 through	 the	 gateway	 and	 undergo	 catalysis.22,38	 In	 the	 crystal	 structure	 of	
product	or	substrate	however,	the	arch	presents	a	gap	too	small	for	dsDNA.	Therefore	the	arch	
was	 postulated	 to	 exist	 in	 an	 extended	 conformation,	 which	 must	 position	 the	 catalytic	
machinery	 in	 a	 state	 amenable	 for	 hydrolysis.	 Therefore	 the	 current	 hypothesis	 is	 that	 a	
disorder-to-order	transition	of	the	arch	must	occur	for	catalysis	to	happen.	
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Figure	1.vii.	Illustration	of	a	blocked	or	trapped	reaction	schematic.	Both	DNA	strands	contain	a	5’	biotin	
attachment,	which	the	streptavidin	 (orange	oval)	binds	 to.	 (A)	 Illustration	of	 the	sequence	of	a	blocked	
reaction.	First,	streptavidin	is	added	to	the	substrate	DNA	and	allowed	to	equilibrate.	Second,	the	protein	
along	with	catalytically	essential	Mg2+	 ions	are	added,	 the	result	 is	an	 inhibited	reaction,	as	 the	protein	
cannot	access	the	5’	end	of	the	substrate.	(B)	 Illustration	of	a	trapped	complex	reaction.	First	protein	is	
added	in	absence	of	Mg2+	 ions,	so	reaction	is	halted.	Second,	addition	of	the	streptavidin	allows	for	the	
protein	to	become	trapped	on	the	substrate,	confirmed	by	the	subsequent	addition	of	Mg2+	ions	allowing	
for	reaction	to	occur.	
	
The	 role	 of	 the	 α2-α3	 loop	 is	 less	 known,	 although	 it	 displays	 similar	 levels	 of	 structural	
heterogeneity	 in	 X-ray	 crystals.	 Unpublished	 results	 by	 Dr.	Mark	 Thompson	 show	 the	 loop	 is	
important	for	catalysis	however,	and	reactions	without	a	1nt	3’	flap	have	single-turnover	rates	
up	 to	1000-fold	 lower	 than	 the	double-flapped	 substrate.	Mutating	 the	 residue	R47,	which	 is	
said	to	mediate	contact	with	α5,	to	an	alanine	displays	single-turnover	rates	300-fold	lower	than	
the	wild	type	protein.	Furthermore,	the	structured	loop	present	in	3Q8K	fits	the	categorisation	
of	an	omega	loop	(Ω-loop).	Ω-loops	are	non-regular	secondary	structures	 involved	in	catalysis,	
folding	and	stability.39	Thus	it	could	be	very	likely	that	the	α2-α3	loop	mediates	the	binding	of	
the	3’	flap	and	hence	aids	folding	of	the	arch.	
	
1.3d DNA Dynamics 
Aside	 from	 the	 protein’s	 conformational	 change	 there	 are	 also	 conformational	 changes	
associated	with	the	DNA.	Förster	resonance	energy	transfer	(FRET)	analysis	with	a	donor	dye	on	
the	 downstream	 DNA	 and	 an	 acceptor	 on	 the	 upstream	 part	 of	 the	 DNA	 (Fig.	 1.viii.a)	 can	
illustrate	how	close	 the	 two	ends	of	 the	duplexes	are	 to	each	other.	An	assay	with	 increasing	
concentrations	of	hFEN1	can	illustrate	the	ability	of	hFEN1	to	bend	the	substrate.	It	was	shown	
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that	substrate	bending	happens	regardless	of	many	catalytic	mutations,	a	mismatch	at	 the	+1	
nucleotide	(relative	to	hydrolysis),	a	 lack	of	5’	flap	entirely	or	even	blocking	of	the	5’	flap	with	
streptavidin.28	This	shows	that	simply	having	a	nicked	structure	is	sufficient	for	hFEN1	to	bend	
the	DNA,	despite	some	modifications	or	mutants	having	drastically	reduced	rates.	
	
Further	analysis	using	single-molecule	FRET	assays	 illustrates	how	hFEN1	protein	can	 induce	a	
1nt	3’	flap.	This	has	lent	some	weight	to	an	induced	fit	model	of	DNA	bending.40	It	is	likely	to	be	
much	more	 complex	 than	 this,	 as	 the	 nicked	 substrate	 is	 documented	 to	 be	 able	 to	 exhibit	
extreme	flexibility	and	it	could	adopt	this	conformation	by	itself.41	For	now,	whether	the	protein	
induces	bending	by	binding	or	whether	 the	protein	 selects	a	 transient	bent	conformation	 is	a	
point	of	contention.	
	
Figure	 1.viii.	 Substrate	 DNA	 used	 to	 investigate	 DNA	 conformational	 changes.	 (A)	 Schematic	 of	 the	
substrate	used	in	the	bulk	FRET	assay	with	a	donor	dye,	fluorescein	(blue)	on	the	upstream	section	and	an	
acceptor	dye,	5-Carboxytetramethylrhodamine	(red)	on	the	downstream	section.	When	hFEN1	is	added	
to	the	DNA	it	bends	around	the	nick	and	brings	the	dyes	closer	together,	increasing	the	FRET	efficiency.	
(B)	 Schematics	 of	 ECCD	 substrates	 used,	 with	 tandem	 amino-purine	 bases	 marked	 in	 purple.	 The	
positioning	of	 the	bases	 (e.g,	 +1,	 -1	 and	 -2)	 are	 relative	 to	 the	 scissile	 bond	marked	with	 a	 red	 arrow.	
When	hFEN1	binds	it	causes	a	deformation	that	is	detectable	by	circular	dicrhoism	at	around	326	nm.	
	
	As	seen	from	the	DNA-bound	crystal	structures	(3Q8K	and	5UM9),	the	bend	in	the	DNA	causes	
the	5’	flap	to	protrude	into	the	active	site	region.	The	active	site	residues	position	themselves	
into	the	correct	orientation	to	perform	cleavage.	However,	the	dsDNA	still	needs	to	deform	in	
order	 to	 position	 the	 phosphate	 next	 to	 the	 active	 site.	 This	 deformation	 was	 visible	 using	
exciton-coupled	circular	dichroism	(ECCD).	By	placing	the	exciton	pairs	of	2-aminopurine	bases	
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next	to	each	other	(Fig.	1.viii.b),	it	was	possible	to	measure	deformations	in	the	structure	of	the	
5’	 reacting-strand,	which	 showed	whether	 the	 5’	 end	 of	 the	DNA	has	 twisted	 into	 the	 active	
site.28	 For	 the	 DNA,	 it	 must	 not	 be	 blocked	 by	 bulky	 groups,	 have	 no	mismatch	 and	 have	 a	
phosphate	on	the	5’	end.	For	the	protein,	certain	key	residues	must	be	present	(L130,	Y40,	D181	
and	R100)	and	it	must	have	divalent	cations	(Ca2+	in	this	case).	The	physical	manifestation	of	the	
inferred	conformational	change	is	not	known	but	has	been	postulated	to	involve:	DNA	twisting,	
deformation	 or	 double-nucleotide-unpairing,	 but	 it	 is	most	 likely	 twisting,	 as	 observed	 in	 the	
5UM9	crystal	 structure.29	Thus,	 the	process	 is	 likely	 involved	 in	substrate	specificity	as	well	as	
being	one	of	the	major	conformational	changes	that	influence	the	rate	of	catalysis.	
	
1.3e Kinetics 
	
Figure	1.ix.	The	proposed	reaction	pathway	of	hFEN1.	Each	step	has	a	rate	constant	associated	with	it,	
but	most	are	not	directly	measurable	 in	bulk,	 for	example	kchem.	 The	bracketed	values	displayed	above	
and	 below	 are	 macroscopic	 quantities	 that	 can	 be	 experimentally	 obtained	 by	 kinetic	 experiments.	
Therefore	 kcat/KM	 measures	 all	 micro-rates	 up	 to	 and	 including	 the	 first	 irreversible	 step	 (kchem).	 kcat	
measures	everything	after	substrate	binding,	and	finally	kst	measures	everything	after	binding	but	before	
release.	 The	 proposed	 conformational	 change	 rates	 (kCC	 and	 kRCC)	 could	 be	 due	 to	 many	 physical	
movements	and	 it	 is	 thought	that	 the	kst	 reflects	 the	rate	of	 this	conformational	change.	Adapted	from	
(Finger	et.	al.	2012).8	
	
A	further	look	at	kinetics	can	reveal	a	potential	link	between	single-turnover	rates	and	rates	of	
conformational	change.	The	proposed	model	for	the	catalytic	cycle	of	hFEN1	is	shown	in	figure	
1.ix.	Enzyme	(E)	binds	to	substrate	(S)	and	forms	an	enzyme	substrate	complex	(ES).	This	then	
has	to	undergo	a	conformational	change	to	become	chemistry	competent	(ES)’’,	at	which	point	
reaction	 occurs	 and	 the	 small	 5’	 flap	 product	 (P)	 is	 released,	 forming	 an	 enzyme	 product	
complex	 (EQ).	 The	 nicked	 DNA	 product	 (Q)	 then	 needs	 to	 be	 released	 in	 order	 for	 the	 free	
enzyme	to	be	ready	to	turnover	and	bind	more	(S).	There	has	been	a	wealth	of	kinetic	studies	
done	to	establish	which	of	these	processes	play	an	important	role.	
	
Firstly	the	catalytic	efficiency	(kcat/KM)	of	FEN1	is	close	to	the	bimolecular	diffusion	association	
rates	 in	 solution	 (kon)	 roughly	 of	 107-1010	M-1	 s-1.	 This	 suggests	 that	 under	 pseudo	 first-order	
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conditions	where	 substrate	 concentration	 is	 lower	 than	KM,	 the	 rate	of	 the	hFEN1	 reaction	 is	
diffusion	 limited.42	Under	 substrate-saturating	multiple-turnover	 conditions,	 the	maximal	 rate	
(kcat	=	3	s-1)	is	slower	than	the	respective	single-turnover	maximal	rate	(kSTmax	=	22	s-1),	suggesting	
that	product	release	(krelease)	is	the	rate-limiting	step	under	saturating	substrate	conditions.22	It	is	
interesting	to	note	that	product	release	and	diffusion	are	probably	minor	factors	at	the	 in	vivo	
replication	 fork,	 as	 hFEN1	 location	 is	 mediated	 by	 various	 controls	 such	 as	 the	 PCNA.25,43,44	
Therefore	the	kinetic	parameters	after	binding	and	before	product	release	are	 likely	 the	most	
biologically	 relevant.	 This	 means	 that	 the	 rate	 of	 conformational	 change	 after	 substrate	 is	
bound	is	likely	to	be	an	important	factor	in	the	catalytic	cycle.	
	
1.3f The Model So far 
Conformational	 changes	 within	 the	 protein	 and	 DNA	 are	 likely	 to	 be	 key	 factors	 in	 the	
biologically	relevant	catalysis	for	hFEN1.	They	are	also	expected	to	play	a	key	role	in	substrate	
recognition	 and	 hence	 aid	 specificity.	 There	 are	 various	 proposals	 as	 to	 what	 some	 of	 these	
conformational	changes	could	be:	
1) The	arch	going	from	a	disordered	to	an	ordered	conformation.	
2) The	DNA	bending.	
3) Placement	of	the	phosphodiester	in	the	active	site	(threading	and	positioning)	
4) 3’	Flap	engagement	
The	order	and	relative	speed	at	which	any	of	these	processes	happen,	or	even	what	the	physical	
manifestation	of	each	process	is	of	debate	at	the	moment.	From	FRET	experiments,	the	DNA	is	
likely	 to	 bend	 regardless	 of	 any	 other	 process.	 From	 the	 streptavadin	 trapped/blocked	
experiments,	 it	 is	 likely	 that	 the	5’	 flap	must	 thread	before,	 or	 at	 the	 same	 time	as,	 the	 arch	
orders	or	else	it	gets	blocked	from	entering	the	active	site.	Without	a	3’	flap	the	rate	of	reaction	
is	 reduced	 up	 to	 1000-fold,	 but	 it	 is	 difficult	 to	 explain	 this	 difference	 in	 rate	 based	 on	 its	
interaction	far	away	from	the	active	site.	It	is	still	unknown	how	fast	the	arch	is	moving	into	its	
ordered	state	and	how	fast	5’	DNA	placement	occurs.	It	is	also	a	mystery	what	changes	happen	
to	 residues	 in	 the	 rest	 of	 the	 protein	 and	 how	 fast	 they	 occur.	 Further	 information	 on	 these	
conformational	changes	 is	not	only	one	of	the	key	means	to	understanding	the	mechanism	of	
hFEN1,	 but	 it	 might	 explain	 its	 specificity	 towards	 its	 substrate.	 In	 order	 to	 ascertain	 what	
particular	residues	are	moving	and	how	fast,	a	probe	that	can	be	used	to	monitor	the	motions	
of	all	the	residues	in	the	protein	is	necessary.	
	
Chapter	1:	Introduction	
	18	
1.4 Measuring dynamics 
1.4a Types of dynamic motions in proteins 
	
Figure	 1.x.	A	 free	 energy	profile	 of	 a	 protein.	Bond	vibrations	and	more	 local	 flexibility	 (blue	box)	will	
have	 small,	 low	energy	 conformational	 changes,	which	occur	on	 the	ps-ns	 timescale.	A	 conformational	
change	 for	 regional	 protein	motions	 (e.g.	 open	 to	 closed	 transition)	 (red	 box)	will	 have	 a	much	 larger	
energy	barrier	that	takes	place	on	the	μs-ms	timescale.	
	
Proteins	 are	 in	 essence	 folded	 chains	of	 chiral	 amino	acids.	Many	 ‘weak’	 interactions	 such	 as	
hydrogen	 bonding,	 ionic	 interactions	 and	 hydrophobic	 forces	 hold	 them	 together.	 Therefore,	
proteins	are	not	static	molecules	in	solution;	they	are	constantly	sampling	many	conformations	
at	timescales	of	femtoseconds	to	hours.	A	potential	energy	profile	of	an	enzyme	is	not	a	simple	
curve;	it	is	a	complex	mixture	of	transiently	formed	states,	folded	to	unfolded,	or	conformation	
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A	 to	 conformation	 B	 (Fig.	 1.x).	 Slow	 dynamic	 changes	 can	 be	 interpreted	 as	 loop	 or	 domain	
movements	and	these	can	play	a	key	role	in	catalytic	turnover	or	protein	folding	events.45	There	
is	 also	 fast	 sampling	 of	 similar	 conformational	 changes	 on	 a	 bond	 vibrational	 timescale	 that	
allows	 for	 fast	 energy	 barrier	 crossing	 (Fig.	 1.x).46	 In	 this	 way	 the	 protein	 is	 sampling	 many	
states,	 some	of	which	are	non-productive	while	others	drive	 the	catalytic	 cycle	 forward.	Both	
fast	 and	 slow	 dynamics	 of	 proteins	 are	 therefore	 very	 important	 for	 catalysis	 as	 well	 as	
signaling,47	thermostability48	and	folding.49,50	
	
There	are	a	few	experimental	techniques,	as	well	as	computational	methods	that	can	be	utilised	
to	 ascertain	 the	 rates	 of	 protein	 dynamics.	 Single-molecule	 fluorescence,	 or	 FRET,	 involves	
labeling	a	donor	and	acceptor	site	on	a	protein	with	suitable	chromophores	and	measuring	the	
FRET	 efficiency	 or	 a	 fluorescence	 for	 a	 ‘reactive’	 or	 ‘unreactive’	 state.	 This	 is	 a	 powerful	
technique,	particularly	if	the	protein	can	be	easily	labeled	and	can	offer	very	fast	measurements	
in	the	microsecond	timescale.	Methods	 like	this	are	often	used	 in	tandem	with	computational	
molecular	 modeling	 for	 complex	 systems.	 Furthermore,	 computationally	 harder	 quantum	
modeling	 is	 used	 for	 situations	 of	 electron	 transfer.	 However,	 by	 far	 the	 most	 important	
technique	in	terms	of	versatility	and	analytical	power	is	NMR	spectroscopy.	
	
1.4b NMR Spectroscopy and protein dynamic measurements 
NMR	 spectroscopy	 can	 provide	 insights	 into	 a	 broad	 range	 of	 dynamic	 timescales.	 These	
methods	 can	 show	 protein	 structural	 changes	 related	 to	 side	 chain	 rotation,	 loop	 motion,	
molecular	tumbling,	overall	folding	and	domain	reorientation	of	the	protein.51	There	are	several	
ways	of	measuring	dynamics	between	 two	 states	using	NMR	observables	 (chemical	 shift,	 line	
width	 and	 intensity).	 These	 include	 line-shape	 analysis,	 exchange	 spectroscopy,	 relaxation	
dispersion	 techniques	 and	 real-time	NMR	 for	 slower	motions.51	NMR	approaches	 can	 also	 be	
used	 to	measure	 exchange	 between	 protein	 states	 by	 changing	 an	 external	 property	 such	 as	
temperature	 or	 pressure,	 or	 by	 titration	 of	 a	 substrate,	 product	 or	 co-factor.	 However,	 a	
powerful	method	to	 initially	 identify	residues	of	 interest	as	well	as	to	gain	a	representation	of	
the	 flexibility	of	all	 residues	within	a	protein	 is	nuclear	spin	relaxation	 (NSR),	and	 in	particular	
the	application	of	model-free	analysis.	
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Figure	1.xi.	Two	mechanisms	of	spin	relaxation.	(A)	R1,	longitudinal	or	spin-lattice	relaxation	is	where	the	
bulk	 spins	 transfer	 their	 energy	 to	 neighboring	 atoms,	 resulting	 in	 a	 re-equilibration	 to	 the	 Boltzmann	
distribution.	The	rate	at	which	this	happens	is	measured	as	R1.	(B)	R2,	transverse	or	spin-spin	relaxation.	
The	figure	shows	the	spins	of	one	proton	for	all	molecules	in	solution,	in	the	rotating	frame	of	reference.	
After	a	90°	pulse	into	the	X-Y	plane,	initially	all	spins	are	coherent.	However,	minute	differences	in	their	
rotations	compared	to	the	Larmor	 frequency	will	cause	them	to	 lose	coherence,	which	causes	a	 loss	of	
signal	in	the	X-Y	plane,	or	a	relaxation.	
	
NSR	 uses	 the	 site	 specific	 NMR	 spectroscopy	 observables:	 Longitudinal	 Relaxation	 (R1),	
Transverse	Relaxation	 (R2)	and	 the	Heteronuclear	Nuclear	Overhauser	Effect	 (hNOE).	R1	 is	 the	
rate	 at	which	 spins	 relax	 to	 the	 Boltzmann	 population	 of	 spin-up	 and	 spin-down	 states	 in	 an	
applied	Z-axis	magnetic	 field	B0	 (Fig.	 1.xi.a).	 The	value	of	R1	 can	 influence	 the	maximum	scan	
rate	 available	 for	 spectrum	 acquisition.	 R2	 is	 the	 rate	 of	 loss	 of	 coherence	 from	 spins	 in	 the	
rotating	X-Y	reference	frame	(Fig.	1.xi.b)	and	results	in	line-broadening	in	NMR	spectra.	For	R1,	
the	 spins	 can	 only	 make	 an	 energy	 transition	 via	 interactions	 between	 fluctuating	 magnetic	
dipoles	at	the	Larmor	precession	frequency.	R1	and	R2	relaxation	rates	are	very	slow	compared	
to	 the	much	 faster	 flexibilities	of	bonds.	Nevertheless,	 it	 is	possible	 to	 link	 the	 relatively	 slow	
millisecond	−	 second	 (ms-s)	 relaxation	 rates	of	R1	 and	R2	 to	picosecond	−	nanosecond	 (ps-ns)	
dynamics	of	a	backbone	N-H	bond.	
	
The	speed	of	molecular	tumbling	affects	the	proportion	of	the	lattice	that	is	available	to	receive	
energy	 from	 nuclear	 spins.	 For	 large	 proteins	 which	 have	 slow	 molecular	 tumbling,	 a	 low	
proportion	 of	 the	 lattice	 is	 available	 and	 consequently	 R1	 is	 slow.	 Conversely,	 small	 proteins	
have	much	 faster	molecular	 tumbling	and	R1	 is	 fast.	R2	 is	more	 complex,	 as	 slower	molecular	
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motions	 such	 as	 chemical	 exchange	 further	 enhance	 R2,	 so	 for	 macromolecules,	 R2	 is	 fast.	
Chemical	 exchange	 is	 the	 process	 by	 which	 one	 atom	 moves	 to	 another	 chemically	 distinct	
state,	with	 the	 resultant	 loss	of	 coherence.	This	 rate	of	exchange	 (Rex)	 can	 reveal	more	about	
the	 slower	 domain	 movements	 in	 proteins.	 Overall,	 the	 tumbling	 of	 the	 molecule	 therefore	
affects	 relaxation	 process	 of	 the	whole	molecule.	However,	 bond	 flexibility	 also	 changes	 spin	
relaxation	through	two	major	mechanisms:	nuclear	dipole-dipole	interactions	and	chemical	shift	
anisotropy.	
	
	
Figure	1.xii.	 The	main	 two	mechanisms	 that	 link	bond	 flexibility	with	R1	 and	R2.	 (A)	Two	nuclear	spin	
dipoles	are	aligned	in	a	magnetic	field.	When	one	moves	relative	to	the	other,	it	creates	its	own	magnetic	
field	 and	 will	 aid	 the	 relaxation	 of	 its	 dipole	 partner.	 The	 efficiency	 of	 relaxation	 enhancement	 is	
dependent	on	r-6	and	the	gyromagnetic	ratio	of	the	nuclei.	(B)	Two	nuclei	are	shown	with	spherical	(left)	
and	ellipsoidal	 (right)	electronic	orbitals.	When	both	are	subjected	to	an	outside	magnetic	field	(B0)	the	
effective	 magnetic	 field	 observed	 (Beff)	 is	 affected	 by	 the	 shielding	 of	 the	 electrons	 in	 the	 orbitals.	
Electron	 density	 in	 molecules	 is	 almost	 never	 symmetrical,	 hence	 when	 nuclei	 move	 relative	 to	 one	
another	 there	 is	 a	 change	 in	 the	 Beff.	 This	 gives	 rise	 to	 an	 anisotropy	 in	 the	 chemical	 shifts,	 which	
fluctuates	with	fast	bond	flexibility	enhancing	relaxation	mechanisms.	
	
1. Dipolar	Coupling	(DC)	(Fig.	1.xii.a)	is	the	through-space	interaction	between	two	nuclei	
and	 their	magnetic	 dipoles.	 The	 distance	 and	 orientation	 of	 the	 dipoles	 in	 space	will	
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change	 with	 the	 molecular	 vibrations	 and	 rotations	 and	 hence	 create	 a	 fluctuating	
magnetic	 field	 in	 relation	 to	 B0,	 which	 will	 in	 turn	 enhance	 the	 relaxation	 rates.	 The	
strength	of	the	dipole	and	the	distance	between	the	nuclei	will	affect	this	mechanism,	
with	 distance	 being	 r-6	 dependent	 and	 the	 strength	 being	 depending	 on	 the	
gyromagnetic	ratio	of	the	nuclei	involved,	hence	protons	one	bond	away	are	by	far	the	
most	efficient	relaxation	enhancers.	
2. Chemical	 Shift	Anisotropy	 (CSA)	 (Fig.	 1.xii.b)	arises	because	chemical	 shielding	of	 the	
nucleus	by	its	electrons	is	dependent	on	its	orientation	with	respect	to	the	applied	field	
B0.	CSA	also	affects	relaxation	rates,	because	as	the	molecule	tumbles	slowly	or	a	bond	
vector	rotates	at	ps-ns	times,	the	electronic	orbitals	create	a	fluctuating	local	magnetic	
field	for	every	nucleus	with	respect	to	B0,	which	will	change	the	relaxation	rates.	
	
	
Figure	 1.xiii.	Quantum	mechanism	 of	 the	 heteronuclear	 NOE	 (hNOE).	 Energy	 levels	 indicate	 the	 four	
combinations	(αα,	αβ,	βα	and	ββ)	which	can	be	occupied	by	two	nuclear	spins.	Blue	dots	indicate	relative	
populations	 in	each	 level	and	 the	 I	and	S	 labels	 indicate	which	nuclei	are	undergoing	a	single	quantum	
transition,	either	I	or	S.	The	relative	‘signal’	output	is	measured	as	the	difference	in	populations	between	
S	single	quantum	states.	Upon	saturating	I,	the	populations	of	I	single	quantum	transitions	are	equalised.	
During	this	time	there	is	a	probability	of	spins	relaxing	by	either	single	quantum	transition	(WI	or	WS),	or	
by	 double	 (W2),	 or	 by	 zero	 (W0)	 quantum	 transitions.	 If	 W0	 dominates,	 then	 the	 I	 transition	 is	 less	
numerous	than	before	and	therefore	a	reduction	in	signal	is	observed	(in	this	case	a	reduction	of	4	to	2).	
	
Finally,	 the	 hNOE	 is	 the	 transfer	 of	magnetisation	 via	 dipolar	 coupling	 in	 free	 space	 between	
different	nuclei,	typically	1H	with	either	13C	or	15N	nuclei.	The	hNOE	is	another	effect	induced	by	
quantum	 nuclear	 spin.	 It	 too	 depends	 on	 macromolecular	 molecular	 motion	 and	 the	 fast	
motions	of	bonds.	Consider	the	energy	states	of	two	 I	=	1/2	nuclei	 I	and	S	 in	a	magnetic	field,	
there	 are	 4	 possibilities	 of	 α	 and	 β	 states	 (αα,	 αβ,	 βα	 and	 ββ)	 the	 transitions	 of	 which	 are	
related	to	the	gyromagnetic	ratio	of	each	nuclei	(Fig.	1.xiii).	If	nuclei	I	was	saturated,	the	normal	
single	quantum	transitions	of	I	would	be	equalized	and	no	relaxation	would	take	place.	However	
what	happens	 is	either	a	double	quantum	(flip-flip)	or	a	zero	quantum	(flip-flop)	 relaxation	of	
both	spins,	the	probability	of	each	one	(W2	or	W0)	determining	whether	an	overall	loss	(W0)	or	
gain	(W2)	in	signal	occurs.	In	large,	slow	macromolecules	the	probability	W0	dominates	and	the	
degree	 of	W0	 compared	 to	W2	 depends	 on	 the	 speed	 at	 which	 the	 spin	 pair	 are	 rotating	 in	
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solution.	Thus,	the	hNOE	provides	yet	another	way	of	linking	an	observable	measurement	to	the	
dynamics	of	the	system.	
	
1.4c Model Free Analysis 
Once	R1,	R2	and	hNOE	measurements	have	been	obtained,	they	are	then	linked	mathematically	
to	 the	 motions	 of	 the	 molecule	 by	 a	 correlation	 function	 or	 C(t).	 This	 is	 a	 common	 way	 of	
analysing	motions	of	macromolecules	tumbling	or	even	bonds	vibrating	randomly	in	a	protein.	
The	function	gives	a	representation	of	the	time	 it	 takes	for	the	orientation	of	the	molecule	or	
bond	 vector	 to	 become	 randomised.	 For	 an	 ensemble	 measurement	 of	 one	 bond	 for	 many	
proteins	 in	 solution,	 the	 C(t)	 is	 assumed	 to	 be	 an	 exponential,	 with	 the	 time	 constant,	 or	
correlation	 time	 (τC)	 being	 approximately	 the	 time	 it	 takes	 a	bond	 to	 rotate	by	one	 radian.	A	
Fourier	 transformation	 of	 C(t)	 produces	 a	 Lorentzian	 distribution	 called	 a	 spectral	 density	
function	 J(ω),	 showing	 the	 proportion	 of	 time	 a	 bond	 is	 moving	 at	 a	 frequency	 (ω).	 This	
effectively	 informs	what	 proportion	 of	 spins	 in	 an	 ensemble	 are	moving	 close	 to	 the	 Larmor	
frequency,	and	hence	how	fast	they	relax.	
	
Figure	1.xiv.	The	principle	of	Model-Free	analysis,	and	the	link	between	fast	bond	motions	and	the	S2	
parameter.	A	 cartoon	 representation	of	a	protein	 tumbling	 in	 solution	 (left),	with	a	 correlation	 time	 τC	
illustrating	the	time	for	the	protein	to	tumble	by	roughly	one	radian	and	can	be	interpreted	well	by	R1	and	
R2.	According	to	model-free	analysis	the	very	fast	motion	of	a	single	N-H	bond	is	completely	independent	
to	the	tumbling	of	the	molecule.	These	fast	motions	will	enhance	the	NMR	observables	R1	R2	and	hNOE	
by	changing	the	spectral	density	function.	Thus,	when	modeled	by	model-free	formalism	there	will	be	a	
difference	between	an	effective	correlation	time	(τe)	and	the	rotational	correlation	time	of	the	molecule	
(τC).	The	right	chart	shows	S
2	values,	and	how	much	the	bond	is	tumbling	in	line	with	the	overall	motions	
of	the	molecule	(high	S2)	or	vice	versa.		
	
The	R1,	R2	 and	hNOE	values	 can	be	used	 to	 calculate	 the	 spectral	density	 function	and	hence	
quantify	 τC.	 Using	 the	model	 free	 approach,	 it	 is	 possible	 to	 deconvolute	 the	 contribution	 to	
relaxation	 from	 molecular	 tumbling	 (τC),	 and	 from	 much	 faster	 bond	 motions.	 The	 analysis	
models	J(ω)	as	a	combination	of	τC	and	an	effective	correlation	time,	τe	for	fast	internal	motions.	
Model	 free	 analysis	 assumes	 that	 the	 motions	 of	 individual	 residues	 are	 much	 faster	 and	
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independent	 of	 the	much	 slower	molecular	 tumbling	 of	 the	 protein.	 It	 also	 has	 (as	 its	 name	
suggests)	no	model	for	the	motions;	 it	simply	quantifies	the	motions	present.	The	most	useful	
parameter	 that	 is	obtained	 from	the	model	 is	 the	S2	or	order	parameter,	which	 takes	a	value	
between	1	and	0	 (Fig.	 1.xiv).	A	 residue	with	a	perfect	match	of	 τe	with	 the	τC	 shows	absolute	
rigidity,	and	has	an	S2	value	of	1.	Conversely,	a	residue	with	significantly	different	values	for	τe	
and	τC	shows	absolute	flexibility,	and	has	an	S2	value	of	0.	Order	parameters	are	not	a	rate,	and	
confusingly	are	not	related	to	entropy.	They	have	no	units;	they	simply	give	a	general	number	
for	the	ps-ns	timescale	motions	around	each	residue.	Although	S2	cannot	be	compared	to	actual	
rates,	the	value	is	still	incredibly	useful.	It	has	been	shown	empirically	that	for	backbone	amide	
15N	sites,	rigid	structures	like	α-helices	and	β-sheets	have	S2	values	≥	0.8,	whereas	flexible	loops,	
turns	and	termini	have	S2	values	between	0.5	and	0.8.52	
	
1.4d Exchange and Relaxation Dispersion. 
The	order	parameter	provides	a	good	indication	whether	a	residue	is	more	flexible	than	others	
or	 more	 flexible	 than	 its	 environment	 would	 suggest,	 and	 can	 be	 used	 to	 direct	 further	
experiments	that	can	quantify	rates	of	exchange	(kex).	Consider	a	nucleus	exchanging	between	
two	 states,	where	 the	 chemical	 shift	 of	 each	 state	 is	 different.	 If	kex	 is	much	 slower	 than	 the	
difference	in	chemical	shift	(Δδ	in	Hz),	then	two	distinct	peaks	are	present	with	peak	intensities	
reflecting	the	relative	population	of	each	state,	this	is	known	as	slow	exchange.	Conversely,	if	kex	
is	much	 faster	 than	 Δδ,	 the	 spectrum	will	 display	 an	 average	 chemical	 shift	 at	 the	 weighted	
average	of	populations	between	the	two	exchanging	states;	this	is	known	as	fast	exchange.	As	
the	 kex	 approaches	 equality	 with	 Δδ,	 the	 peak	 broadens	 out,	 usually	 disappearing	 into	 the	
baseline;	 this	 is	 known	as	 intermediate	 exchange.	As	mentioned	above,	 the	mechanism	of	R2	
relaxation	 can	 be	 significantly	 affected	 by	 exchange	 broadening,	 and	 several	 methods	 have	
been	designed	to	determine	the	added	effect	of	exchange	on	R2.	
	
One	method	 is	 to	 deploy	Relaxation	Dispersion	 (RD)	 experiments	 that	measure	 the	 exchange	
rates	 (kex)	 between	 two	 different	 transiently	 populated	 states	 PA	 and	 PB,	 where	 the	 minor	
species	PB	has	a	population	of	1-10	%.	There	are	two	widely	used	methods,	the	first	being	Carr-
Purcell	 Meiboom-Gill	 Relaxation	 Dispersion	 (CPMG	 RD).	 This	 is	 used	 to	 quantify	
intermediate/fast	exchange	processes	in	the	0.3-10	ms	time	range.53	This	timescale	is	relevant	
to	 a	 lot	 of	 domain	 motions	 and	 secondary	 structure	 changes	 within	 proteins;	 these	 can	
influence	 ligand	 binding	 or	 release	 and	 hence	 in	 some	 cases	 catalytic	 turnover	 (See	 section	
1.5d:	 RNase	A).	 Any	R2	 relaxation	 combined	with	 an	 exchange	process	 (Rex)	will	 decrease	 the	
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signal	 received	 at	 acquisition	 since,	 R2obv	 =	 R20	 +	 Rex.	 In	 brief,	 the	 CPMG	 pulse	 sequence	
refocuses	all	 spins	 irrespective	of	chemical	 shift	by	using	a	 spin-echo	 τ-180-x-τ	pulse	sequence	
(Fig.	 1.xv).	 In	 a	 series	 of	 2D	 experiments	 with	 different	 values	 of	 τ,	 the	 contribution	 of	 the	
exchange	 process	 on	 R2	 relaxation	 is	 decreased	 by	 shortening	 the	 τ	 period	 between	 pulses	
(equal	to	an	increase	in	CPMG	pulse	frequency	or	νCPMG).	The	increase	in	νCPMG	means	that	there	
is	 less	 time	 for	 an	 exchange	 event	 to	 occur	 during	 the	 spin-echo	 pulse	 sequence;	 hence	 the	
observed	R2	relaxation	 is	 less	affected	by	the	exchange	process.	The	observed	effective	R2eff	 is	
plotted	versus	νCPMG	and	by	using	fitting	models	a	range	of	parameters	describing	the	exchange	
process	can	be	derived	from	the	dispersion	profiles	(kex,	|Δδ|,	PA	and	R20).	
	
	
Figure	1.xv.	The	spin	echo	pulse	sequence	for	CPMG.	The	τ-180-x,-τ	refocuses	the	magnetisation	back	to	
+x	irrespective	of	chemical	shift.	Even	though	the	chemical	shifts	of	A	and	B	are	different	and	hence	they	
evolve	with	different	times	in	τ,	the	fact	that	they	have	been	‘mirrored’	with	the	180	pulse	should	refocus	
them	 to	 the	 same	 point	 after	 another	 τ	 time	 period.	 The	 only	 reason	 the	 signal	 at	 x	 after	 this	 pulse	
sequence	 would	 be	 less	 than	 expected	 is	 due	 to	 an	 exchange	 process	 happening,	 thus	 changing	 the	
chemical	shift	 in	one	τ	period	but	not	 in	the	other	resulting	in	a	 loss	of	signal	coherence.	Adapted	from	
(Kleckner	and	Foster	2011).51	
	
A	second	method	used	to	derive	information	from	exchange	processes	is	the	rotating	frame	RD	
(RT	 RD),	 which	 is	 applied	 to	 faster	 exchange	 events	 with	 timescales	 of	 around	 20-100	 μs	
occurring	in	the	intermediate	exchange	regime.	In	this	method,	the	magnetisation	is	‘locked’	in	
place	by	a	radio	frequency	soft	pulse	at	a	tilted	angle	to	the	magnetic	field	B0;	the	relaxation	is	a	
combination	of	R1	and	R2	relaxation	rates,	designated	R1ρ.54	If	exchange	processes	are	occurring,	
the	 nucleus	 spends	 more	 time	 in	 different	 chemical	 shift	 environments	 during	 the	 spin-lock	
period	resulting	in	a	faster	relaxation	or	a	larger	R1ρ.	By	increasing	the	effective	field	strength	of	
the	spin-lock	pulse	it	is	possible	to	reduce	the	frequency	that	an	exchange	event	can	take	place.	
The	 remaining	analysis	 is	 very	 similar	 to	 that	of	CPMG	RD,	with	R2eff	 being	plotted	versus	 the	
effective	 field	 strength	 to	 determine	 the	 timescale	 of	 the	 exchange	 process	 (kex)	 by	 a	
subsequent	model	fitting.	
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RD	 is	 a	powerful	 technique	 that	 allows	analysis	of	 exchange	processes	 taking	place	at	 a	wide	
variety	 of	 timescales.	 NSR	 and	 the	 subsequent	 model	 free	 analysis	 are	 equally	 powerful,	
allowing	 for	 an	 overview	 of	 flexibility	 in	 proteins.	 Both	 these	 approaches	 allow	 for	 dynamic	
measurements	at	residue	resolution.	The	information	gained	can	shed	light	on	the	dynamics	of	
protein	 systems,	 which	 have	 implications	 for	 understanding	 their	 catalytic	 mechanism.	
Presented	 below	 is	 the	 NMR	 spectroscopic	 work	 done	 on	 hFEN1	 prior	 to	my	work,	 and	 two	
examples	 of	 proteins	 that	 have	 been	 extensively	 studied	 using	 NMR	 spectroscopy,	 which	
highlight	some	of	the	strengths	and	weaknesses	of	the	NMR	techniques.	The	information	from	
the	examples	will	be	applied	to	novel	studies	involving	hFEN1.	
	
1.5 Studies using NMR spectroscopy on hFEN1 and case studies of NMR 
techniques applied to dynamic proteins. 
1.5a Protein stability and spectral quality optimisation of the hFEN1 protein 
The	hFEN1	protein	without	the	extended	C-terminus	is	around	38	kDa.	Experiments	done	by	Dr.	
David	 Finger	 have	 shown	 that	 trying	 to	 keep	 it	 soluble	 above	 concentrations	 of	 100	 μM	 is	
difficult	 at	 room	 temperature.	The	problem	with	 collecting	viable	NMR	spectroscopic	data	on	
the	protein	is	therefore	is	twofold.	First,	the	large	molecular	weight	causes	a	fast	R2	relaxation	
rate,	meaning	less	information	is	gathered	per	FID,	resulting	in	a	decrease	in	the	signal-to-noise	
ratio	 (S:N)	and	an	 increase	 in	signal	broadening.	Second,	 the	protein	precipitates	during	pulse	
sequences	 causing	 the	 uniformity	 of	 the	 sample	 to	 deteriorate	 thus	 ruining	 any	 magnet	
shimming	and	causing	large	linewidths	on	peaks.	
	
To	 solve	 the	 first	 problem	of	 large	molecular	weight,	 a	 specific	NMR	 technique	 can	 be	 used:	
Transverse	 Relaxation-Optimised	 SpectroscopY	 (TROSY).	 The	 TROSY	 pulse	 sequence	 was	 first	
reported	 20	 years	 ago	 and	was	 shown	 to	 decrease	 the	 line	width	 of	 signals	 dramatically.55	 It	
works	by	 relying	on	 the	destructive	 interference	 caused	by	CSA	and	dipole-dipole	 coupling	 in	
one	of	the	four	components	in	the	signals	of	a	heteronuclear	correlation	spectrum.	Rather	than	
using	decoupling	methods	to	merge	all	four	components	into	one,	¾	of	the	signal	is	sacrificed	in	
order	 to	 use	 the	 very	 slowly	 relaxing	 doubly	 destructive	 peak	 only	 (Fig.	 1.xvi).	 This	 results	 in	
very	 sharp	 peaks,	 which	 in	 this	 case	 the	 signal	 lost	 is	 overcome	 by	 the	 reduction	 of	 line	
broadening.	With	the	TROSY	pulse	program	it	is	possible	to	achieve	meaningful	results	on	larger	
biomacromolecules	 (>	28	kDa).	For	hFEN1	this	 is	 ideal	and	the	 initial	experiments	done	by	Dr.	
David	Finger	reported	TROSY	pulse	sequences	improving	spectral	quality	significantly.	
Chapter	1:	Introduction	
	 27	
	
Figure	 1.xvi.	 Transverse	 Optimised	 SpectroscopY	 (TROSY)	 spectra	 (A)	 The	 decoupled	 heteronuclear	
correlation	spectrum	for	one	system,	there	is	only	one	broad	peak.	(B)	The	four	components	associated	
with	 the	 four	 transitions	of	 the	heteronuclear	 correlation,	 the	bottom	 right	peak	being	 the	destructive	
coherent	peak	and	the	top	left	being	the	constructive	coherent	peak.	(C)	The	TROSY	spectra.		The	other	
three	 peaks	 are	 silenced	 from	 the	 spectra,	 leaving	 only	 the	 much	 sharper	 doubly	 destructive	 peak,	
although	much	 less	 signal	 is	obtained	 the	sharpness	of	 the	peak	allows	 for	a	much	greater	S:N.	 	Taken	
from	the	patent	for	TROSY	by	Pervushin	et.	al.56	
	
The	second	issue	of	the	protein,	precipitation,	proved	far	more	problematic.	A	range	of	sample	
conditions	was	experimented	by	Dr.	Finger	to	improve	protein	stability.	The	initial	conditions	for	
a	15N-labelled	hFEN1	protein	sample	were:	50	mM	sodium	phosphate,	1	mM	DTT	and	0.1	mM	
EDTA.	Temperature,	pH,	mono-	and	di-valent	 ion	concentrations	were	screened	for	conditions	
that	 afforded	 an	 optimal	 1H-15N	 TROSY	 spectrum.	 Although	 hFEN1	 was	 initially	 stable	 when	
concentrated	to	500	μM	 in	 the	phosphate	buffer,	protein	precipitation	was	observed	after	12	
hours	at	4	°C	and	could	not	be	prevented	until	the	solution	was	below	100	μM.	Therefore	the	
aim	was	to	screen	for	sample	conditions	that	afforded	optimal	spectra	while	minimizing	protein	
precipitation.	 It	was	 found	 the	 temperature	 that	gave	 the	best	 spectrum	with	minimal	 loss	of	
protein	due	to	precipitation	was	25	°C;	lower	temperatures	presented	broader	peaks	likely	due	
to	 slower	 molecular	 tumbling,	 whereas	 temperatures	 above	 25	 °C	 greatly	 expedited	 protein	
precipitation.	The	solution	pH	was	adjusted	between	6.0	to	8.5.	Lowering	the	pH	resulted	in	an	
increase	 in	 peak	 broadening,	 sample	 turbidity	 and	 increased	 precipitation.	 This	 was	 not	
surprising	as	the	theoretical	pI	of	the	hFEN1	construct	is	pH	6.0.	Although	pH	8.5	resulted	in	the	
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slowest	rate	of	precipitation,	the	number	of	observable	peaks	was	decreased	considerably	due	
to	 the	 increased	 rate	 of	 amide	 proton	 exchange.	 Thus,	 pH	 7.5	 was	 deemed	 optimal	 as	 it	
provided	the	most	number	of	peaks	and	a	moderate	rate	of	precipitation.		
	
1.5b Assignment of hFEN1 protein 
The	 first	 step	 towards	 analysing	 backbone	 dynamics	 is	 to	 assign	 as	many	 amide	moieties	 as	
possible	in	a	protein.	The	conditions	described	above	were	suitable	for	an	assignment	of	triply	
labeled	protein	with	 15N,	 13C	and	 2H.	Dr.	David	Finger	and	Dr.	Andrea	Hounslow	employed	six	
TROSY	 triple-resonance	 experiments:	 HNCO,	 HNCA,	 HNCACB,	 HN(CA)CO,	 HN(CO)CA	 and	
HN(CO)CACB.	Each	experiment	transfers	magnetisation	from	the	amide	proton	to	the	nitrogen,	
and	then	to	a	specific	carbon	on	the	peptide	chain,	and	then	transfers	it	back	to	the	proton	for	
detection	(Fig.	 1.xvii).	Therefore	chemical	shifts	of	Cα,	Cβ	or	CO	are	obtained	and	they	are	all	
correlated	to	a	specific	amide.	The	assignment	data	was	processed	on	the	analysis	software	felix	
and	 was	 confirmed	 using	 the	 asstools	 assignment	 program.57	 The	 hFEN1	 protein	 assignment	
was	 able	 to	map	 chemical	 shifts	 of	 backbone	 amides	 for	 70%	 of	 all	 theoretically	 observable	
backbone	 N-H	 groups	 (uploaded	 to	 the	 BioMagResBank	 under	 the	 BMRB	 accession	 code	
27160).	The	assignment	was	lacking	in	regions	of	interest,	for	example	at	the	bottom	of	α4	and	
residues	known	to	be	in	the	active	site	(Fig.	1.xviii).		
	
	
Figure	 1.xvii.	 A	 resonance	 transfer	 diagram	 for	 Cα	 atoms.	 Arrows	 represent	 resonance	 transfer;	 the	
reverse	 resonance	 transfer	 for	detection	goes	 in	 the	opposite	direction.	The	directed	experiment	 (Red,	
HN(CO)CA)	first	directs	the	magnetisation	to	i-1’s	carbonyl	carbon	(C’)	and	then	subsequently	to	the	i-1’s	
Cα,	hence	triple	resonance	only	happens	for	the	previous	carbon.	The	undirected	(Blue,	HNCA)	directs	the	
magnetisation	to	Cα	straight	away,	there	is	a	major	peak	present	at	i’s	Cα,	and	a	minor	peak	sometimes	
present	at	i-1’s	peak.	
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Figure	1.xviii.	Cartoon	representation	of	the	hFEN1	molecule	to	illustrate	location	of	assigned	backbone	
amides.	(A)	A	cartoon	showing	the	3Q8K	structure	with	important	regions	highlighted,	the	arch	(red),	the	
α2-α3	loop	(blue),	the	saddle	region	(orange	saddle),	the	positions	of	the	two	catalytic	metal	ions,	i.e.	the	
active	site	(black	spheres)	and	the	potassium	ion	in	the	H2tH	motif	(purple	sphere).	(B)	The	assigned	(red)	
and	unassigned	(grey)	residues	are	coloured	onto	the	product	crystal	structure	3Q8K.	Only	residues	with	
chemical	shifts	assigned	to	a	backbone	amide	are	considered	assigned.	Secondary	structure	elements	are	
labeled	for	clarity.	
	
1.5c Protein stability optimisation of buffer, monovalent and divalent salt conditions 
The	 protein	 in	 its	 current	 state	 was	 not	 soluble	 for	 long	 timescales.	 Therefore,	 differing	
conditions	 of	 buffer,	 monovalent	 salts	 and	 divalent	 salts	 were	 screened	 for.	 Dr.	 Finger	
experimented	with	different	buffer	molecules	(Tris,	HEPES,	potassium	phosphate),	but	they	did	
not	make	 a	 noticeable	 difference	 to	 the	NMR	 spectra.	 Therefore	HEPES	was	 used	 for	 further	
experiments,	as	 its	pKa	was	closest	 to	 the	optimal	pH	of	 the	protein	 (pH	7.5).	Because	hFEN1	
requires	 divalent	 metal	 ions	 (Mg2+)	 for	 catalysis,	 Mg2+	 was	 added	 to	 the	 protein	 sample	 to	
investigate	 changes	 in	 the	 spectrum.	 Small	 changes	 were	 observed	 in	 the	 spectra	 at	
concentrations	 of	 8	 mM	 MgCl2	 (Fig.	 1.xix).	 Most	 notably	 changes	 were	 observed	 in	 the	 N-
terminus	of	the	protein,	which	is	consistent	with	the	N-terminus	of	hFEN1	pointing	towards	the	
active	 site.	 Other	 chemical	 shift	 differences	 were	 noted	 in	 residues	 next	 to	 active	 site	
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carboxylates	(for	example	S157	and	L190).	Furthermore,	other	diamagnetic	multi-valent	cations	
(Ca2+,	 Zn2+	 and	 Lu3+)	 were	 also	 tried.	 Ca2+	 afforded	 spectra	 similar	 to	 the	 Mg2+	 (Fig.	 1.xix),	
whereas	Zn2+	resulted	in	precipitation	and	Lu3+	resulted	in	poor	linewidths.	The	crystal	structure	
of	hFEN1	in	complex	with	DNA	(3Q8K)	shows	that	in	addition	to	divalent	cation	ion	binding	sites,	
the	protein	also	has	a	potassium	 ion	binding	site.	Titration	of	KCl	 into	the	solution	resulted	 in	
minor	improvements	in	the	spectra	with	76	mM	resulting	in	the	optimal	spectrum.	The	addition	
of	mono-	and	di-valent	cations	did	not	prevent	the	slow	precipitation.	
	
	
Figure	1.xix.	 1H-15N	TROSY	spectrum	of	hFEN1	with	different	divalent	cations	added.	hFEN1	protein	in	
0.1	mM	EDTA	(grey),	8	mM	CaCl2	(blue)	and	8	mM	MgCl2	(cyan).	Some	dispersed	residues	are	labeled,	of	
particular	 note	 are	 4Q	 and	 5G,	 which	 change	 chemical	 shifts	 upon	 addition	 of	 Mg2+	 ions,	 and	 show	
chemical	shift	differences	between	Ca2+	ions	or	Mg2+	ions.	Some	peaks	are	missing	due	to	poor	linewidths	
in	non-perdeuterated	samples.	Only	the	EDTA	spectrum	is	from	perdeuterated	sample.	
	
The	 hFEN1	 construct	 and	 its	 sample	 conditions	 set	 up	 by	 Dr.	 Finger	 are	 suitable	 for	 an	
assignment	 of	 hFEN1.	 However	 the	 longer	 timescales	 needed	 for	 NMR	 relaxation	
measurements	 means	 that	 sample	 stability	 has	 to	 be	 solved	 before	 moving	 onto	 these	
experiments.	 However,	 the	 two	 examples	 below	 highlight	 what	 sort	 of	 analyses	 could	 be	
performed	upon	protein	systems	that	are	soluble	for	extended	periods.		
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1.5d Example 1. Ribonuclease A: The model dynamic protein system. 
Pancreatic	ribonuclease,	or	RNase	A	has	around	300	X-ray	crystallographic,	neutron	diffraction	
and	NMR	resolved	structures	present	in	the	Protein	Data	Bank	due	to	its	high	stability	and	ease	
of	 purification.	 RNase	 A	 activity	 and	 catalytic	 cycle	 have	 also	 been	 studied	 in	 great	 detail,	
making	 it	an	excellent	case	study	of	 the	use	of	NMR	dynamics.58	 In	 terms	of	activity,	RNase	A	
catalyses	transesterification	and	then	hydrolysis	of	RNA	without	any	metal	ions	or	cofactors.	It	
has	 been	 shown	 that	 the	 enzyme	has	 a	 shallow	 ‘U’	 shape	with	 the	 active	 site	 of	 the	 enzyme	
lying	in	the	middle	of	the	cleft	(Fig.	1.xx).	Key	residues	in	the	active	site	include	H12	and	H119,	
which	act	as	general	bases	and	K41,	which	acts	as	a	general	acid.	All	 these	play	an	 important	
role	 in	 the	catalytic	 step	by	using	general	acid-base	catalysis	 to	hydrolyse	 the	phosphodiester	
bond.	
	
	
Figure	1.xx.	X-ray	crystal	structure	of	RNase	A	(5RSA).59	The	overall	structure	of	the	protein	is	seen	as	a	
‘U’	 shape	 with	 a	 wedge	 in	 the	 middle,	 where	 the	 substrate	 would	 pass	 through.	 This	 crystal	 has	 a	
phosphate	present	in	the	active	site.	Active	site	bases	H12	and	H119	are	present	in	blue,	while	the	active	
site	acid	K41	is	seen	in	red.	H48	is	far	away	from	the	active	site	(around	18	Å).	
	
Kinetic	experiments	showed	that	product	release	is	the	rate-limiting	step	in	catalysis,	with	a	kcat	
of	around	1700	s-1.	Furthermore,	the	second-order	rate	constants	approach	the	value	expected	
for	 diffusion.	 So	 the	 motion	 of	 the	 protein	 and	 the	 conformational	 change	 could	 have	
something	 to	 do	 with	 catalytic	 function.60	 Various	 NMR	 and	 X-ray	 structures	 showed	 that	
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residues	in	the	active	site	sampled	different	conformers,	in	particular	H119,	and	it	was	thought	
that	 when	 a	 ligand	 was	 bound	 it	 initiated	 this	 conformational	 change.	 However,	 it	 was	
subsequently	 reported	 that	 the	 apo-enzyme	was	 apparently	 in	 a	 constant	 shift	 between	 two	
distinct	states	-	A	and	B	-	confirmed	by	other	NOE-based	structural	studies.61,62	Examination	by	
model	free	analysis	showed	that	certain	key	active	site	residues	were	in	fact	moving	at	a	ms-to-
μs	 timescale,	 hence	 showing	 inherent	 flexibility	 in	 these	 residues.63	 To	 quantify	 the	 rate	 of	
exchange,	CPMG	RD	NMR	experiments	showed	that	the	16	quantifiable	residues	were	moving	
on	average	Rex	1640	s-1.	 Interestingly	this	rate	 is	almost	 identical	to	the	catalytic	turnover	rate	
(kcat)	and	that	of	product	release	(koff)	as	measured	by	line	shape	analysis.64	It	was	implied	that	
these	dynamics	played	a	 role	 in	product	 release	and	 therefore	 the	catalytic	 cycle,	but	 further	
studies	with	unreactive	ligand	substitutes	revealed	more	information.	
	
The	 result	of	 looking	at	enzyme	 (E),	unreactive	enzyme	substrate	 (ES)	and	unreactive	enzyme	
product	 (EP)	 (Fig.	 1.xxi)	 complexes	 is	 that,	 while	 binding	 with	 the	 substrate	 or	 product	 the	
structure	of	the	enzyme	changes	subtly.	The	main	structural	difference	is	seen	for	H119,	which	
changes	 conformation	 from	 being	 hydrogen	 bonded	 to	 D121	 in	 the	 ES	 complex	 to	 solvent	
exposed	 in	 the	EP	complex.	 These	 structures	were	 time-averaged	 structures	by	 solution	 state	
NMR	and	X-ray	crystallography,	which	would	suggest	that	there	is	some	kind	of	conformational	
change	occurring.	In	order	to	ascertain	the	dynamics	between	these	lowly	populated	transient	
states	additional	RD	NMR	was	undertaken	on	these	complexes.64	It	was	found	that	there	is	no	
change	between	the	dynamics	of	the	protein	 in	E,	ES	or	EP.	This	means	that	the	dynamics	are	
independent	of	 ligand.	 Furthermore	 the	 states	 are	being	 sampled	at	 a	 rate	equivalent	 to	kcat,	
which	 implies	 strongly	 that	 the	 enzyme	 motion	 is	 linked	 to	 the	 catalytic	 turnover.	 This	
information,	 coupled	 with	 the	 X-ray	 structures	 indicates	 that	 RNase	 A	 will	 open	 up	 bind	 a	
substrate	and	release	a	product	all	on	the	timescale	of	this	exchange	process.	
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Figure	 1.xxi.	 RNase	 A	 structures	 with	 product	 or	 substrate	 bound.	 Highlighted	 residues	 from	 each	
structure	show	the	main	differences	between	the	substrate	bound	 (ES)	 (1U1B,	magenta)64	and	product	
bound	(EP)	(1RPF,	cyan)65	structures.	The	product	analogue	used	was	a	3’	cytidine	monophosphate,	while	
the	substrate	analogue	was	an	adenine	pyrophosphate	thiamine	dinucleotide	(pTppAp).	H119	shows	the	
greatest	difference	when	bound	to	the	substrate,	forming	a	hydrogen	bond	with	D121	indicating	a	subtle	
change	in	structure.	
	
In	addition	to	 the	many	analyses	described	above,	mutagenesis	experiments	were	carried	out	
on	the	protein	to	link	catalytic	rates	with	koff	values	as	determined	by	NMR.	Residues	mutated	in	
the	 active	 site	were	 found	 to	 increase	 the	 koff	 values	 of	 the	 product	 considerably	which	was	
again	 linked	with	a	decrease	 in	 catalytic	 turnover.66	H48,	which	 is	a	highly	 conserved	 residue,	
was	mutated	 to	 an	 alanine	 and	 a	 subsequent	 decrease	 in	motion	 and	 kcat	 values	 was	 noted	
despite	it	being	18	Å	away	from	the	active	site	(Fig.	1.xx).67	H48	clearly	has	some	kind	of	link	to	
the	speed	of	opening	and	closing	of	the	enzyme	suggesting	an	allosteric	effect	present.	
	
Overall	 in	this	example	the	NMR	dynamic	measurements	proved	not	to	be	a	definitive	tool	to	
infer	 catalytic	 activity	when	 used	 on	 their	 own.	 Rather	 NMR	was	 used	 in	 conjunction	with	 a	
plethora	 of	 biochemical	 and	 biophysical	 methods	 in	 order	 to	 provide	 new	 insights	 into	 the	
function	of	the	protein.	Not	only	were	conformational	exchange	rates	acquired	for	the	opening	
and	 shutting	 of	 RNase	 A	 but	 also	 exchange	 rates	 for	 individual	 residues	were	 obtained.	 This	
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allowed	a	great	deal	of	insight	to	be	gained	in	the	catalytic	cycle	of	the	protein,	including	if	any	
allosteric	effects	were	present.	
	
1.5e Example 2. Triosephosphate Isomerase (TIM): A large molecular weight example. 
In	 some	 regards	 RNase	 A	 can	 be	 seen	 as	 an	 ideal	 case	 study	 for	 NMR	 and	 biochemical	
techniques	coming	together	to	ascertain	catalytic	activity.	As	mentioned	before,	the	protein	 is	
small,	very	stable	and	easy	to	produce	and	purify,	which	is	ideal	for	solution	NMR	experiments.	
NMR	experiments	designed	 to	probe	dynamics	 are	 typically	 run	 for	extended	 time	periods	at	
room	temperature	with	relatively	high	concentrations	of	protein	(0.1	to	1	mM)	and	with	a	total	
of	about	500	μL	of	sample	required.	This	 is	unsuitable	for	the	main	protein	of	 interest	hFEN1,	
which	in	its	current	state	is	not	very	soluble	over	extended	timescales.	The	second	example,	the	
53	 KDa	 protein	 Triosephosphate	 isomerase	 (TIM)	 will	 highlight	 how	 larger	 proteins	 can	 be	
optimised.	
	
Because	 of	 its	 size,	 TIM	 has	 a	 very	 large	 rotational	 correlation	 time	 of	 30	 ns	 at	 293	 K.45	 The	
protein	 is	 therefore	 a	 good	example	of	 how	TROSY	pulse	 sequences	 can	be	used	 to	measure	
relaxation	properties.	TROSY	also	allows	unique	relaxation	experiments,	which	can	be	applied	to	
the	TIM	enzyme,	in	particular	the	off-resonance	R1ρ	experiment,	which	can	be	used	to	observe	
very	 fast	motions	up	 to	 rates	of	105	s-1.68,69	TIM	 is	 the	enzyme	responsible	 for	 isomerising	 the	
two	 products	 of	 aldolase	 in	 glycolysis,	 D-glyceraldehyde	 3-phosphate	 (GAP)	 and	
dihydroxyacetone	 phosphate	 (DHAP).70	 Since	 only	 GAP	 can	 continue	 along	 the	 glycolytic	
pathway	it	is	essential	for	DHAP	to	be	isomerised	to	GAP	in	order	for	100%	of	the	energy	from	
one	glucose	molecule	to	be	obtained.	The	activity	of	TIM	is	linked	heavily	to	a	Ω-loop	structure	
(loop	6)	present	near	the	active	site	(Fig.	1.xxii.a).39	The	loop	can	move	between	an	open	and	
closed	conformation	 (Fig.	 1.xxii.b,c).	 Looking	at	various	structures	and	computational	models,	
when	 in	 the	 open	 state,	 the	 substrate	 is	 free	 to	 bind	 and	 the	 product	 is	 free	 to	 dissociate.70	
When	the	loop	is	in	the	closed	state,	it	conveniently	borders	the	active	site	allowing	for	catalysis	
to	 occur.71,72	 Furthermore	 a	 key	 residue	 in	 catalysis	 (E165)	 has	 been	 found	 to	 be	 aligned	
perfectly	 for	 catalysis	 in	 the	 closed	 conformation.73	 The	motion	 between	 these	 two	 states	 is	
what	 is	 thought	 to	 provide	 the	 catalytic	 activity	 to	 the	 protein.74	 So	 studying	 the	 dynamics	
between	the	two	states	should	provide	a	good	insight	into	the	catalytic	rate.	
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Figure	1.xxii.	Illustration	of	the	dynamics	of	an	Ω-loop	in	and	out	of	the	active	site.	A)	The	full	structure	
of	the	TIM	dimer,	with	loops	and	active-site	residues	colour	labeled.		The	important	loop	is	loop	6,	which	
can	be	seen	to	move	in	and	out	of	the	active	site	in	the	free	B)	enzyme	and	the	substrate	bound	enzyme	
C),	indicating	conformational	changes	in	this	region	of	the	protein.		These	changes	have	clear	implications	
on	catalysis	as	the	labeled	key	residues	G171,	E165	are	placed	into	the	active	site	upon	substrate	binding.		
Diagram	taken	from	(Kempf	et.	al.	2007).75	
	
The	 closed	 state	 is	 stabilised	 by	 many	 hydrogen	 bonds	 between	 residues	 in	 loop	 6	 and	
neighboring	 loop	7.	One	such	 interaction	 thought	 to	be	 important	 is	 the	hydrogen	bond	 from	
the	amide	of	A176	and	the	Oη	of	Y208.	When	Y208	is	mutated	to	a	hydrophobic	phenylalanine	it	
results	in	a	2400-times	decrease	in	activity	(kcat/KM),	suggesting	that	having	a	H-bond	stabilised	
closed	 state	 impacts	 on	 catalytic	 efficiency.76	 NMR	 R1ρ	 RD	 experiments	 were	 done	 on	 WT	
protein	 residues	 in	 loop	6	 and	 an	 exchange	 time	of	 roughly	 100	μs	 (or	 a	Rex	 of	 8900	 s-1)	was	
observed.77	Motions	 in	the	C	and	N-termini	were	found	to	be	very	similar,	suggesting	a	global	
motion.	 In	 the	 mutant	 Y208F,	 the	 same	 R1ρ	 experiments	 were	 carried	 out,	 and	 site-specific	
information	was	gathered	on	the	dynamics	in	the	loop.	Interestingly	the	exchange	rate	of	the	N-
terminus	of	the	loop	in	Y208F	is	very	similar	to	that	of	the	WT	protein	(around	10	000	s-1).	The	
main	 difference	 is	 in	 the	 C-terminus	 which	 has	 flat	 relaxation	 curves,	 suggesting	 that	 the	
population	of	the	open	state	is	stabilised	so	much	that	no	exchange,	and	therefore	no	dynamics	
are	occuring.	The	NMR	data	shows	that	one	side	of	the	loop	is	disrupted	more	than	the	other	by	
the	loss	of	the	one	hydrogen	bond.		
	
1.6 Measurement of potential dynamics of hFEN1 
1.6a Application of NMR relaxation experiments to the hFEN1 protein system 
	
As	 is	shown	in	the	examples,	NMR	methods	can	be	applied	to	 larger	proteins,	and	to	motions	
which	are	on	the	timescale	of	1	ms	to	100	μs.	Crucially	with	NMR	experiments,	they	are	amino	
acid	residue	specific,	allowing	a	great	deal	of	information	to	be	gathered	on	one	protein	system.	
Using	NMR	measurements	to	assess	dynamics	with	hFEN1,	what	questions	can	be	addressed?	In	
hFEN1	the	proposed	model	shows	that	a	slow	conformational	process	plays	an	important	part	
in	 catalysis	 and	 potentially	 allows	 for	 specificity	 for	 the	 ideal	 substrate.	 This	 conformational	
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change	could	be	attributed	to	a	variety	of	structural	changes	both	for	the	protein	and	the	DNA	
molecule.	In	the	protein,	the	arch	becomes	ordered	or	structured	around	the	5’	flap,	and	the	3’	
flap-binding	 pocket	 engages	 with	 a	 1nt	 flap.	 In	 the	 DNA,	 there	 is	 bending	 at	 the	 nick	 and	
positioning	of	the	5’	flap	into	the	active	site.	There	is	speculation	to	how	all	these	processes	act	
to	perform	catalysis	and	at	what	rate	they	all	happen.	
	
NMR	 relaxation	 measurements	 and	 subsequent	 model-free	 analysis	 can	 ascertain	 S2	
parameters.	This	will	reveal	unusually	fast-moving	residues	within	hFEN1	and	can	direct	further	
dynamic	studies.	This	would	be	applicable	to	the	arch	region,	as	X-ray	crystallography	snapshots	
have	 shown	 that	 the	 arch	 exhibits	 a	 wide	 variety	 of	 conformations	 in	 the	 absence	 of	 DNA.	
Therefore	 ascertaining	 the	 true	 dynamic	 properties	 of	 the	 arch	 in	 solution,	 as	 well	 as	 other	
regions	 such	 as	 the	 3’	 flap-binding	 pocket	would	 confirm	how	 flexible	 these	 regions	 are.	 The	
model-free	analysis	should	also	highlight	any	hitherto	unknown	regions	of	flexibility.	Finally,	the	
analysis	 can	 also	 be	 applied	 to	 the	DNA,	 allowing	 for	 very	 fast	 (ns-ps)	 flexibilities	 in	 a	 nicked	
substrate	to	be	ascertained,	to	see	if	the	DNA	exhibits	fast	sampling	of	a	bent	conformation.	
	
Model-free	 analysis	 can	 also	 yield	 Rex	 terms,	 which	 indicate	 slow	 millisecond	 timescales	 of	
motion.	A	more	thorough	analysis	using	RD	through	CPMG	or	R1ρ	would	allow	for	a	classification	
of	these	slow	motions,	and	equally	would	be	applicable	to	the	arch.	If	the	arch	has	to	undergo	a	
conformational	change	when	bound	to	substrate,	it	would	be	interesting	to	know	if	the	arch	is	
already	sampling	this	conformation	in	the	absence	of	substrate,	like	in	the	example	of	RNase	A.	
Or,	 equally	 likely,	 whether	 the	 arch	 simply	 adopts	 this	 closed	 conformation	 when	 bound	 to	
DNA.	RD	analysis	could	also	reveal	other	residues	moving	at	similar	timescales	highlighting	slow	
flexibilities	 in	 other	 parts	 of	 the	 protein,	 with	 potential	 allosteric	 effects,	 like	 in	 the	 3’	 flap-
binding	pocket	or	further	afield	in	the	H2tH	motif.	
	
The	dynamics	of	 residues	 can	also	be	 analysed	 for	 substrate	 and	product	 complexes.	As	with	
RNase	A,	the	presence	of	a	substrate/product	might	not	change	the	dynamics	of	the	underlying	
conformational	change	associated	with	catalysis.	Or	perhaps	there	will	be	a	change	in	dynamics,	
as	 in	 the	 example	 with	 TIM,	 with	 implications	 for	 catalysis.	 Furthermore	 other	 essential	 co-
factors	 for	 the	 enzyme	might	 change	 dynamics	 or	 conformation	 upon	 binding.	 For	 example,	
divalent	cations,	such	as	Mg2+	and	Ca2+	play	an	important	role	in	the	conformational	change	of	
the	 DNA	 as	 seen	 from	 ECCD	 studies,	 and	 in	 the	 complete	 absence	 of	 these	 ions	 there	 is	 no	
hydrolysis.	As	has	already	been	seen	in	1H-15N	TROSY	spectra,	the	presence	of	these	ions	does	
perturb	the	structure	of	the	protein,	but	not	significantly.	Therefore	it	would	be	interesting	to	
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see	if	these	ions	have	an	effect	on	the	architecture	and	mobility	of	the	protein	in	the	presence	
and	absence	of	a	DNA	substrate.	
	
1.6b Aims and hypothesis 
Overall,	 the	 first	 aim	 of	 the	 study	 would	 be	 to	 confirm	 by	 biochemical	 kinetic	 studies	 the	
conformational	change	as	the	main	rate-limiting	factor	in	single-turnover	rates.	Next	would	be	
to	quantify	 the	 flexibility	of	all	backbone	amides	of	hFEN1,	 to	highlight	 regions	of	 interest.	Of	
particular	 interest	would	be	 to	 know	 the	 flexibility	of	 the	3’	binding-pocket	 and	 the	arch	 in	 a	
solution	 state,	 for	 free	 enzyme,	 for	 a	 bound	 enzyme-substrate/product	 complex	 and	with	 or	
without	divalent	cations.	Furthermore,	if	exchange	rates	can	be	ascertained	for	certain	residues	
that	match	up	to	a	biochemical	rate	constant	(in	hFEN1’s	case,	the	single	turnover	rate	kST)	then	
a	rate-limiting	conformational	change	can	be	invoked.	In	this	way	not	only	can	a	conformational	
change	be	confirmed	or	disproved,	but	the	site(s)	of	motion	can	also	be	elucidated.	
	
The	 conformational	 change	 can	 be	 categorized	 into	 two	 archetypical	 mechanisms:	
conformational	selection,	and	induced	fit.	In	a	conformational	selection	model,	the	protein	(or	
substrate)	already	exhibits	all	 the	conformations	necessary	 to	achieve	catalysis	 (i.e.	RNase	A).	
Whereas	the	induced	fit	model	proposes	that	the	substrate	induces	the	protein	to	adapt	a	new	
conformation	by	binding	in	the	correct	way.	If	the	types	of	motion	and	the	degree	of	motion	can	
be	 quantified	 by	 NMR	 spectroscopy,	 it	 would	 help	 decide	 whether	 the	 protein	 displays	
conformational	 selection	 or	 induced	 fit.	 This,	 potentially	 could	 help	 discern	 how	 the	 protein	
selects	a	preferred	DNA	structure.	The	hypothesis	is	that,	(i)	the	rate	of	conformational	change	
occurs	 on	 a	 timescale	 relevant	 to	 the	 single	 turnover	 rate	 (kST).	 Therefore	 the	 NMR	 dynamic	
measurements	will	quantify	and	locate	the	region	at	which	this	conformational	change	occurs,	
(ii)	that	the	conformational	change	occurs	only	when	the	correct	substrate	is	presented,	which	
thereby	provides	hFEN1	its	specificity.	
Chapter	2:	Materials	and	Methods	
	38	
Chapter 2: Materials and Methods 
2.1 Protein expression and purification 
2.1a Buffers 
All	 buffers	 used	 in	 expression	 and	 purification	 of	 the	 protein	 are	 listed	 in	 bold	 and	 their	
composition	is	listed	in	Table	1.	
	
Buffer	Name	 Composition	
LB	Agar	(1	L)	 10	 g	 Tryptone,	 10	 g	NaCl,	 10	 g	 Yeast	 Extract,	
10	g	Agarose	
SOC	Media	(1	L)	 20	 g	 Tryptone,	 0.5	 g	 NaCl,	 5	 g	 Yeast	 Extract,	
0.19	g	KCl,	0.95	g	MgCl2,	3.6	g	D-Glucose	
2×YT	(1	L)	 16	g	Tryptone,	5	g	NaCl,	10	g	Yeast	Extract	
TB	(1	L)	 12	g	Tryptone,	24	g	Yeast	Extract,	9.4	g	K2HPO4	
and	2.2	g	KH2PO4	pH	7.2	
15N-M9	Autoinduction	Media	 50	mM	Na2HPO4	 and	 50	mM	 KH2PO4	 pH	 7.5,	
50	mM	15NH4Cl,	5	mM	Na2SO4,	2	mM	MgSO4,	
0.5%	 glycerol,	 0.05%	 D-glucose,	 0.2%	 α-
lactose,	 12×BME	 vitamins	 (USBiological	
B0110),	1×Trace	Metals	(Teknova	1000x	Trace	
Metals	T1001)	
15N,2H,13C-M9	Minimal	Media	 50	mM	Na2HPO4	 and	 25	mM	 KH2PO4	 pH	 7.5,	
18	mM	15NH4Cl,	1%	13C6,2H7-D-glucose	 (U-13C6,	
99%;	1,2,3,4,5,6,6-d7	97-98%),	0.2	mM	CaCl2,	5	
mM	MgSO4,	10	mM	NaCl,	0.25×BME	vitamins	
(USBiological	 B0110),	 0.25×Trace	 Metals	
(Teknova	1000x	Trace	Metals	T1001)	
PBS	 10	 mM	 Na2HPO4	 and	 2	 mM	 KH2PO4	 pH	 7.4,	
137	mM	NaCl,	2.7	mM	KCl	
Buffer	A	(IMAC	and	Lysis	buffer)	 20	 mM	 Tris-HCl	 pH	 7.4,	 1	 M	 NaCl,	 5	 mM	
imidazole,	5	mM	βME	
Buffer	B	(IMAC)	 25	 mM	 Tris-HCl	 pH	 7.4,	 0.5	 M	 NaCl,	 40	 mM	
imidazole,	0.01%	Tween-20,	5	mM	βME	
Buffer	C	(IMAC)	 250	mM	imidazole	pH	7.2,	0.5	M	NaCl,	5	mM	
βME	
Bufer	D	(Anion	Exchange)	 20	mM	 Tris-HCl	 pH	 7.4,	 1	mM	 EDTA,	 20	mM	
βME	
Buffer	E	(Heparin)	 25	mM	 Tris-HCl	 pH	 7.5,	 1	mM	 CaCl2,	 20	mM	
βME	
Storage	Buffer	(after	glycerol	addition)	 100	 μM	 hFEN1,	 50	 mM	 HEPES-KOH	 pH	 7.5,	
100	mM	KCl,	0.5	mM	EDTA,	5	mM	DTT,	0.02%	
NaN3	(50%	glycerol)	
Table	1.	Media	and	Buffers	for	Expression	and	Purification.	Antibiotics	for	growth	media	were	all	added	
when	required	and	are	mentioned	in	the	text.	
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2.1b Protein Transformation into Escherichia coli (E. coli) cells. 
Human	 flap	 endonuclease	 protein	 (hFEN1-336)	 was	 expressed	 from	 a	 pET29b-hFEN1-336	
plasmid	 construct	 with	 kanamycin	 and	 chloramphenicol	 resistance,	 made	 previously	 by	 Dr.	
Brian	Chapados.27	The	plasmid	encoded	hFEN1-336	protein	and	contained	a	human	rhinovirus	
(HRV)	type-14	3C	protease-cleavable	(His)6-tag	located	at	the	C-terminus	of	the	protein.	It	also	
contained	a	lac-operon	promoter	to	control	expression.	From	now	on	this	construct	and	protein	
will	both	be	referred	to	as	hFEN1.	Dr.	David	Finger	prepared	the	hFEN1	mutants,	Y40A,	P188A,	
K93A,	 C163T,	 C182T,	 C235T	 and	 C311T	 by	 site-directed	 mutagenesis	 of	 the	 pET29b-hFEN1	
vector	 using	 the	 Stratagene	 quick	 change	 kit.	 The	 chosen	 expression	 vector	was	 transformed	
into	Escherichia	coli	BL21(DE3)-RILP	cells.	The	cells	were	thawed	on	ice,	and	approximately	100	
ng	of	vector	was	added	to	50	μL	of	cells.	The	cells	were	incubated	on	ice	for	45	minutes	before	
being	heat-shocked	at	42	°C	 for	90	seconds	and	subsequently	quenched	on	 ice	 for	5	minutes.	
The	transformed	cells	were	rescued	by	addition	of	800	μL	of	SOC	media	and	incubated	at	37	°C	
for	one	hour.	The	cells	were	pelleted,	the	supernatant	removed	and	resuspended	in	250	μL	of	
SOC	 media.	 The	 cells	 were	 then	 spread	 onto	 LB	 agar	 plates	 supplemented	 with	 50	 μg.mL-1	
kanamycin	and	34	μg.mL-1	 chloramphenicol,	and	 then	subsequently	 incubated	 for	18	hours	at	
37	°C.	
	
2.1c Protein expression for kinetic analyses. 
Natural	 abundance	 hFEN1	 and	 for	 hFEN1Y40A	 were	 expressed	 previously	 in	 terrific	 broth	 (TB)	
containing	 25	 μg.mL-1	 kanamycin	 and	 34	 μg.mL-1	 chloramphenicol	 and	 induced	 by	 an	 IPTG	
methodology.27	
	
2.1d 15N-labelled Protein expression for 1H-15N HSQC experiments. 
15N-labelled	protein	was	expressed	using	15N-M9	autoinduction	media	with	added	400	μg.mL-1	
kanamycin	and	34	μg.mL-1	chloramphenicol.78	A	single	colony	was	added	to	5	mL	of	2×YT	media	
with	25	μg.mL-1	kanamycin	and	34	μg.mL-1	chloramphenicol	and	shaken	overnight	at	37	°C.	0.5	
mL	of	the	starter	culture	was	used	to	inoculate	a	flask	with	50	mL	of	2×YT	media	with	the	same	
concentrations	of	antibiotics.	This	was	subsequently	grown	overnight	at	37	°C.	An	appropriate	
amount	 of	 the	 50	 mL	 2×YT	 culture	 was	 taken	 and	 added	 to	 2	 L	 (4	 ×	 500	 mL)	 of	 15N-M9	
autoinduction	 media	 with	 the	 same	 concentrations	 of	 antibiotics,	 in	 order	 to	 bring	 the	 A600	
down	 to	0.05	 in	each	 flask,	 and	 this	was	 incubated	at	 37	 °C.	After	 2-4	hours	or	until	 the	A600	
reached	 0.5	 the	 incubation	 temperature	 was	 reduced	 to	 18	 °C,	 and	 the	 cells	 expressed	 by	
autoinduction	overnight.	
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2.1e 15N,13C,2H-triple-labelled Protein expression for assignment and relaxation 
experiments. 
2H,13C,15N-labelled	 protein	 was	 prepared	 using	 a	 high	 cell-density	 procedure	 in	 combination	
with	 isopropyl-β-D-thiogalatopyranoside	 (IPTG)	 induction.79	 A	 single	 colony	 was	 chosen	 to	
inoculate	5	mL	of	50	%	D2O	2×YT	media	supplemented	with	25	μg.mL-1	kanamycin	and	34	μg.mL-
1	 chloramphenicol	 (all	 2×YT	 media	 were	 grown	with	 these	 concentrations	 of	 antibiotics)	 and	
grown	 for	 24	hours	 at	 37	 °C.	A	 100-fold	 dilution	of	 this	 saturated	50%	D2O	2×YT	 culture	was	
then	used	to	 inoculate	50	mL	of	2×YT	media	 in	100%	D2O	to	allow	the	cells	 to	acclimatise	 for	
growth.	This	was	subsequently	grown	for	another	24	hours	at	37	°C.	This	50	mL	starter	culture	
was	then	added	to	a	500	mL	100	%	D2O	2×YT	flask	and	grown	for	24	hours	or	until	a	A600	of	5.0	
was	reached.	At	this	point,	the	culture	was	pelleted	by	ultracentrifugation	(6000×g	at	4	°C	for	30	
min)	and	the	supernatant	was	discarded.	The	pellet	was	resuspended	 in	500	mL	of	 15N,2H,13C-
M9	minimal	media	with	400	μg.mL-1	kanamycin	and	34	μg.mL-1	chloramphenicol,	and	grown	for	
2	 hours	 more	 at	 37	 °C	 to	 clear	 unlabeled	 metabolites.	 Subsequently	 IPTG	 to	 a	 final	
concentration	of	0.1	mM	was	added,	 the	 temperature	was	 reduced	 to	18	 °C,	 and	 the	 culture	
was	grown	for	a	further	72	hours	until	A600	=	10-13.	
	
2H,15N-labelled	protein	was	prepared	analogously	except	that	the	1%	13C6,2H7-D-glucose	(U-13C6,	
99%;	1,2,3,4,5,6,6-d7	97-98%)	was	replaced	with	1%	2H7-D-glucose	(1,2,3,4,5,6,6-d7	97-98%).	
	
2.1f Cell harvesting and lysing 
In	all	cases	after	growth,	cells	were	harvested	by	centrifugation	(6000×g	at	4	°C	for	15	min)	and	
the	supernatant	was	removed.	The	cell	pellet	was	resuspended	in	ice-cold	phosphate	buffered	
saline	 (PBS),	where	 the	volume	added	was	 roughly	1:10	of	PBS	 to	cell	 culture.	The	cells	were	
pelleted	again	 at	 6000×g	at	 4	 °C	 for	 15	minutes	 and	 the	 supernatant	was	 removed.	 The	 cells	
were	then	resuspended	 in	the	same	volume	of	 Buffer	A	containing	an	additional,	0.1	mg.mL-1	
lysozyme	 and	 one	 EDTA-free	 protease	 inhibitor	 cocktail	 tablet	 (Sigma	 S8830).	 Cells	 were	
incubated	on	ice	for	at	least	1	hour	and	were	frozen	at	−20	°C	until	required.	
	
2.1g Protein Purification 
To	prepare	the	cell	lysate	for	purification,	the	suspensions	were	thawed	in	cold	water.	The	cells	
were	 then	 sonicated	 (Sonics	 Vibra-Cell	 VCX	 130)	 on	 ice	 at	 75	 %	 intensity	 for	 60	 cycles	 of	
pulsation	 for	 5	 seconds	 with	 30	 second	 cooling	 intervals.	 To	 each	 lysate	 5	 mL	 of	 Buffer	 A	
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containing	 1	 %	 v/v	 Tween-20	 was	 added	 and	 the	 insoluble	 cell	 debris	 was	 removed	 by	
ultracentrifugation	(40,000×g	at	4	°C	for	30	min).	
All	 purification	 buffers	 were	 filtered	 and	 degassed	 prior	 to	 use	 and	 an	 ÄKTA	 pure	
chromatography	 system	 (GE	 Healthcare	 Life	 Sciences)	 was	 used	 for	 all	 column	 purification	
steps.	 The	 supernatant	 was	 applied	 to	 four	 columns	 in	 tandem	 (each	 one	 ID	 =	 1.6	 cm,	 bed	
volume	=	5	mL)	containing	Chelating	Sepharose	6	Fast	Flow	agarose	beads	(GE	Healthcare	Life	
Sciences)	 that	 had	 been	 previously	 charged	 with	 Co2+	 ions	 according	 to	 the	 manufacturer's	
protocol	and	pre-equilibrated	with	 five	column	volumes	of	Buffer	A.	The	column	was	washed	
with	five	column	volumes	of	Buffer	A	and	five	column	volumes	of	Buffer	B.	The	bound	hFEN1	
protein	was	eluted	with	eight	column	volumes	of	Buffer	C.	Fractions	containing	hFEN1	protein	
were	 identified	 by	 sodium	 dodecyl	 sulphate-polyacrylamide	 gel	 electrophoresis	 (SDS-PAGE),	
pooled	and	immediately	diluted	with	an	equal	volume	of	Buffer	D,	which	was	then	applied	to	a	
5-mL	HiTrap	Q	HP	 column	 (bed	 volume	=	5	mL,	GE	Healthcare	 Life	 Sciences)	 pre-equilibrated	
with	 the	 Buffer	 D.	 hFEN1	 protein	 was	 found	 in	 the	 flow	 through,	 whereas	 nucleic	 acid	
contamination	 was	 retained	 by	 the	 column	 which	 was	 eluted	 using	 ten	 column	 volumes	 of	
Buffer	D	containing	a	linear	gradient	of	0	to	1	M	NaCl.	The	amount	of	hFEN1	protein	in	the	flow	
through	was	estimated	by	measuring	the	absorbance	at	280	nm	(ε280	=	22,920	M-1.cm-1)80	using	
a	UV-Vis	NanoDrop	spectrophotometer	(ThermoFisher	Scientific).	Two	units	of	Turbo3C	(HRV3C	
protease)	(BioVision)	were	added	for	every	mg	of	protein,	and	the	mixture	was	allowed	to	stand	
overnight	at	4	 °C	 to	catalyse	cleavage	of	 the	 (His)6-tag	 from	the	hFEN1	protein.	The	extent	of	
affinity	 tag	 removal	was	 assessed	by	 SDS-PAGE,	 and	 the	 solution	was	 diluted	 further	with	 an	
equal	 volume	 of	 Buffer	 E.	 The	 hFEN1	 protein	 solution	 was	 then	 applied	 to	 a	 20-mL	 HiPrep	
Heparin	 FF	 16/10	 column	 (ID	 =	 1.6	 cm,	 length	 =	 10	 cm,	 GE	 Healthcare	 Life	 Sciences)	 pre-
equilibrated	 with	 two	 column	 volumes	 of	 Buffer	 E	 and	 eluted	 using	 15	 column	 volumes	 of	
Buffer	E	containing	a	linear	gradient	of	0	to	1	M	NaCl	(hFEN1	protein	eluted	at	350	mM	NaCl).	
Fractions	containing	hFEN1	protein	were	pooled	and	concentrated	to	less	than	10	mL	using	an	
Amicon	 Ultrafiltration	 cell	 with	 a	 10-kDa	 MWCO	 polyethersulphone	 (PES)	 membrane	
(MerckMillipore)	 pressurised	 using	 nitrogen	 gas.	 The	 protein	 was	 exchanged	 into	 the	
appropriate	buffer	 (Table	7)	using	a	53-mL	HiPrep	26/10	desalting	column	(GE	Healthcare	Life	
Sciences).	The	hFEN1	protein	concentration	was	determined	using	the	absorbance	at	280	nm	as	
described	above.	Unlabelled	samples	for	kinetic	measurements	were	exchanged	into	2×Storage	
Buffer,	and	adjusted	to	a	concentration	of	200	μM.	An	equal	volume	of	glycerol	was	added	to	
each	 sample	 to	 allow	optimal	 storage	 conditions.	 Samples	were	 stored	at	 −20	 °C.	 Isotopically	
labelled	 hFEN1	 protein	 samples	 were	 exchanged	 into	 the	 appropriate	 NMR	 buffer	 and	
concentrated	to	0.5	mM	using	a	Vivaspin	20	(10	kDa	MWCO)	concentrator	(4000×g	at	4	°C).	
Chapter	2:	Materials	and	Methods	
	42	
	
2.2 Kinetic studies of natural abundance hFEN1 and hFEN1Y40A 
2.2a Substrate design 
All	 substrates	 for	 kinetic	 studies	 were	 ordered,	 synthesised	 using	 standard	 phosphoramidite	
chemistry	 and	 purified	 using	 reverse-phase	 high	 performance	 liquid	 chromatorgraphy	 (HPLC)	
from	 LGC	 Biosearch	 Technologies	 (Risskov,	 Denmark).	 Two	 single-stranded	 oligonucleotides	
were	prepared	to	make	the	substrate	construct	S1-X.	Each	strand,	F1-X	and	T1	were	quantified	
by	 the	 Beer-Lambert	 law	 using	 a	 calculated	 extinction	 coefficient	 at	 260	 nm	 using	 a	 UV-Vis	
NanoDrop	 spectrophotometer	 (ThermoFisher	 Scientific)	 (Table	 2).	 The	 calculated	 ε260	 value	
was	obtained	using	the	nearest	neighbor	method	on	the	Integrated	DNA	Technologies	website	
(https://www.idtdna.com/calc/analyzer).81	S1-X	was	prepared	by	heating	the	two	strands	F1-X	
and	T1	at	a	ratio	of	1:1.1	at	95	°C	for	5	minutes	in	10	mM	HEPES-KOH	pH	7.5,	6	mM	KCl,	4	mM	
NaN3	and	0.1	mM	EDTA.	The	solution	was	subsequently	left	to	anneal	at	room	temperature.	F1-
X	 contains	 a	 5’	 terminal	 fluorescein	 (FAM)	 phosphoramidite	 for	 subsequent	 fluorescence	
detection.	The	X	refers	to	the	moiety	on	the	2’	position	of	the	labeled	adenosine	ribose	in	Table	
2,	prepared	by	using	a	suitably	modified	adenosine	phosphoramidite.	There	were	a	total	of	four	
different	moieties	on	 the	2’	position	as	 listed	below.	Each	has	a	pKa	value	derived	 from	their	
corresponding	triphosphate	varieties	(Table	3).82	
	
Oligonucleotide	
Strand	
Sequence	 ε260	(L	mol-1	cm-1)		
F1-X	 3’-CACAGCTCGTCAGGAACATTTTT-5’-FAM	 236760	
T1	 3’-CCTGCTGAAGCAGCAGTGTTCCTGACGAGCTGTG-5’	 323200	
Table	 2.	Oligonucleotides	used	 for	kinetic	studies.	The	red	adenosine	 in	F1-X	 represents	 the	nucleotide	
where	the	2’	position	is	altered.	
	
Adenosine	2’-X	Moiety	 pKa	value	of	the	3’-OH	ribose	position	
-H	 14.3	
-OCH3	(-OMe)	 13.8	
-OH	 12.98	
-F	 12.74	
Table	3.	The	four	different	2’-X	moieties	and	the	corresponding	pKa	of	the	3’-OH	group.	
	
2.2b Measuring linear free energy relationships of hFEN1 and hFEN1Y40A 
For	steady-state	substrate-limiting	multiple	turnover	reactions,	reaction	mixtures	(180	μL)	were	
assayed	at	2.5,	5,	7.5	and	10	nM	substrate	in	50	mM	HEPES	pH	7.5,	100	mM	KCl,	8	mM	MgCl2,	
0.1	mg.mL-1	BSA,	0.02	%	NaN3	1	mM	dithiothreitol	 (DTT)	at	37	°C.	Reactions	were	 initiated	by	
adding	 hFEN1	 (10	 pM)	 or	 hFEN1Y40A	 (Table	 4).	 The	 concentration	 of	 enzyme	was	 designed	 to	
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give	 roughly	10%	product	 formation	after	10	minutes	 to	avoid	product	 inhibition	or	 substrate	
depletion,	 thus	 giving	 initial	 rates	 (V0).	 Aliquots	 (20	 μL)	 of	 reaction	were	 quenched	 in	 excess	
EDTA	(50	μL	of	500	mM	EDTA	pH	8),	at	2,	4,	6,	8,	10	and	20	minutes.	Reactions	with	the	S1-OH	
were	quenched	in	200	mM	EDTA	and	8	M	urea,	pH	7,	to	avoid	base-catalysed	auto-hydrolysis.	
Reactions	 at	 each	 substrate	 concentration	 were	 independently	 repeated	 three	 times.	 These	
experiments	were	carried	out	for	all	2’	modified	substrates.		
	
Substrate	
Concentration	(nM)	
S1-X	Moiety	and	hFEN1Y40A	concentration	used	for	each	reaction	(pM)	
	 2’-H	 2’-OMe	 2’-OH	 2’-F	
2.5	 40	 10	 10	 10	
5	 40	 10	 10	 10	
7.5	 40	 10	 1	 1	
10	 40	 10	 1	 1	
Table	 4.	Protein	concentrations	used	 for	 the	hFEN1Y40	 reaction	 to	give	 true	 initial	 rates	of	 roughly	10%	
product	formation	after	10	minutes.	
	
The	 rate	 of	 product	 formation	 was	 assessed	 by	 denaturing	 high-performance	 liquid	
chromatography	 (dHPLC)	 (Wave	 fragment	 analysis	 dHPLC	 fitted	with	 a	 fluorescence	 detector;	
Transgenomic,	Glasgow).	Roughly	65	μL	of	each	quenched	reaction	was	injected	onto	a	reverse-
phase	 ion-pairing	 column	 (DNAsep,	 Transgenomic).	 The	 mobile	 phase	 consisted	 of	 0.1%	
acetonitrile,	1	mM	EDTA,	2.5	mM	tetrabutyl-ammonium	bromide	(TBAB)	in	water.	A	gradient	of	
3.6%-70%	 acetonitrile	 (Fig.	 2.i)	 allowed	 for	 separation	 of	 5’FAM	 labelled	 product	 (6	 nt)	 and	
substrate	 (23	 nt)	 as	 detected	 using	 an	 attached	 fluorescence	 detector	 (excitation	 494	 nm,	
emission	525	nm).	Integrals	of	product	and	substrate	peaks	gave	the	percentage	of	the	product	
hydrolysed	 at	 any	 given	 time,	 which	 when	multiplied	 by	 the	 total	 substrate	 added	 gave	 the	
concentration	of	product	produced,	as	given	by	equation	2.1.	𝑃 = 𝐴𝑟𝑒𝑎 𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝐴𝑟𝑒𝑎 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 + 𝐴𝑟𝑒𝑎 𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒 × 𝑆 !"#$%  (2.1)	
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Figure	2.i.	Gradient	from	the	dHPLC	system.	The	gradient	runs	as	follows	with	percentage	MeCN	listed:	0	
min	3.6%,	1	min	21%,	5.5	min	39%,	7.1	min	70%,	8.5	min	70%,	8.6	min	3.6%	and	then	3.6%	until	the	end	
at	11	minutes.	
	
Normalised	initial	rates	were	calculated	by	linear	regression	of	[P]	versus	time	and	subsequently	
dividing	 by	 enzyme	 concentration	 used,	 hence	 giving	 V0/[E].	 The	 second	 order	 rate	 constant	
kcat/KM	 for	 each	 2’-X	 substrate	was	 calculated	 by	 plotting	 a	 linear	 regression	 through	plots	 of	
V0/[E]	 versus	 [S].	 Brønsted	 plots	 and	 subsequent	 βlg	 values	 were	 calculated	 according	 to	
equation	2.2.	All	linear	regression	was	carried	out	using	least-squares	fitting	in	Graph	Pad	Prism	
software.	All	experiments	were	independently	repeated	three	times.		𝐿𝑜𝑔 𝑘!"#𝐾! = 𝛽𝑙𝑔. 𝑝𝐾𝑎 + 𝐴 (2.2)	
For	 rapid-quench	 single-turnover	 reactions,	 enzyme	 (E)	 was	 mixed	 with	 S	 in	 a	 1:1	 volume	
mixture	(80	μL	of	each)	 	using	a	quench	flow	device	(Hi-Tech	Sci	Ltd,	Sailsbury,	UK).	To	obtain	
maximal	 single	 turnover	 conditions,	 E	 concentrations	 were	 at	 least	 8	 times	 the	 KM	 of	 hFEN1	
while	S	concentrations	were	1/40	times	the	KM.83	The	KM	was	previously	determined	by	Dr.	Jack	
Exell	to	be	151	nM.84	Therefore	[E]	was	1200	nM,	while	[S]	was	3.75	nM.	80	μL	of	both	[E]	and	
[S]	in	55	mM	HEPES-KOH	pH	7.5,	110	mM	KCl,	8	mM	MgCl2,	0.1	mg.mL-1	BSA,	0.02	%	NaN3	and	1	
mM	DTT	at	37	°C	were	prepared.	After	mixing	and	a	delay	of	4.5,	9,	12.1,	19.4,	27.6,	30.6,	40.8,	
41.8,	 57.5,	 82.1,	 124.2,	 140.8,	 240.8,	 440.8,	 840.8,	 1640.8,	 3240.8,	 6440.8,	 12841,	 25641	 or	
51241	ms,	the	reaction	was	subsequently	quenched	with	80	μL	of	quench	solution	(8	M	urea,	
200	mM	 EDTA	 pH	 7).	 Quenched	 reactions	 were	 analysed	 by	 dHPLC	 on	 the	WAVE	 system	 as	
described	 above	 in	 order	 to	 obtain	 percentage	 of	 product.	 All	 reactions	 were	 independently	
repeated	three	times	for	all	S1-X	substrates.	The	first	order	rate	of	product	formation	was	fit	to	
a	one	phase	(equation	2.3)	and	a	two	phase	exponential	fit	(equation	2.4).	
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𝑃 = 𝑃 ! 1 − 𝑒!!"  (2.3)	𝑃 = 𝑓!"#$ 𝑃 ! 1 − 𝑒!!!"#$.! + 1 − 𝑓!"#$ 𝑃 ! 1 − 𝑒!!!"#$.!  (2.4)	
Where	 [P]0	 is	 the	maximal	product	produced	 ([P]0	=	 [ES]	=	 [S]),	 ffast	 is	 the	 fraction	of	 the	span	
(from	 0	 to	 [P]0)	 accounted	 by	 the	 faster	 of	 the	 two	 components	 and	 kfast	 and	 kslow	 are	 two	
individual	rate	constants.	The	Brønsted	plot	of	Log10(kfast)	versus	pKa	of	3’-OH	leaving	group	was	
plotted	as	described	above	 (equation	2.2),	 but	 replacing	 the	 second	order	 rate	 constant	with	
first	order	single-turnover	rates.	
	
2.2c Second Order Rate Constant Determination as a Function of Viscosity 
hFEN1	was	assayed	at	different	viscosities	using	 the	5'-fluorescein	 (FAM)	 labelled	bimolecular	
DNA	 oligo	 construct	 S1-H,	 prepared	 as	 described	 above	 in	 2.2a.	 Substrate-limiting	 multiple	
turnover	reactions	reaction	mixtures	(180	μL)	were	assayed	at	2.5,	5,	7.5	and	10	nM	substrate	in	
50	mM	HEPES	pH	7.5,	100	mM	KCl,	8	mM	MgCl2,	0.1	mg.mL-1	BSA,	0.02	%	NaN3	and	1	mM	DTT	
at	37	°C	and	the	indicated	relative	viscosity.	Buffer	viscosity	(η)	was	adjusted	using	glycerol	(0-
36%	v/v).	Glycerol	relative	viscosities	(η/η0)	and	their	corresponding	%	v/v	were	calculated	using	
temperature-corrected	 density	 calculations	 at	 37	 °C	 and	 compared	 to	 the	 viscosity	 of	 water	
(η0).85	Reactions	were	initiated	by	adding	appropriate	amounts	of	hFEN1	(Table	5),	and	aliquots	
(20	μL)	of	reaction	were	quenched	in	excess	EDTA	(50	μL	of	500	mM	EDTA	pH	8)	at	2,	4,	6,	8,	10	
and	20	minutes.	All	reactions	were	repeated	independently	three	times.	
Relative	viscosity	(η/η0)	 Enzyme	concentration	(pM)	
1	 1	
1.5	 1.5	
2	 2	
2.5	 2.5	
3	 3	
3.5	 3.5	
Table	5.	The	enzyme	concentrations	used	in	reactions	with	differing	relative	viscosity		
	
The	rate	of	product	formation	was	assessed	by	dHPLC	as	described	previously	 in	section	2.2b.	
Estimates	of	second-order	rate	constants	were	derived	from	the	slope	of	normalized	initial	rate	
(V0/[E])	versus	the	concentration	of	substrate	[S1-H].	The	reciprocal	of	the	mean	kcat/KM	values	
for	 each	 relative	 viscosity	 were	 plotted	 and	 linear	 regression	 was	 performed	 on	 the	 linear	
portion	of	the	plot	(η/η0	1-2).	The	equation	of	the	slope	(equation	2.5)	was	solved	for	η/η0	=	1	in	
order	to	calculate	the	second	order	rate	constant	with	no	viscogen	present	(kcat/KM)0.	1𝑘!"#𝐾! = 1𝑘!"!  𝜂𝜂! + 𝑘!""
!𝑘!"! + 𝑘!!!"  2.5 	
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The	normalised	second	order	rate	constant	(kcat/KM)0(kcat/KM) 	was	plotted	versus	relative	viscosity	to	give	
the	relationship	given	in	equation	2.6.86		(kcat/KM)0(kcat/KM) = 𝑘!!!"𝑘!""! + 𝑘!!!"  𝜂𝜂! + 𝑘!""!𝑘!""! + 𝑘!!!"  (2.6)	
	
2.3 NMR spectroscopic studies of isotopically labeled hFEN1 
2.3a Spectrometer details 
All	NMR	experiments	were	performed	using	standard	pulse	sequences	on	either	a	Bruker	600	
MHz	Avance	DRX	spectrometer	equipped	with	a	5-mm	TXI	cryoprobe	with	z-axis	gradients	or	a	
Bruker	800	MHz	Avance	I	spectrometer	equipped	with	a	5-mm	TXI	probe	with	z-axis	gradients.	
Both	spectrometers	were	operated	with	TopSpin	2.	
	
2.3b NMR sample conditions 
A	variety	of	temperatures,	pH	and	buffer	molecules	were	screened	by	Dr.	David	Finger	in	order	
to	 obtain	 both	 acceptable	 1H-15N	 TROSY	 spectra	 and	 stabilise	 15N-labelled	 0.5	 mM	 protein	
samples	to	remain	in	solution	for	long	timescales	(months).	A	summary	of	temperature	and	pH	
conditions	tried	can	be	found	in	Table	6.	Following	the	screen,	samples	were	henceforth	always	
recorded	at	pH	7.5	and	a	temperature	of	25	°C	(298K,	relative	to	d4-methanol	signal).	
	
pH	 Observation	 Temperature	°C	 Observation	
<7.5	 Very	rapid	aggregation	 <25	 Decrease	in	S:N	with	no	
noticeable	increase	of	
protein	stability	
7.5	 Mixture	of	stability	and	
acceptable	S:N	
25	 Mixture	of	stability	and	
acceptable	S:N	
>7.5	 Poor	S:N	due	to	exchange	of	
amides	
>25	 Protein	aggregation	
accelerated	with	no	
noticeable	increase	in	S:N	
Table	6.	Properties	of	NMR	experiments,	pH	and	temperature.	
	
The	 buffering	 molecules	 screened	 were:	 10	 mM	 Tris-HCl,	 10	 mM	 HEPES-KOH	 and	 10	 mM	
potassium	phosphate.	No	apparent	changes	were	noted	between	them,	so	HEPES	was	chosen	
at	pH	7.5,	due	to	its	pKa	being	closest	to	the	desired	pH.	KCl	was	added	and	enhanced	protein	
stability	 and	 quality	 of	 spectra	 up	 to	 about	 76	 mM.	 The	 effect	 of	 multi-valent	 cations	 was	
assessed	by	adding	8	mM	MgCl2,	8	mM	CaCl2,	6	mM	LuCl3,	8	mM	ZnCl2	or	by	leaving	the	buffer	
in	the	presence	of	0.1	mM	EDTA.	The	different	reducing	agents	tried	were	100	mM	DTT,	tris(2-
carboxyethyl)phosphine	(TCEP)	and	beta-mercaptoethanol	(βME).	βME	gave	the	best	response	
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and	 high	 concentrations	 prevented	 depletion	 due	 to	 oxidation	 with	 air.	 Further	 oxidation	
prevention	was	achieved	by	blanketing	samples	with	argon	and	sealing	with	a	Precision	Seal®	
rubber	 septa	 cap	 (Sigma-Aldrich	 Z554014).	 The	 buffer	 solution	 called	NMR	 buffer	 (Table	 7)	
contained:	10	mM	HEPES-KOH	pH	=	7.5,	76	mM	KCl,	0.1	mM	EDTA,	4	mM	NaN3,	100	mM	β-ME.	
Furthermore,	D2O	(10%	v/v)	and	0.05	mM	trimethylsilyl	propanoic	acid	(TSP)	were	added	for	the	
deuterium	 lock	 and	 chemical	 shift	 reference	 standard,	 respectively.	 Samples	 (0.5	 mL)	 were	
transferred	into	a	5	mm	NMR	tube,	blanketed	with	argon	and	sealed	with	the	rubber	septa	cap.	
	
Buffer	Name	 Composition	
NMR	Buffer	 10	mM	HEPES-KOH	pH	7.5,	76	mM	KCl,	0.1	mM	EDTA,	4	mM	NaN3,	100	
mM	βME,	10%	v/v	D2O	and	0.05	mM	trimethylsilyl	propanoic	acid	(TSP)	
NMR	Buffer	Low	Salt	 10	mM	HEPES-KOH	pH	7.5,	6	mM	KCl,	0.1	mM	EDTA,	4	mM	NaN3,	100	
mM	βME,	10%	v/v	D2O	and	0.05	mM	trimethylsilyl	propanoic	acid	(TSP)	
Table	7.	NMR	Buffers	used	for	assignment,	relaxation	and	titration	experiments	
	
15N-labelled	hFEN1	samples	in	NMR	buffer	had	different	small	molecules	added	to	it	to	improve	
stability	of	the	sample	or	quality	of	the	spectra.	The	list	of	small	molecules	added	are	listed	in	
table	8.	
	
Small	Molecule	 Concentration	relative	to	hFEN1	
Arginine/Glutamic	Acid	1:1	mixture	
(Arg:Glu).	
Always	50	mM	Arg:Glu.	
Deoxyribose	adenosine	monophosphate	 10	X	
3’-5’	adenosine	bis-phosphate	 10	X	
dTpdA	dinucleotide	 1	X	
Cyclopropyl	inhibitor26		 2	X	
Table	8.	List	of	small	molecules	added	to	the	NMR	buffer	solution.	Additional	molecules	were	added	to	
the	buffers	as	mentioned	in	the	text.	
	
2.3c Assignment of hFEN1P188A 
Comparison	of	1H-15N	TROSY	spectra	of	2H,15N,13C-labelled	hFEN1P188A	with	15N-labelled	protein	
showed	that	all	backbone	amide	groups	had	back	exchanged	from	deuterium	to	protium	atoms.	
For	 the	 backbone	 resonance	 assignment	 of	 hFEN1P188A,	 a	 0.5	 mL	 sample	 contained	 0.5	 mM	
2H,15N,13C-labelled	hFEN1	in	NMR	buffer.	hFEN1P188A	backbone	1HN,	15N,	13Cα,	13Cβ	and	13C'	were	
assigned	 using	 the	 standard	 suite	 of	 1H-15N	 TROSY	 and	 3D	 TROSY-based	 constant	 time	
experiments	 (HNCA,	 HN(CO)CA,	 HNCACB,	 HN(CO)CACB,	 HN(CA)CO	 and	 HNCO).87	 1H	 chemical	
shifts	were	 referenced	 relative	 to	 the	 internal	 TSP	 signal,	whereas	 15N	and	 13C	 chemical	 shifts	
were	indirectly	referenced	using	nuclei-specific	gyromagnetic	ratios.	Peak	picking	and	frequency	
matching	 was	 carried	 out	 within	 CCPNMR	 Analysis	 version	 2.4,88	 and	 backbone	 assignments	
were	compared	to	the	previous	assignment	of	wild	type	hFEN1	(BMRB	accession	code	27160)	to	
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confirm	assigned	residues.	The	secondary	structure	content	and	Random	Coil	 Index-S2	 (RCI-S2)	
prediction	of	wild	type	hFEN1	was	conducted	by	uploading	the	backbone	1HN,	15N,	13Cα,	13Cβ	and	
13C'	chemical	shifts	to	the	TALOS-N	webserver.89		
	
2.3d Relaxation measurements of hFEN1 
Wild	 type	 hFEN1	 and	 hFEN1K93A	 samples	 for	 15N	 backbone	 fast	 timescale	 relaxation	
measurements	were	performed	using	2H,15N-labelled	protein	(section	2.1e)	in	a	5-mm	Shigemi	
NMR	microtube	assembly	matched	with	D2O.	The	sample	was	in	NMR	buffer.	
	
Spin-lattice	15N	relaxation	rates	(R1),	rotating	frame	15N	relaxation	rates	(R1ρ)	and	heteronuclear	
steady-state	15N-{1H}	NOE	(hNOE)	values	were	obtained	using	interleaved	TROSY-readout	pulse	
sequences.90	Temperature	compensation	was	applied	 in	 the	R1	experiment	by	 incorporating	a	
spin-lock	pulse	placed	off-resonance	in	the	inter-scan	delay,	equal	to	the	longest	spin-lock	time	
and	 RF	 power	 of	 the	 R1ρ	 experiment.	 Relaxation	 delays	 (t)	 of	 0,	 80,	 240,	 400,	 400,	 640,	 800,	
1200,	1760	and	2400	ms	were	used	to	calculate	R1,	and	delays	(t)	of	1,	20,	20,	30,	40,	60,	90,	
110,	150	and	200	ms	were	used	to	calculate	R1ρ.	The	inter-scan	delay	was	3.5	s	and	the	strength	
of	the	RF	spin-lock	field	during	R1ρ	measurement	was	1400	Hz	at	600	MHz	and	1866.7	Hz	at	800	
MHz.	For	the	hNOE	measurement,	two	interleaved	experiments	were	acquired	with	relaxation	
delays	of	 10	 s.	 For	 the	determination	of	R1	 and	R1ρ	 rates,	 the	decay	of	backbone	amide	peak	
heights	 were	 fitted	 using	 a	 decaying	 exponential	 function	 in	 CCPNMR	 according	 to	 equation	
2.7.88	 𝑃𝑒𝑎𝑘 𝐻𝑒𝑖𝑔ℎ𝑡 = 𝐴. 𝑒!!.! (2.7)	
Where	A	is	the	height	at	time	0,	and	R	is	either	R1	or	R1ρ	relaxation	rates.	The	error	of	the	fit	was	
done	by	a	covariance	method.	Relaxation	parameters	were	obtained	for	192	residues	because	
59	 residues	 were	 omitted	 from	 further	 analysis	 due	 to	 peak	 overlap	 or	 poor	 signal-to-noise	
ratios.	 For	 hNOE	 experiments,	 the	 ratio	 of	 the	 unsaturated	 to	 unsaturated	 peak	 height	 was	
measured	and	the	error	was	taken	as	a	percentage	of	the	average	noise	level	of	the	spectra.	R2	
values	were	calculated	from	R1	and	R1ρ	rates	according	to	equation	2.8.	𝑅! = 𝑅!!𝑠𝑖𝑛! 𝜃 − 𝑅!𝑡𝑎𝑛! 𝜃  (2.8)	
Where	𝑡𝑎𝑛 𝜃 = !!! ,	and	ω1	is	the	spin	lock	RF	field	(1400	Hz	at	600	MHz	and	1866.7	Hz	at	800	
MHz)	 and	 Ω	 is	 the	 offset	 of	 the	 15N	 resonance	 of	 interest	 with	 respect	 to	 the	 15N	 carrier	
frequency.90	
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2.3e Model free analysis 
Model-free	 analysis	 was	 performed	 using	 relax91–95	 on	 the	 Sheffield-WRGRID	 ICEBERG	 high	
performance	computing	cluster.	Using	the	R1,	R2	and	hNOE	values	at	600	MHz	and	800	MHz	and	
the	 coordinate	 geometry	 of	 backbone	 amide	 N-H	 bonds	 as	 provided	 by	 the	 crystal	 structure	
3Q8K,27	model-free	analysis	was	executed.	 Initial	analysis	provided	τm	values	 for	all	analysable	
residues.	16	residues	from	the	arch	region,	α2-α3	loop	and	the	C-terminus	were	then	excluded	
due	 to	 lack	 of	 coordinates	 in	 the	 crystal	 structures.	 The	 remaining	 176	 residues,	 called	
‘structured’	residues	were	subjected	to	a	full	analysis	with	each	diffusion	tensor	being	judged	by	
an	 Akaike	 information	 criteria	 (AIC)	 (Section	 5.2b,	 Table	 11).	 The	 omitted	 ‘unstructured’	 16	
residues	were	modeled	with	a	spherical	diffusion	tensor	and	oblate	spheroid	to	see	which	was	
preferable	by	AIC.	Both	analyses	were	conducted	for	the	192	residues	for	which	relaxation	data	
at	 both	 field	 strengths	 was	 available;	 of	 these,	 only	 179	 were	 processed	 fully,	 as	 13	 were	
removed	due	to	large	errors	or	computational	eliminations.	
	
2.3f Chemical shift perturbation mapping of Ca2+ and dAMP 
A	 15N-labelled	 hFEN1	 containing	 the	 K93A	 mutation	 (hFEN1K93A)	 that	 hindered	 catalysis,	 was	
expressed	using	a	custom-mutated	pET29b-hFEN1-336	vector	as	described	in	section	2.1b.	The	
hFEN1K93A	 protein	 was	 prepared	 as	 described	 for	 the	 wild	 type	 protein	 using	 the	 15N	
autoinduction	method	(section	2.1d).	 1H-15N	TROSY	spectra	were	separately	 recorded	 in	NMR	
buffer,	with	either	0	mM	or	8	mM	CaCl2	added.	Differences	in	chemical	shift	(ΔδH	or	ΔδN)	were	
calculated	using	equation	2.9.	𝛥𝛿 =  𝛿!"#$% !"#$%  –  𝛿!"#$% !"##  (2.9) 
Absolute	changes	in	weighted	chemical	shifts	(ω)	were	determined	using	equation	2.10.	𝜔 = 𝛥𝛿!!  +  𝛼.𝛥𝛿! !  (2.10) 
Where	 the	 correction	 factor,	 α,	 for	 15N	was	 0.14,	 roughly	 the	 fraction	 of	 gyromagnetic	 ratios	
between	1H	and	15N.		
Absolute	 weighted	 chemical	 shifts	 were	 measured	 in	 the	 same	 fashion	 for	 the	 titration	 of	
deoxyribose	adenosine	monophosphate	(dAMP)	into	hFEN1,	with	each	titration	point	measured	
versus	 the	original	unbound	chemical	 shift	 for	 1H	and	 15N.	A	solution	of	0.39	mM	15N-labelled	
hFEN1	in	NMR	buffer	with	8	mM	MgCl2	had	aliquots	of	200	mM	dAMP	added	to	it	according	to	
table	 9.	 Dissociation	 constant	 (KD)	 values	were	 calculated	 from	 plots	 of	 dAMP	 concentration	
versus	ω,	fitted	in	KaleidaGraph	4.0	(Kaleidagraph,	Synergy	Software,	Reading,	PA,	USA)	using	a	
quadratic	binding	equation	(equation	2.11).96	
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𝜔 = 𝜔!"# 𝐸 + 𝑑𝐴𝑀𝑃 + 𝐾! − 𝐸 + 𝑑𝐴𝑀𝑃 + 𝐾! ! − 4[𝐸][𝑑𝐴𝑀𝑃]2[𝐸]  (2.11)	
Where	[E]	and	[dAMP]	are	the	total	enzyme	and	dAMP	concentrations	respectively.	ωmax	is	the	
theoretical	weighted	chemical	shift	difference	when	fully	bound	to	dAMP.	
	
Titration	 dAMP	(mM)	 [E]	(mM)	 dAMP	stock	added	(μL)	
0	 0	 0.39	 0	
1	 0.39	 0.39	 1	
2	 0.78	 0.39	 1	
3	 1.6	 0.39	 2	
4	 3.1	 0.38	 4	
5	 4.7	 0.38	 4	
6	 6.2	 0.38	 4	
7	 7.8	 0.38	 4	
Table	9.	dAMP	titration	table	with	concentrations	of	both	15N-labelled	hFEN1	and	dAMP,	along	with	the	
volume	of	200	mM	dAMP	stock	added	at	each	titration	point.	
	
2.3g Substrate DNA preparation for NMR studies 
The	 DNA	 oligonucleotide	 used	 for	 NMR	 studies	 was	 purchased,	 synthesised	 using	 standard	
phosphoramidite	 chemistry	 and	 purified	 using	 reverse-phase	 high	 performance	 liquid	
chromatorgraphy	(HPLC),	from	LGC	Biosearch	Technologies	(Risskov,	Denmark)	(Table	10).	The	
concentration	of	the	dual-hairpin	substrate	(DHPS1)	was	quantified	using	absorbance	at	260	nm	
and	 molar	 extinction	 coefficients	 calculated	 according	 to	 the	 ‘nearest-neighbor’	 method	 the	
same	 as	 in	 section	 2.2a.81	 The	 formation	 of	 the	 secondary	 structure	 required	 the	
oligonucleotide	to	be	heated	at	95	°C	for	5	minutes	in	10	mM	HEPES-KOH	pH	7.5,	6	mM	KCl,	4	
mM	NaN3	and	0.1	mM	EDTA	and	subsequently	annealed	at	room	temperature.		
	
Oligonucleotide	
Strand	
Sequence	 ε260	 (L	
mol-1	cm-1)		
DHPS1	 5'-dTGAAAGGCAGAGCGCTAGCTCTGCCTTTCGAGCGAAGCTCC-3'	 382900	
Table	10.	Oligonucleotide	used	for	NMR	studies.	
	
2.3h hFEN1K93A substrate DNA complex formation 
Initially,	 500	 μM	 15N-labelled	 hFEN1K93A,	 2H,13C,15N-labelled	 hFEN1K93A	 or	 2H,15N-labelled	
hFEN1K93A,	 prepared	 as	 described	 above,	 in	NMR	 buffer	 was	 titrated	with	 sub-stoichiometric	
aliquots	 (0,	 50,	 100,	 200,	 250	 μM)	 of	 lyophilized	DHPS1	 until	 the	DNA	was	 equivalent	 to	 the	
protein	(500	μM).	At	50-100	μM	of	DNA,	the	sample	precipitated	and	the	quality	of	the	spectra	
decreased	 rapidly.	 To	 overcome	 protein	 precipitating	 in	 complex	with	 DNA,	 a	 hFEN1K93A-DNA	
complex	was	prepared	 in	NMR	buffer	 low	 salt:	10	mM	HEPES-KOH	pH	7.5,	6	mM	KCl,	4	mM	
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NaN3	and	0.1	mM	EDTA	in	the	presence	of	excess	DNA	substrate	(1:1.1)	under	dilute	conditions	
of	protein	and	DNA	(roughly	5	μM).	Low	KCl	concentrations	were	used	to	slow	dissociation	of	
the	 complex.	 The	 sample	was	 concentrated	 to	~500	μM	using	 a	Vivaspin	 20	 (10	 kDa	MWCO)	
spin	 columns	 and	 100	 mM	 βME,	 10%	 D2O	 (10%	 v/v)	 and	 0.05	 mM	 TSP	 were	 added	 (final	
conditions	 in	Table	 7).	 The	 same	 resonance	 assignment	 strategy,	 using	 3D	NMR	 spectra,	was	
conducted	with	a	2H,15N,13C-labelled	hFEN1K93A-DNA	complex	prepared	 in	this	manner	(section	
2.3c).	 Furthermore	 1H-15N	 TROSY	 relaxation	 measurements,	 as	 described	 previously	 (section	
2.3d)	were	carried	out	on	a	2H,15N-labelled	hFEN1K93A-DNA	complex	sample.	
	
A	Ca2+	titration	was	performed	on	a	15N-labelled	hFEN1K93A-DNA	complex.	1H-15N	TROSY	spectra	
were	acquired	at	0,	0.5,	1,	2,	4,	6	and	8	mM	CaCl2,	and	chemical	shift	differences	were	recorded	
as	described	in	equation	2.10.	
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Chapter 3: Confirmation of a conformational change in the 
hFEN1 catalytic cycle 
3.1 Introduction to kinetic assays of human flap endonuclease 
3.1a Overview of the current kinetic model of hFEN1 
Kinetic	studies	on	FENs	are	numerous	and	have	revealed	much	about	specific	residues	and	their	
importance	to	catalysis.	Such	studies	have	compared	altered	enzymes	and	substrates	with	their	
unmodified	 forms.37,38,97	 Kinetic	 studies,	 and	 in	 particular	 non-equilibrium	 or	 pre-steady	 state	
kinetics	 can	 also	 reveal	 further	 information	 about	 the	 enzyme-catalysed	 reaction.	 This	 can	
include	information	about	the	catalytic	chemistry	as	well	as	provide	evidence	for	intermediates	
on	 the	 kinetic	 pathway.	 Thus	 one	 approach	 to	 elucidating	 rate-limiting	 steps	 such	 as	
conformational	change	is	to	perform	kinetic	studies.	
	
When	modeling	the	rate	of	an	enzyme,	it	is	useful	to	use	the	Michaelis-Menten	relationship.	In	
Michaelis-Menten	kinetics	the	overall	rate	v	is	a	combination	of	two	processes.	First,	enzyme	[E]	
and	 substrate	 [S]	 equilibrate	 reversibly,	 forming	 an	 enzyme-substrate	 complex	 [ES].	 Second,	
there	is	a	first-order	rate	of	[ES]	decay	to	[E]	and	product	[P]	called	kcat.	The	equation	is	shown	
below:	 𝑣[𝐸]! = 𝑘!"#[𝑆]𝐾! + [𝑆]  (3.1)	
Where	 [E]0	 is	assumed	 to	be	 the	 total	enzyme	concentration	 in	 the	system	 ([𝐸]! = [𝐸]!"## +[𝐸𝑆]),	and	KM	is	the	Michaelis	constant.	Using	this,	a	simple	rate	equation	can	be	drawn	up	for	
hFEN1	 (Fig.	 3.i).	 The	mechanism	 of	Michaelis-Menten	 has	 three	main	 assumptions.	 First,	 the	
rates	of	 formation	and	decay	of	 [ES]	are	equal,	or	 in	other	words	 [ES]	 is	under	a	 steady	state	
condition.	 Hence,	 it	 is	 important	 to	 measure	 initial	 rates	 of	 reaction,	 devoid	 of	 product	
inhibition	or	 substrate	depletion.	Second,	 the	 total	 substrate	concentration	 [S]	 is	equal	 to	 the	
concentration	of	free	substrate	at	any	given	point	in	the	reaction.	Therefore	the	concentration	
of	[E]	<<	[S]	to	avoid	a	considerable	percentage	of	bound	substrate	versus	free	substrate.	Third,	
that	the	binding	and	dissociation	happen	much	more	rapidly	than	product	formation,	thus	it	is	
assumed	that	kcat	<<	koff.	
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Figure	3.i.	The	simple	Michaelis-Menten	relationship	of	enzyme	kinetics.	Enzyme	[E]	binds	to	substrate	
[S]	 in	an	equilibrium	 to	 form	an	enzyme-substrate	 complex	 [ES].	 The	 [ES]	 complex	 then	decays	by	 rate	
constant	kcat	to	[E]	and	product	[P].	
	
In	 terms	 of	 substrate	 as	mentioned	 before	 (Section	 1.2a),	 human	 flap	 endonuclease	 (hFEN1)	
prefers	to	act	upon	a	double-flapped	(DF)	DNA	substrate	with	a	1nt	3’	flap	and	any	length	of	5’	
flap.22	The	reaction	of	this	substrate	yields	a	short	single	stranded	(ss)	DNA	flap	product	(P)	and	
a	 nicked	 DNA	 duplex	 (Q).	 It	 is	 highly	 likely	 that	 the	 enzyme	 does	 not	 retain	 the	 flap	 P	 after	
hydrolysis	has	occurred;	therefore	 its	departure	does	not	 impact	on	the	rate.	However,	 in	the	
case	of	FEN1,	 the	nicked	DNA	duplex	 is	potentially	 still	bound	to	 the	enzyme	after	hydrolysis,	
contrary	to	the	simple	model	in	Figure	3.i	(Fig.	3.ii).	
	
	
Figure	 3.ii.	 An	 updated	 kinetic	 model	 based	 on	 the	 fact	 that	 a	 product	 has	 to	 be	 released	 after	
chemistry.	Due	to	the	nature	of	nucleases	binding	double	stranded	(ds)DNA,	it	is	common	to	see	a	final	
release	step	(krelease)	of	said	dsDNA.	Meanwhile	the	small	flap	product	P	dissociates	rapidly.	Macroscopic	
experimental	kinetic	quantities	and	what	they	can	measure	are	represented	in	brackets.	kcat/KM	measures	
all	 micro-rates	 up	 to	 and	 including	 the	 first	 irreversible	 step	 (kchem).	 kcat	 measures	 everything	 after	
substrate	binding,	and	finally	kst	measures	everything	after	binding	but	before	release.	
	
Pre-steady	 state	 conditions,	 or	 single-turnover	 conditions,	where	 [E]	 >>	KM	>	 [S]	measure	 the	
rates	 associated	 with	 processes	 after	 substrate	 is	 bound	 but	 before	 product	 is	 released.	
Previous	 studies	have	shown	 that	 for	a	multitude	of	FENs	 the	 single-turnover	 rates	 (kST)	were	
faster	 than	 multiple-turnover	 kcat	 values.22,83,97,98	 In	 hFEN1	 the	 difference	 is	 an	 order	 of	
magnitude	slower	(kcat	3	s-1	versus	kST	of	22	s-1).22	Therefore	the	release	of	nicked	DNA	product	
(Q)	 was	 determined	 to	 be	 rate	 limiting	 under	 substrate-saturating	 multiple-turnover	 (kcat)	
conditions.	
	
The	third	assumption	of	the	Michaelis-Menten	mechanism	is	not	always	accurate	for	a	protein	
system	and	sometimes	kcat	≈	koff	(Briggs-Haldane)99	or	the	more	extreme	condition	where	kcat	>>	
koff	 (Van	Slyke-Cullen).100	 If	kcat	>>	koff,	any	kinetic	step	after	substrate	association	occurs	much	
faster	 than	 dissociation,	 so	 the	 enzyme	 is	 said	 to	 be	 diffusion	 controlled/limited.	 Therefore	
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steady-state	 kinetic	 rates	 under	 substrate-limiting	 conditions	 (([E]	 <	 [S]	 <	 KM,	 or	 kcat/KM	
conditions)	will	 be	 close	 to	 that	 of	 bimolecular	 association	 (107-10-9	M-1	 s-1).101	 Indeed	 for	 T5	
bacteriophage	 FEN,83	 and	 hFEN122	 the	 rate	 has	 been	 shown	 to	 be	 within	 this	 range.	
Furthermore,	 increasing	the	viscosity	of	the	reaction	solution	can	allow	for	a	slow	kon	and	koff,	
without	affecting	kcat,	hence	probing	for	diffusion	control.	Under	kcat/KM	conditions	the	T5	FEN	
was	 found	 to	 be	 dependent	 on	 the	 rate	 of	 diffusion,	 hence	 it	 was	 found	 to	 be	 diffusion	
controlled.42		
	
As	hFEN1	is	sequestered	to	replication	forks	in	vivo,44	the	physical	limitation	of	diffusion	is	likely	
a	 minor	 factor.	 Thus,	 it	 has	 been	 suggested	 that	 the	 single-turnover	 rates	 are	 likely	 more	
biologically	relevant.8	The	single-turnover	reaction	measures	all	rates	after	binding,	and	before	
product	 release,	 which	 according	 to	 figure	 3.ii	 just	 encompasses	 the	 rate	 of	 chemistry.	
However,	earlier	studies	with	T5	bacteriophage	FEN	show	no	change	in	the	kST	when	chemically	
altering	the	pKa	of	the	3’	hydroxyl	leaving	group,	suggesting	that	another	slower	rate	masks	the	
kST.42	Applying	this	knowledge	from	older	FENs,	a	more	detailed	model	for	hFEN1	catalysis	has	
been	proposed	(Section	1.3e	and	Fig.	3.iii).8	The	presence	of	a	conformational	change,	slower	
than	kchem,	 has	 been	 suggested	 between	 the	 initial	 [ES]	 complex	 and	 a	 chemically	 competent	
complex	 [ES]''.	 In	 this	 chapter	 the	 presence	 of	 this	 conformational	 change	 step	 will	 be	
confirmed	for	hFEN1	along	with	its	implications	for	catalysis.	
	
Figure	 3.iii.	The	 proposed	 reaction	 pathway	 of	 for	 hFEN1.	 The	proposed	conformational	 change	 rates	
(kCC	and	kRCC)	are	so	slow,	they	mask	any	augments	of	kchem.	Therefore	it	is	thought	that	the	kst	reflects	the	
rate	of	 this	 conformational	 change.	 It	 should	also	be	noted	 that	 the	 conformational	 change	 step	 could	
encompass	many	subsequent	steps.	
	
3.1b The theory of Brønsted analysis and previous work done on T5 FEN 
In	single-turnover	conditions	for	hFEN1,	there	are	two	proposed	kinetic	steps:	a	conformational	
change	and	the	chemical	reaction.	In	order	to	confidently	assign	the	single-turnover	rates	as	a	
rate	of	conformational	change,	the	rate	of	the	chemical	step	needs	to	be	decoupled	from	kST.	As	
discussed	 in	 section	 1.1b,	 phosphate	 diester	 hydrolysis	 occurs	 most	 likely	 as	 an	 in-line	
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associative	nucleophilic	reaction	(comparable	to	SN2	reactions	with	carbon).	After	an	activated	
nucleophile	 attacks	 the	 phosphorus,	 a	 penta-covalent	 phosphate	 transition	 state	 or	
intermediate	 is	 formed.	 This	 collapses	back	 to	 a	normal	 tetrahedral	 structure	when	 the	bond	
forming	the	axial	3’	bridging	oxygen	 is	broken	(Fig.	 3.iv).	The	breaking	of	 this	bond	requires	a	
buildup	of	negative	charge	on	the	3’-OH	leaving	group.	Thus	by	stabilising	the	negative	charge	
on	the	3’-OH	the	reaction	can	progress	faster.	
	
	
Figure	3.iv.	Base-catalysed	Phosphodiester	hydrolysis.	The	water	is	activated	by	a	base	and	attacks	the	
phosphorus.	This	 forms	a	penta-covalent	 intermediate.	There	 is	a	buildup	of	negative	charge	on	the	3’-
bridging	oxygen	during	 the	penta-covalent	phosphorus	 intermediate.	This	 causes	 the	axial	P-O	bond	 to	
break.		
	
A	measure	of	ability	of	the	3’-OH	to	stabilise	negative	charge	is	its	pKa.	A	lower	value	represents	
a	higher	proportion	of	conjugate	base	present	(O-)	at	equilibrium.	3!𝑂𝐻 ⇋  3!𝑂! + 𝐻! (3.2. 𝑎)	𝑝𝐾𝑎 = −𝐿𝑜𝑔!" [3′𝑂]![𝐻]![3′𝑂𝐻]  (3.2. 𝑏)	
So	by	having	a	lower	3’-OH	pKa	value,	the	penta-covalent	phosphate	diester	will	collapse	faster	
as	the	negative	charge	is	stabilised	on	the	3’-bridging	oxygen.	Furthermore	the	negative	charge	
on	 the	 3’-O-	 product	 will	 be	 stabilised	 more,	 the	 lower	 the	 pKa	 value	 is.	 Therefore	 base-
catalysed	 phosphodiester	 hydrolysis	 should	 occur	 faster	 at	 lower	 3’-OH	 pKa	 values.	
Experimentally	 this	 effect	 can	 be	measured	 by	 plotting	 the	 log	 of	 rate	 versus	 the	 pKa	 of	 the	
leaving	group,	called	a	Brønsted	plot	 (Fig.	 3.v).	A	 linear	 relationship	of	 this	plot	 is	known	as	a	
linear	 free	energy	relationship	(LFER),	with	the	mathematical	 relationship	shown	 in	figure	3.v.	
The	βlg	value	represents	the	sensitivity	of	the	leaving	group	to	pKa	and	A	is	the	reaction	specific	
constant.	As	βlg	approaches	zero	the	transition	state	becomes	less	sensitive	to	the	pKa,	and	vice	
versa.	 Brønsted	 analysis	 of	 non-enzymatic	 base-catalysed	 methylphenylphosphate	 diesters	
shows	a	large	βlg	of	-0.94.102	
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Figure	3.v.	Brønsted	plot	of	a	phosphate	diester.	The	gradient	of	the	plot	provides	information	as	to	how	
sensitive	the	rate	of	reaction	is	to	the	buildup	of	charge	on	the	3’-OH	leaving	group.	The	equation	for	the	
slope	is	given	on	the	right.	
	
However	 for	 enzymatic	 reactions	 the	 situation	 is	 more	 complex.	 Enzymes	 that	 rely	 on	 acid	
catalysis	show	small	βlg	values.103	However,	for	two-metal	ion	nucleases	similar	to	FEN1,	like	the	
bacterial	 alkaline	 phosphatase,	 a	 large	 βlg	 was	 observed.104	 Therefore	 it	 is	 more	 likely	 that	
hFEN1	would	display	a	similar	large	βlg.	Interestingly	the	opposite	is	seen	for	T5	bacteriophage	
FEN-catalysed	 reactions;	 changing	 the	 pKa	 of	 the	 3’-OH	 leaving	 group	 does	 not	 affect	 rates	
under	 kcat/KM	 conditions.	 This	 might	 be	 unsurprising	 considering	 that	 the	 rate	 is	 diffusion	
controlled	at	 low	substrate	concentrations.	Therefore	 the	rate	of	kchem	 is	masked	by	diffusion.	
However,	 the	 same	 result	 is	 obtained	 for	 single-turnover	 reactions,	 indicating	kST,	 even	when	
augmented	 by	 lower	 pKa,	 does	 not	 increase.	 This	 is	 evidence	 that	 some	 other	 process,	 a	
conformational	rearrangement	(kCC,	kRCC)	of	the	protein	after	being	bound	must	be	rate-limiting	
or	close	to	rate-limiting.	Furthermore,	measurement	of	this	single-turnover	rate	would	give	an	
idea	of	 the	 timescale	 of	which	 this	 process	 is	 happening.	 Similar	 experiments	were	 therefore	
carried	out	on	human	FEN1	to	see	if	a	similar	relationship	could	be	found.	
	
3.2 Substrates used in kinetic experiments 
In	 order	 to	 analyse	 the	 leaving	 group	 LFER	 of	 hFEN1,	 four	 substrates	 were	 designed	 with	 a	
variety	of	2’	groups	present	on	the	departing	nucleoside	in	the	flap	strand	(Fig.	3.vi).	In	order	of	
decreasing	3’	OH	pKa	the	2’	groups	(X)	on	the	adenosine	sugar	were	hydrogen	(2’-H),	methoxy	
(2’-OMe),	 hydroxyl	 (2’-OH)	 and	 fluoride	 (2’-F).	 An	 optimal	 double	 flapped	 substrate	 structure	
was	used	for	all	reactions.22	The	overall	substrate	secondary	structure	was	engineered	to	be	a	
static	double-flapped	structure	(DF1),	with	an	interchangeable	flap	strand	(F1-X)	and	a	constant	
template	strand	(T1).	A	mismatch	on	the	3’	upstream	flap	was	also	present	so	the	flap	structure	
does	 not	 equilibrate,	 preventing	 interchangeable	 lengths	 of	 5’	 and	 3’	 flaps	 in	 solution.	
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Fluorescein	was	attached	on	the	5’	terminus	of	the	flap	strand	for	detection	by	DNA	denaturing	
high	performance	liquid	chromatography	(dHPLC).		
	
	
Figure	3.vi.	Schematic	of	the	double	flapped	hFEN1	substrate	used	in	kinetic	experiments.	The	template	
strand,	T1	has	a	GAA	hairpin	resulting	in	a	duplex	upstream	region	with	a	1nt	3’	flap.	This	was	annealed	
with	 an	 interchangeable	 5’	 flap	 strand,	 F1-X	 with	 a	 5’	 fluorescein	 on	 the	 5’	 terminus.	 The	 expected	
hydrolysis	site	is	noted	with	an	orange	arrow.	The	2’	position	(X)	of	the	adenosine	ribose	sugar	(red	circle)	
was	altered	according	to	the	table.	pKa	values	for	the	3’-leaving	group	are	listed	in	the	table,	determined	
as	their	triphosphate	equivalents.82		
	
3.3 Brønsted analysis to determine chemistry dependence on the rate of 
reaction of hFEN1. 
3.3a Brønsted analysis under kcat/KM conditions  
Initially	 LFER	 were	 assessed	 under	 substrate-limiting	 multiple-turnover	 conditions	 where	 the	
rate	 constant	 for	 the	 reaction	 is	 kcat/KM.	 Rates	 of	 reaction	 for	 the	 various	 modified	 hFEN1	
substrates	were	measured	by	a	discontinuous	time	assay	at	37	°C.	Reaction	vessels	with	2.5,	5,	
7.5	 and	 10	 nM	 of	 appropriate	 substrate	 were	 prepared	 and	 initiated	 with	 an	 appropriate	
amount	of	enzyme.	Aliquots	of	 the	 reaction	 removed	at	defined	 times	were	quenched	 in	500	
mM	 EDTA	 pH	 8	 to	 chelate	 any	 catalytic	 Mg2+	 ions,	 hence	 halting	 reaction.	 For	 the	 2’-OH	
substrate	 a	 quench	 of	 200	mM	EDTA	 pH	 7	 and	 8	M	 urea	was	 used	 instead	 to	 prevent	 base-
catalysed	 auto-hydrolysis	 of	 the	 phosphate	 group.	 Each	 time	 point	 was	 analysed	 by	 reverse	
phase	 ion	pairing	dHPLC	with	 tetrabutyl-ammonium	bromide	 (TBAB)	as	 the	 interface	with	 the	
solid	 phase.	 By	 using	 a	 gradient	 of	 acetonitrile,	 substrate	 (23nt)	 and	 flap	 product	 (6nt)	 were	
separated	 and	 detected	 using	 a	 fluorescence	 detector	 for	 enhanced	 sensitivity	 allowing	 pico-
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moles	of	DNA	to	be	detected.	By	using	the	integral	of	each	peak	and	the	known	total	substrate	
concentration	[S]Total	 it	was	possible	to	work	out	the	concentration	of	product	[P]	at	each	time	
point	by	the	equation	below:	𝑃 = 𝐴𝑟𝑒𝑎 𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝐴𝑟𝑒𝑎 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 + 𝐴𝑟𝑒𝑎 𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒 × 𝑆 !"#$%(3.3)	
Product	 concentration	 versus	 time	was	 plotted	 and	 a	 linear	 relationship	 indicated	 that	 initial	
rates	 (V0)	 under	 steady-state	 kinetics	 were	 being	measured.	 Least	 squares	 fits	 of	 these	 lines	
produced	initial	rates,	which	were	normalised	versus	the	total	enzyme	concentration	[E]0	then	
plotted	versus	substrate	concentration.	A	full	rate	profile	for	each	substrate	concentration	was	
repeated	three	times.	
	
	
Figure	 3.vii.	 Apparent	 second-order	 rate	 plots	 with	 different	 2’	 substrates.	 Both	 plots	 show	 each	
replicate	for	substrate	containing	2’H	(greyshade),	2’OMe	(purples),	2’OH	(blues)	and	2’F	(greens).	On	the	
left	(A)	is	wild	type	hFEN1	and	on	the	right	(B)	is	the	mutant	Y40A.	Each	linear	regression	was	fitted	using	
least	squares	fits.	
	
Normalised	 rates	 of	 reaction	 (V0/[E]0)	 versus	 [S]	 data	 for	 each	 replicate	 were	 fit	 by	 linear	
regression	 to	 obtain	 kcat/KM	 rate	 constants	 using	 a	 least	 squares	 fit	 (Fig.	 3.vii).	 The	 average	
kcat/KM	 for	 the	 2’-deoxyriboadenosine	 containing	 substrate	 (0.43	 nM-1	 min-1)	 was	 similar	 to	
previously	 reported	kinetic	 studies.22,27	The	 rates	of	 reaction	 for	 the	other	 substrates	were	all	
within	an	order	of	magnitude.	The	2’OMe	containing	substrate	was	the	closest	at	0.32	nM-1	min-
1,	while	the	2’F	(1.3	nM-1	min-1)	and	2’OH	(1.1	nM-1	min-1)	were	slightly	higher	in	rate.	When	the	
log	of	 the	mean	 rate	 constant	was	plotted	 against	 the	pKa	of	 the	 leaving	 group,	 there	was	 a	
shallow	slope.	This	was	fitted	with	a	least	squares	fit	to	produce	Brønsted	coefficient	(βlg)	value	
of	around	-0.38	±	0.1	(Fig.	3.viii.a).		
	
To	see	 if	a	negative	LFER	could	be	achieved	with	hFEN1,	the	same	experiment	was	conducted	
but	with	a	previously	reported	mutant	hFEN1.	The	point	mutation	was	present	in	the	active	site	
at	the	nucleobase	stacking	residue	tyrosine	40,	which	was	mutated	to	an	alanine	(Y40A).	Initial	
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catalytic	 efficiency	 of	 hFEN1Y40A	 protein	 with	 the	 deoxyribo-adenosine	 substrate	 was	 5-times	
lower	 than	 wild	 type	 protein,	 a	 bit	 less	 pronounced	 than	 previous	 studies.27	 However	 the	
reaction	with	 the	mutant	was	highly	 sensitive	 to	 the	 leaving	group	pKa.	There	was	a	100-fold	
increase	 in	 rate	 for	 2’OH	 containing	 substrate	 and	 a	 50-fold	 increase	 for	 the	 2’F	 containing	
substrate	 compared	 to	 2’H.The	 Brønsted	 plot	 showed	 a	 βlg	 value	 of	 -1.2	 ±	 0.4	 (Fig.	 3.viii.b),	
close	 to	 that	 of	 the	 T5	 FEN	 catalytic	 mutant	 K83A.42	 The	 2’OMe	 containing	 substrate	 was	
problematic	with	high	uncertainty	in	the	results.	Furthermore	its	rate	constant	was	much	lower	
than	expected,	which	could	be	due	to	steric	hindrance	during	reaction.	Therefore	it	was	omitted	
from	the	least	squares	fit	of	the	Y40A	Brønsted	plot,	although	it	would	have	enhanced	the	βlg	
value	to	-1.5	if	included.	
	
	
Figure	3.viii.	LFER	of	hFEN1	and	hFEN1Y40A	mutant.	The	wild	type	(A)	is	in	blue,	and	the	Y40A	mutant	(B)	
is	in	red.	Error	bars	are	shown	as	the	standard	error	of	the	mean	from	each	replicate,	where	not	shown	
they	are	smaller	than	the	size	of	the	point.	The	fit	was	done	by	 linear	regression	using	 least	squares,	 in	
Y40A	(B)	the	2’OMe	data	point	was	omitted	from	the	fit.	
	
The	 shallow	LFER	obtained	 for	hFEN1	under	 kcat/KM	 conditions	 could	be	due	 to	a	 few	 factors.	
Either	the	reaction	of	hFEN1	has	an	element	of	acid	catalysis	involved	in	its	hydrolysis,	therefore	
nullifying	the	affect	of	3’OH	pKa	dependence.	However	this	is	would	not	be	explained	by	a	steep	
βlg	 for	 the	Y40A	mutant,	as	 this	 residue	 is	not	 implicated	 in	contact	with	 the	phosphodiester,	
but	is	responsible	for	positioning	of	the	nucleobase.	It	is	also	inconsistent	with	other	two-metal	
ion	 enzyme	 catalysed	 systems	 like	 the	 bacterial	 alkaline	 phosphatase.	 The	 second	 option	 for	
hFEN1	 is	 that	 the	 rate	 is	 indeed	 sensitive	 to	 3’OH	 pKa	 but	 the	 measured	 macroscopic	 rate	
constant	is	masked	by	a	much	slower	rate	of	another	process,	which	would	be	consistent	with	
T5	FEN	results	under	similar	conditions.	Physical	processes	responsible	for	this	slower	rate	could	
include	 bimolecular	 association	 between	 substrate	 and	 enzyme	 or	 a	 conformational	 change	
after	 substrate	 binding.	 The	 Y40A	 mutant	 can	 be	 rationalised	 by	 the	 second	 theory:	 kchem	
becoming,	or	becoming	close	to	the	rate-limiting	step	in	catalysis.	Reducing	the	kchem	to	within	
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orders	 of	 magnitude	 of	 a	 slower	 micro-rate(s)	 would	 make	 the	 macroscopic	 rate	 constant	
sensitive	 to	kchem.	Therefore,	by	altering	kchem	by	altering	 the	pKa	of	 the	3’OH,	 the	kcat/KM	rate	
constant	is	changed.	For	wild	type	hFEN1,	the	kchem	is	much	faster	and	is	masked	by	potentially	
slower	 kinetic	 steps,	 which	 results	 in	 the	 shallow	 LFER.	 Therefore	 another	 microrate,	 either	
bimolecular	association,	or	a	conformational	 change	after	association,	 is	probably	 limiting	 the	
rate	of	reaction	under	these	conditions.	
	
3.3b Brønsted analysis to determine chemistry dependence at single-turnover conditions. 
The	 LFER	 of	 hFEN1	 was	 assessed	 under	 maximal	 single-turnover	 conditions	 to	 eliminate	 the	
effects	of	diffusion.	Rates	of	reaction	for	the	same	modified	hFEN1	substrates	were	measured	at	
37	°C	at	single-turnover	conditions	where	[E]	was	at	least	eight	times	KM	and	[S]	was	1/40	times	
KM.	These	reaction	conditions	were	used	previously	to	assess	the	maximal	single	single-turnover	
rate,	as	further	addition	of	enzyme	yielded	no	further	increase	in	rate.83	Under	these	conditions	
[E]	and	[S]	were	instantaneously	mixed	and	left	to	react	at	set	times	(a	range	of	10	ms	to	50	s,	
section	2.2b)	before	being	quenched	in	a	solution	of	8	M	urea	and	200	mM	EDTA	pH	7.	This	was	
done	on	a	quench-flow	apparatus,	mixing	1:1:1	volumes	of	[E],	[S]	and	quench	solutions.	Each	
time	course	for	a	substrate	was	repeated	three	times.	Aliquots	of	the	quenched	reaction	were	
taken	and	analysed	by	dHPLC	as	described	previously	(section	3.3a).	Analysis	of	the	integrals	of	
peaks	showed	the	percent	product	produced	versus	time	(Fig.	3.ix.a).	
	
	
Figure	3.ix.	Single	Turnover	Brønsted	analysis	of	hFEN1.	 (A)	The	single	turnover	two-phase	exponential	
(by	 least-squares)	 fits	of	each	 replicate.	 The	 substrates	were	2’-H	 (greyshade),	 2’-OMe	 (purples),	 2’-OH	
(blues)	and	2’-F	(greens).	(B)	The	plot	of	log(kST)	versus	3’-OH	pKa	of	hFEN1	protein	with	error	bars	visible	
except	when	smaller	than	the	data	points.	The	fit	was	a	linear	regression	using	least	squares	fit	through	
all	but	the	2’-OMe	point.	
	
It	is	expected	for	the	rate	of	reaction	to	be	first	order,	as	it	is	measuring	the	rate	of	production	
of	 product	 following	 the	 equation:	 𝐸𝑆 → 𝐸𝑄 + [𝑃] .	 Therefore	 product	 should	 rise	
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exponentially	 by	 the	 equation	 𝑃 = 𝑃 !(1 − 𝑒!!") 	(where	 [P]0	 =	 [ES]	 =	 [S]Total).	 In	 reality	
however,	the	data	is	observed	to	have	a	two-phase	exponential	relationship.	Comparing	fits	of	
single	 and	 two	 phase	 exponentials	 by	 an	 extra	 sum	 of	 squares	 F	 test	 found	 the	 two-phase	
preferable	 in	 all	 cases.	 This	 could	 be	 interpreted	 by	 a	 percentage	 of	 the	 substrates	 failing	 to	
react,	 and	 could	 be	 due	 to	 a	 few	 reasons.	 Firstly	 non-productive	 complex	 formation	 at	 high	
enzyme	 concentrations	 could	 occur,	 whereby	 an	 enzyme	 is	 bound	 to	 the	 substrate	 at	 an	
inactive	location	(i.e.	the	blunt	ended	downstream	region,	Fig.	3.vi),	meaning	the	enzyme	would	
first	need	 to	dissociate	before	another	bound	 in	 the	correct	position.	This	 could	be	especially	
true	 if	 multiple	 enzymes	 at	 high	 concentration	 bind	 to	 one	 substrate.	 Secondly,	 enzyme	
denaturation	 could	 occur	 when	 injected	 under	 high	 pressures	 in	 the	 quench-flow	 apparatus	
inactivating	a	proportion	of	the	bound	[ES]	complexes.	On	another	note,	the	plateau	at	higher	
time	points	should	converge	towards	100%	product	formation	(i.e.,	 [S]Total),	however	most	the	
plots	 only	 reached	 around	 70%	 product	 (Fig.	 3.ix.a).	 The	 anomalous	 results	 for	 the	 2’-F	
substrate	shows	a	very	 low	percentage	(50%)	of	product	formed.	 It	 is	not	known	why	the	2’-F	
substrate	would	display	this	unusually	low	plateau.		
	
When	log(kST)	values	were	plotted	versus	3’-OH	leaving	group	values	there	was	a	near-zero	βlg	of	
-0.14	±	0.1	(Fig.	3.ix.b).	The	kST	of	the	2’-OMe	substrate	 is	much	 lower	than	expected	and	has	
been	 omitted	 from	 the	 fit.	 This	 could	 be	 due	 to	 steric	 clashes	 when	 bound	 to	 the	 enzyme,	
causing	a	much	slower	than	expected	reaction.	This	has	been	noted	in	the	previous	study	with	
T5	bacteriophage	FEN.42	The	βlg	value	is	comparable	to	that	under	kcat/KM	conditions,	showing	
that	the	measured	kST	is	insensitive	to	3’-OH	leaving	group	pKa.	This	further	suggests	that	kchem	is	
a	 much	 faster	 rate	 than	 other	 slower	 rate	 determining	 processes.	 One	 such	 process	 that	 is	
eliminated	 at	 maximal	 single-turnover	 conditions	 is	 the	 bimolecular	 association	 step,	 as	 all	
enzyme	is	assumed	to	be	bound	to	substrate	from	the	start	of	the	reaction.	Therefore	the	slow	
microrate	masking	kchem	is	likely	to	occur	once	enzyme	is	bound	to	substrate.	This	further	lends	
weight	 to	 the	 T5	 FEN	model,	 whereby	 a	 conformational	 change,	 or	 series	 of	 conformational	
changes	is	rate-limiting.	
	
3.4 Viscosity effects on enzymatic reactions 
3.4a Diffusion-limited reactions and the effect of viscosity on bimolecular association rates 
(kon) 
Changing	 the	 viscosity	 of	 the	 reactant	 medium	 influences	 the	 rates	 of	 enzymatic	 catalysed	
reactions.	 In	 particular	 it	 has	 been	 used	 to	 investigate	 the	 role	 the	 rate	 of	 bimolecular	
Chapter	3:	Conformational	change	in	catalysis	
	62	
association	(kon,	Figs.	3.i-iii)	has	in	the	overall	enzyme-catalysed	reaction.	It	can	be	shown	using	
diffusion	coefficients	that	the	rate	of	association	is	inversely	proportional	to	the	viscosity	(η)	of	
the	 solution.86	 For	 a	 simple	 Michaelis-Menten	 relationship	 (Fig.	 3.i)	 under	 steady-state	
conditions	it	can	be	shown	that	rate	of	product	formation	(EP)	(kprod)	is	given	by:	𝑘!"#$ =  𝑘!!!" 𝑘!"𝑘!""+𝑘!"#  (3.4)	
Assuming	 that	 viscosity	 only	 affects	 the	 bimolecular	 diffusion	 rates,	 and	 noticing	 the	 inverse	
correlation,	it	is	possible	to	derive	the	equations:	𝑘!"!  𝜂! = 𝑘!" 𝜂 (3.5. 𝑎)	𝑘!""!  𝜂! = 𝑘!""𝜂 (3.5. 𝑏)	
Where	 the	 superscript	 0	 indicates	 conditions	 where	 there	 is	 no	 viscosity-enhancing	 agent	
present.	Therefore	by	substituting	equations	(3.5.a-b)	into	(3.4),	and	taking	the	inverse	of	kprod	it	
is	possible	to	obtain:	 1𝑘!"#$ = 1𝑘!"!  𝜂𝜂! + 𝑘!""!𝑘!"! + 𝑘!!!"  (3.6)	
This	means	that	in	theory	by	plotting	the	inverse	of	rate	versus	the	relative	viscosity	(η/η0)	it	is	
possible	 to	 retrieve	 the	 rate	of	 association	as	 the	 inverse	of	 the	gradient.	 Experimentally	 it	 is	
easier	to	represent	this	as	a	ratio	of	kprod0	over	kprod:	𝑘!"#$!𝑘!"#$ = 𝑘!!!"𝑘!""! + 𝑘!!!"  𝜂𝜂! + 𝑘!""!𝑘!""! + 𝑘!!!"  (3.7)	
	
In	 practice	 for	 hFEN1	 the	measurement	 of	 kprod	 was	measured	 under	 kcat/KM	 conditions.	 This	
provided	kinetic	parameters	up	to	and	including	the	first	irreversible	step	of	catalysis,	which	for	
hFEN1	 is	assumed	to	be	hydrolysis	 (kchem).	This	presents	 two	extremes,	one	where	diffusion	 is	
much	faster	than	the	hydrolysis	(koff	>>	kchem)	and	one	where	the	diffusion	is	much	slower	than	
hydrolysis	 (koff	 <<	 kchem).	 In	 equation	 3.7	 if	 koff	 dominates,	 or	 if	 the	 reaction	 is	 not	 diffusion-
limited	then	the	gradient	will	be	0.	However,	 if	kchem	dominates,	or	 if	 the	reaction	 is	diffusion-
limited	 then	 the	equation	above	will	 show	a	 slope	of	1.	Previous	 studies	of	 T5	bacteriophage	
FEN	showed	that	 it	 is	diffusion-limited	under	kcat/KM	conditions,	with	a	normalised	rate	versus	
relative	 viscosity	 slope	 of	 near	 1.42	 Therefore	 the	 same	 viscosity	 studies	 on	 hFEN1	 were	
performed	to	see	if	it	displayed	similar	characteristics.	
	
3.4b The effect of viscosity on the kcat/KM rate constant of hFEN1. 
hFEN1	 was	 subjected	 to	 different	 glycerol	 concentrations	 during	 substrate-limiting	 multiple-
turnover	 reactions.	 The	 same	 discontinuous	 time	 assay	 was	 used	 as	 in	 section	 3.3a	 except	
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different	glycerol	concentrations	were	used	in	the	reaction.	The	same	double-flapped	substrate	
as	in	section	3.2	was	used,	with	a	deoxyribose	adenosine.	Viscosities	of	glycerol	solutions	at	37	
°C	(η)	were	calculated	relative	to	water	(η0)	(Section	2.2c).85	After	analysis	of	peak	integrals	by	
dHPLC,	 the	 resulting	 plots	 of	 initial	 rates	 versus	 substrate	 concentration	 show	 a	 marked	
decrease	 in	 the	slope	 (kcat/KM)	upon	addition	of	more	viscogen	 (Fig.	 3.x).	The	resulting	plot	of	
the	 reciprocal	 of	 kcat/KM	 versus	 relative	 viscosity	 however	 shows	 much	 greater	 viscosity	
dependence	than	anticipated	(equation	3.6).	Therefore	only	the	first	three	points	were	analysed	
by	linear	regression	to	solve	for	(η/η0)	=	1,	to	calculate	1/(kcat/KM)0.	From	equation	3.6	in	theory	
the	slope	should	be	the	inverse	of	kon0,	and	in	fact	the	association	rate	obtained	is	8.2x107	M-1	s-
1,	placing	it	close	to	diffusion	and	comparable	to	the	reported	values	for	T5	FEN.42	
	
	
Figure	 3.x.	 Initial	 rate	 graphs	 of	 hFEN1	 under	 different	 relative	 viscosity	 conditions.	 Each	 relative	
viscosity	 (listed	 on	 the	 right)	 was	 repeated	 three	 times.	 The	 linear	 regression	 by	 least	 squares	 was	
performed	on	the	entire	dataset	to	give	kcat/KM	values	for	six	relative	viscosity	values.	
	
The	 resulting	 plot	 of	 (kcat/KM)0(kcat/KM) 	versus	 η/η0	 is	 expected	 to	 give	 a	 slope	 of	 1	 for	 reactions	
controlled	by	diffusion	 (equation	 3.7).42,86	 The	derived	data	 for	 hFEN1	 shows	 that	 for	 relative	
viscosities	 of	 1	 to	 2,	 the	 slope	was	 approximately	 1,	 as	 expected,	 compared	 to	 T5	 FEN	 data.	
However,	 a	much	 greater	 impact	 on	 relative	 rate	was	 observed	with	 hFEN1	with	 η/η0	 values	
greater	than	2;	this	appears	to	almost	be	exponential	with	a	slope	closer	to	2	(Fig.	3.xi.b).	This	
could	 be	 due	 to	 a	 few	 reasons:	 First,	 an	 assumption	 of	 the	 equations	 above	 is	 that	 only	
bimolecular	association	is	affected	by	viscosity	changes,	thus	the	enhanced	slope	could	be	due	
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to	 more	 than	 one	 kinetic	 process	 being	 affected	 by	 viscogen,	 for	 example	 a	 conformational	
change.	Second,	 it	 could	be	due	to	 the	glycerol	 stabilising	an	 inactive	conformation	of	hFEN1,	
with	 its	 osmolyte	 properties.	 This	 would	 have	 the	 effect	 of	 augmenting	 the	 viscosity	
dependence	 with	 an	 apparent	 inhibition.	 The	 second	 situation	 is	 unlikely	 as	 the	 same	
experiment	 done	 by	 Dr.	 Jack	 Exell	 show	 the	 viscogen	 sucrose	 also	 display	 a	 similar	 viscosity	
dependence.	 Nevertheless,	 the	 data	 suggests	 that	 some	 other	 process	 is	 being	 slowed	 by	
viscosity,	causing	a	much	greater	decrease	in	rate	than	expected,	questioning	whether	hFEN1	is	
solely	diffusion	limited.	
	
	
Figure	 3.xi.	 Assessment	 of	 diffusion	 control	 for	 hFEN1.	 Inverse	 second	 order	 rate	 constants	 plotted	
versus	 relative	viscosity	 (left).	The	 linear	 regression	by	 least	 squares	was	only	done	with	 the	 first	 three	
points.	The	second	order	rate	constant	at	relative	viscosity	of	1,	or	(kcat/KM)
0,	was	calculated	from	the	line	
equation	 according	 to	 equation	 3.6.	 The	 reciprocal	 of	 the	 relative	 second	 order	 rate	 constants	 versus	
relative	viscosity	are	present	on	the	right.	The	linear	regression	of	the	experimental	data	is	represented	
as	a	blue	line,	and	has	a	slope	of	around	2.	Slopes	of	1	for	diffusion	limited	enzymes	and	0	for	no	diffusion	
limitation	are	represented	as	black	dashed	and	dotted	lines	respectively.		
	
3.5 Discussion 
Using	 LFER	 it	 can	be	 shown	 that	 for	 the	WT	hFEN1	 reaction	 chemistry	 is	 not	 slow	enough	 to	
impact	 rates	 under	 multiple	 or	 single-turnover	 conditions.	 The	 chemical	 rate	 kchem	 was	 not	
enhanced	significantly	by	decreasing	the	pKa	of	the	3’-OH	leaving	group	in	the	wild	type	hFEN1	
protein.	 Under	 single-turnover	 conditions	 there	 was	 a	 minimal	 LFER,	 but	 the	 2’-OMe	 group	
skews	the	results,	possibly	due	to	steric	clashes.	More	altered	3’-OH	pKa	substrates	would	be	
preferable	 to	 fully	 confirm	 this	 result.	 But	 it	 does	 suggest	 that	 the	 chemical	 rate	must	 be	 an	
order	of	magnitude	faster	than	another	single-turnover	rate.	Thus,	a	proposed	conformational	
change	is	rate-limiting	or	close	to	rate-limiting	under	single-turnover	conditions.	
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The	mutant	hFEN1Y40A,	while	not	occurring	naturally,	has	a	significant	sensitivity	to	3’-OH	leaving	
group	pKa.	It	displays	a	100-fold	rate	enhancement	at	lower	3’	pKa	values.	This	in	effect	means	
that	 catalytic	 mutants,	 including	 naturally	 found	 mutations	 such	 as	 E160D,	 of	 hFEN1	 could	
preferentially	 target	 RNA	 over	 DNA.105	 One	 important	 location	 in	 vivo	where	 this	might	 have	
implications	is	the	replication	fork.	Okazaki	fragments	are	capped	on	their	5’	termini	by	the	RNA	
primers	 laid	 out	 by	 the	 Pol-α	 primase	 complex.	 Therefore	 the	 activity	 of	 chemically	 impeded	
hFEN1	mutants	may	be	faster	for	RNA	primers	compared	to	DNA	in	the	replication	fork	in	vivo.	
Changing	the	efficiency	by	which	hFEN1	processes	the	RNA	primer	and	DNA	portions	of	Okazaki	
fragments	could	cause	defects	during	Okazaki	fragment	maturation.106	
	
Viscosity	 studies	 on	 multiple-turnover	 rates	 show	 that	 the	 rate	 is	 affected	 in	 a	 non-linear	
fashion	with	respect	to	the	relative	viscosity	of	glycerol.	This	is	most	likely	due	to	the	effects	of	
bimolecular	 diffusion	 and	 one	 or	 more	 physical	 process	 working	 together.	 Similar	 diffusion	
curves	 have	 been	 noticed	 previously	 for	 an	 enzyme	 that	 folds	 upon	 binding.107	 The	 viscogen	
could	 be	 affecting	 the	 kinetics	 of	 a	 folding	 event	 or	 similar	 conformational	 change	 in	 hFEN1	
during	 catalysis.	 Indeed	 it	 has	 been	 noted	 that	 the	 presence	 of	 viscogens	 can	 slow	
conformational	 rearrangements.108	The	presence	of	viscogen	can	even	slow	rates	 for	enzymes	
with	conformational	changes	present	 in	their	catalytic	cycle.109	Furthermore,	 the	effect	 is	only	
seen	for	microviscogens	like	glycerol,	but	it	is	not	noticed	in	the	presence	of	macroviscogens	like	
bovine	serum	albumin	(BSA).	For	hFEN1,	recent	studies	using	single-molecule	techniques	have	
shown	that	glycerol	or	sucrose	inhibits	an	apparent	single-turnover	rate,	which	is	independent	
of	 diffusion.40	 However,	 the	 same	 study	 with	 the	 macroviscogen	 polyethylene	 glycol-8000	
showed	 no	 inhibition	 of	 rate.	 The	microviscogen	 slows	 the	 conformational	 rearrangement	 of	
domains	 by	 solvent	 friction,	 hence	 the	 dependence	 on	 viscosity,	 whereas	 the	macroviscogen	
cannot.	This	 further	 lends	weight	to	the	 idea	of	a	conformational	change	playing	a	role	 in	the	
catalytic	process	of	hFEN1.	Therefore,	the	non-linear	effect	of	viscogen	on	the	relative	second	
order	rate	constants	observed	in	this	chapter	was	likely	due	to	a	combination	of	two	processes.	
Firstly	viscogen	affects	 the	 rates	of	bimolecular	association	and	secondly,	 it	 slows	subsequent	
conformational	 changes.	 The	 rate	of	 the	 conformational	 change	 therefore	plays	an	 important	
role	 in	 catalysis.	 The	 main	 two	 questions	 remaining	 are,	 therefore,	 how	 fast	 is	 this	
conformational	 change	 occurring,	 and	 in	 what	 regions	 of	 the	 protein	 is	 it	 happening?	 The	
remainder	of	the	thesis	will	attempt	to	answer	these	two	questions.	
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Chapter 4: Optimisation of the hFEN1 protein system for 
assignment and subsequent NMR experiments 
4.1 NMR spectroscopic studies of enzymes 
NMR	 spectroscopy	 is	 a	 very	 powerful	 technique,	 used	 for	 decades	 on	 small	 molecules	 to	
characterise	 their	 structure,	 rates	 of	 reaction	 or	 interaction	 with	 each	 other.	 For	
macromolecules,	 such	 as	 proteins,	 the	 technique	 is	 slightly	 more	 complex.	 As	 the	molecular	
weight	of	a	compound	increases	so	does	the	R2	relaxation	rate,	allowing	less	and	less	time	for	
acquisition	of	 coherent	 data.	 Thus,	 line	broadening	 leads	 to	 a	 decrease	 in	 the	 signal	 to	 noise	
ratio	(S:N).	A	spectrum	also	becomes	much	more	crowded,	with	hundreds	of	peaks	rather	than	
tens.	Using	specific	techniques	such	as	multi-dimensional	spectra,	TROSY	pulse	sequences	and	
selective	 labeling	 of	 proteins,	 it	 is	 possible	 to	 nullify	 most	 of	 the	 problems	 associated	 with	
macromolecules	and	garner	useful	information	about	a	protein	system	in	solution.	This	chapter	
will	 cover	 the	 techniques	 for	 assembling	 a	 hFEN1	 protein	 construct	 for	 NMR	 spectroscopic	
studies.	 It	 will	 also	 cover	 the	 screening	 procedures	 applied	 to	 acquire	 TROSY	 spectra	 with	
acceptable	S:N,	and	the	assignment	strategy	of	a	novel	protein	system.	
	
4.2 Preparation of protein for NMR spectroscopic studies 
4.2a Protein expression and purification  
Human	 FEN1	 (hFEN1)	 is	 a	 380-amino	 acid	 residue	 protein	 that	 consists	 of	 a	 nuclease	 core	
domain	(amino	acid	residues	1-336),	which	is	sufficient	for	catalysis	as	shown	by	single-turnover	
rate	constants.27	The	remainder	is	an	extended	C-terminus	that	contains	the	nuclear	localization	
signal	and	a	PCNA	interacting	peptide	box	(PIP	box).110	The	extended	C-terminus	has	also	been	
implicated	as	necessary	for	 interaction	with	several	other	DNA	metabolic	proteins.111	Studying	
the	 protein	 dynamics	 relevant	 to	 catalysis	 was	 the	 main	 aim	 of	 the	 project;	 therefore,	 the	
hFEN1-336	construct	used	previously	for	X-ray	crystallography	was	used.27	A	plasmid	construct	
for	 hFEN1-336,	 complete	 with	 a	 C-terminal	 (His)6-tag	 that	 was	 removable	 using	 the	 human	
rhinovirus	3C	protease	was	produced	previously	by	Dr.	Brian	Chapados.27	Thus,	the	final	hFEN1-
336	construct,	which	is	38	kDa,	contains	336	native	amino	acids	with	an	additional	six	residues	
(LEVLFQ,	see	Fig.	4.i)	present	at	the	C-terminus	from	the	protease	recognition	site.	Herein,	the	
hFEN1-336	construct	will	simply	be	called	hFEN1.	
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Figure	4.i.	A	secondary	structure	map	of	the	hFEN1-336	construct.	The	primary	sequence	of	hFEN1-336	
is	listed,	with	secondary	structures	mapped	and	α	helices	and	β	strands	listed.	It	should	be	noted	that	the	
secondary	 structure	 elements	 are	 not	 spatially	 aligned.	Magenta	 residues	 are	 active	 site	 carboxylates,	
purple	residues	are	part	of	the	H2tH	motif,	blue	residues	are	part	of	the	3’	flap	binding	pocket	and	red	are	
part	of	the	arch.	
	
Isotopically	enriched	hFEN1	protein	was	produced	 in	BL23(DE3)-RILP	E.	coli	cells	 (Section	2.1),	
and	purified	using	three	chromatography	procedures:	Imobilised	metal	affinity	chromatography	
(Co2+-IMAC),	 anion-exchange	 and	 heparin-affinity.	 The	 IMAC	 column	 allows	 capture	 of	 the	
(His)6-tagged	protein	 from	 the	 cell	 lysate.	Anion-exchange	 chromatography	 removes	 any	DNA	
that	is	non-specifically	bound	to	hFEN1.	Purification	attempts	without	this	step	resulted	in	large	
amounts	of	DNA	contamination	present	(Fig.	4.ii.a,b).	Finally	the	heparin	column	separates	out	
any	proteins	that	do	not	bind	to	DNA.	Following	purification,	the	protein	samples	were	buffer	
exchanged	 into	 the	 appropriate	 NMR	 buffer	 (Chapter	 2:	 Table	 7).	 Overall	 this	 procedure	
produced	pure	samples	of	hFEN1	in	sufficient	yield	for	NMR	spectroscopy	samples	(Fig.	4.ii.c).	
For	15N	labeled	hFEN1	a	cell	grow-up	of	1L	resulted	in	1.5	mol	of	protein,	or	approximately	57	
mg.	For	triply	labeled	2H,	15N,	13C	hFEN1	a	cell	grow-up	of	500	mL	resulted	in	1.1	μmol	or	40	mg	
of	protein.	
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Figure	4.ii.	Agarose	gel	electrophoresis	and	SDS	PAGE	of	purified	hFEN1.	 (A)	Agarose	gel,	stained	with	
SYBR	 safe	 of	 a	 protein	 sample	 taken	 after	 the	 purification	 procedure	with	 no	 anion	 exchange	 column.	
There	 are	 large	 smears	 of	 DNA	 contamination,	 despite	 other	 purification	 steps.	 (B)	 Agarose	 gel	 of	
subsequent	purification	procedure	with	an	anion	exchange	column	step	added	after	 the	 IMAC	column,	
the	 gel	 was	 stained	 with	 SYBR	 safe	 (left)	 for	 DNA	 and	 SYPRO	 ruby	 (right)	 for	 protein.	 (C)	 A	 SDS	
polyacrylamide	gel	showing	the	final	purity	of	the	sample.	Bands	at	the	bottom	of	the	gel	are	potential	
degradation	 products	 from	 heating	 SDS	 samples	 at	 95	 °C,	 subsequent	 samples	 heated	 at	 65	 °C	 for	 10	
minutes	do	not	show	these	bands.	
	
4.2b Protein stability optimisation using different reducing agents 
My	contribution	to	the	work	began	with	an	attempt	to	improve	conditions	of	hFEN1	in	solution	
under	high	concentrations,	mainly	in	an	attempt	to	inhibit	precipitation.	hFEN1	protein	contains	
6	 cysteines	 (C141,	C163,	C182,	C227,	C235	and	C311),	with	4	of	 them	containing	buried	 thiol	
side-chains	 (163,	182,	235	and	311)	while	 the	other	 two	are	partially	exposed	 (141,	227).	The	
oxidation	 of	 cysteines	 have	 been	 linked	 to	 protein	 degradation,112	 and	 also	 hFEN1	 is	 more	
catalytically	 active	under	 reducing	 conditions	due	 to	 it	being	a	nuclear	protein.	 Therefore	 the	
reducing	 agent	 dithiothreitol	 (DTT)	 (1-10	 mM)	 was	 always	 included	 into	 the	 buffer	 for	 the	
spectra	 above.	 To	 ensure	 that	 the	 long-term	 instability	 of	 the	 protein	 was	 not	 caused	 by	
exhaustion	 of	 the	 reducing	 agent,	 high	 concentrations	 (100	 mM)	 of	 DTT,	 tris(2-
carboxyethyl)phosphine	(TCEP)	and	beta-mercaptoethanol	(βME)	were	supplemented	to	three	
separate	samples.	Surprisingly,	100	mM	βME	was	the	most	effective	at	preventing	precipitation	
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in	the	time	necessary	for	dynamic	experiments	to	be	conducted	(>	1	month).	The	effect	of	βME	
is	 likely	due	 to	 its	 osmolyte-like	properties	 in	 addition	 to	 its	 reducing	 capacity.	 Samples	were	
also	 placed	 under	 argon	 to	 retard	 the	 oxidation	 of	βME	 as	 well	 as	 preventing	 paramagnetic	
oxygen	 from	dissolving	 in	 solution.	Despite	all	of	 these	measures,	 the	protein	 still	 aggregated	
over	the	course	of	one	month,	although	acceptable	spectra	could	be	obtained	on	this	timescale.	
	
4.3 Optimisation of 1H-15N TROSY spectra by mutagenesis and small 
molecule addition 
4.3a Observations of the wild type 1H-15N TROSY spectra 
Initial	1H-15N	TROSY	spectra	taken	previously	by	Dr.	David	Finger	with	perdeuterated	samples	in	
appropriate	 optimised	 buffer	 were	 promising,	 and	 yielded	 acceptable	 S:N	 for	 assignment	
purposes	(Section	1.5b).	 Inspecting	the	1H-15N	TROSY	assignment	spectra	of	2H,	13C,	15N	hFEN1	
protein	shows	the	scatter	of	chemical	shifts	was	that	of	a	well-folded	protein	(Fig.	 4.iii).	Most	
amide	 peaks	 fit	 within	 105-133	 ppm	 for	 15N	 and	 6.6-9.5	 ppm	 for	 1H.	 There	 were	 large	
differences	 in	peak	height,	most	peaks	exhibited	a	 range	of	1-10	 times	 intensity	 compared	 to	
the	weakest	peak	(E257),	with	some	reaching	25	to	35	times.	This	suggested	that	not	all	peaks	
were	 relaxing	 uniformly.	 There	 were	 292	 observable	 secondary	 amide	 peaks	 (excluding	 side	
chain	 amides	 from	 glutamines	 and	 asparagines	 and	 tryptophan	 N-H	 peaks).	 The	 backbone	
amides	 of	 prolines	 are	 indefinable	 due	 to	 their	 lack	 of	 an	 amide	 proton	 and	 account	 for	 15	
missing	 peaks	 in	 the	 1H-15N	 TROSY	 spectrum.	 The	 initiator	methionine	 is	 not	 present	 due	 to	
removal	 by	 N-terminal	 amino	 peptidase	 during	 expression,	 so	M1	 is	 not	 observed.	 However,	
there	was	still	a	discrepancy	between	the	292	detectable	amide	peaks	and	the	324	theoretically	
detectable	peaks.	This	 inconsistency	could	be	due	to	broad	peaks	or	peak	overlap	 in	crowded	
regions	of	the	spectra.	
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Figure	 4.iii.	 1H-15N	 TROSY	 spectrum	 of	 2H,	 13C,	 15N	 hFEN1	 for	 assignment	 purposes.	 Each	 peak	
corresponds	to	a	1H-15N	correlation,	with	most	backbone	amides	showing	as	a	peak,	alongside	sidechains	
of	 asparagines,	 glutamines	 (green	 box)	 and	 tryptophans	 (cyan	 box).	 The	 scatter	 is	 indicative	 of	 a	 well	
folded	protein	structure.	The	peaks	are	much	sharper	due	to	perdeuteration	of	the	protein	sample.	The	
sample	was	done	in	the	presence	of	0.1	mM	EDTA	
	
Peak	 overlap	 is	 caused	 by	 two	 or	more	 amide	 groups	 sharing	 similar	 chemical	 shifts	 and	 can	
result	 in	confusing	protein	fingerprinting.	Changing	the	chemical	environment	of	each	residue,	
usually	 by	 altering	 the	 tertiary	 protein	 structure,	 can	 separate	 peaks.	 Furthermore,	 triple	
resonance	experiments	 can	usually	 separate	out	overlapped	peaks	due	 to	 the	carbons	having	
distinctive	 chemical	 shifts.	 Inherent	 peak	 broadening	 in	 large	 molecules	 due	 to	 reasons	
discussed	 in	 section	 1.5a	 can	 result	 in	 a	 reduction	 in	 the	 S:N	 to	 the	 point	where	 a	 peak	 has	
vanished	into	the	noise.	Furthermore,	peaks	exchanging	between	two	or	more	distinct	chemical	
states	 could	 cause	 peak	 broadening.	 If	 the	 rate	 of	 exchange	 is	 approximately	 equal	 to	 the	
chemical	shift	difference,	peaks	will	broaden	out	and	can	be	lost	in	the	noise.	Finally,	although	
the	protein	sample	was	optimised	for	stability	it	still	aggregated	over	weeks.	Protein	aggregate	
will	cause	problems	with	magnet	shimming,	as	well	as	differing	conformations	being	sampled	as	
the	 pulse	 sequences	 are	 acquired.	 This	 will	 result	 in	 a	 lowered	 S:N	 as	 well	 as	 undesirable	
conformations,	 which	 are	 unrepresentative	 of	 the	 natural	 protein	 structure.	 Therefore	 two	
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potential	solutions	to	this	problem	were	undertaken.	Firstly,	small	molecules	were	added	in	an	
attempt	 to	 stabilise	 the	 protein	 and	 potentially	 shift	 peaks	 in	 crowded	 regions.	 Secondly,	
residues	were	mutated	on	the	protein,	in	order	to	enhance	stability	and/or	change	the	structure	
enough	to	notice	a	change	of	exchange	regimes.	
	
4.3b Addition of small molecules to enhance spectral quality and sample stability 
Previous	NMR	 studies	 have	 shown	 that	 small	molecules	 can	 also	 increase	 protein	 stability	 at	
high	concentrations.113	A	1:1	arginine/glutamic	acid	mixture,	various	mono-	and	di-nucleotides,	
and	 known	 inhibitors	 of	 hFEN1	 were	 added	 to	 determine	 if	 these	molecules	 would	 improve	
spectra	 and	 stabilize	 the	 sample.	 A	 50	 mM	 1:1	 arginine/glutamic	 acid	 mixture	 did	 not	
significantly	 help	 the	 sample	 in	 stability	 or	 spectral	 quality.	 Addition	 of	 3’-5’	 adenosine	 bis-
phosphate	 (10	 x	protein	 concentration),	 1x	dTpdA	dinucleotide	 (1	 x	protein)	 and	a	previously	
reported	cyclopropyl	 inhibitor	 (2	 x	protein),26	 all	 caused	chemical	 shift	 changes	 in	hFEN1	 (Fig.	
4.iv).	Most	of	the	shifts	were	observed	in	or	around	active	site	regions,	such	as	the	N-terminus	
of	the	protein	or	proximal	to	active	site	carboxylates.	There	were	more	dramatic	changes	with	
the	inhibitor	than	with	the	bis-phosphate	or	dinucleotide.	This	is	consistent,	as	it	is	expected	all	
these	molecules	would	occupy	the	active	site	to	a	certain	degree,	but	the	inhibitor	is	known	to	
bind	to	the	active	site	with	nM	affinity.26,114	
	
Chapter	4:	NMR	optimisation	and	assignment		
	72	
	
Figure	4.iv.	 1H-15N	TROSY	spectra	of	hFEN1	with	different	small	molecules	added.	The	spectra	showed	
are	wild	type	protein	(red),	hFEN1	with	1:1	dTpdA	dinucleotide	(cyan),	10:1	3’-5’	bis-phosphate	(orange)	
and	2:1	cyclopropyl	inhibitor	(dark	grey).	The	spectra	are	all	recorded	in	the	presence	of	8	mM	CaCl2.	
	
Equally	 dramatic	 changes	 were	 observed	 with	 addition	 of	 deoxyribose	 adenosine	
monophosphate	 (dAMP).	Upon	 addition	 of	 dAMP,	 changes	were	 observed	 in	 and	 around	 the	
active	site	regions,	like	with	the	previous	inhibitor	and	nucleotides.	However	there	was	also	an	
unexplained	 change	 in	 dynamics	 of	 certain	 residues	 associated	 with	 the	 arch	 and	 3’	 binding	
pocket	of	hFEN1	(Fig.	4.v).	To	understand	these	exchange	processes	better,	a	titration	of	dAMP	
was	performed	in	the	presence	of	8	mM	CaCl2.	Concentrations	of	dAMP	(0,	0.39,	0.78,	1.6,	2.8,	
4.7,	6.2	and	7.8	mM)	caused	steady	shift	changes	in	active	site	regions	until	reaching	saturation	
around	6.2	mM,	indicating	a	fast	exchange	process.	One	example	was	S157	(Fig.	4.v.d),	which	is	
close	to	the	active	site	carboxylates	E160	and	E158,	that	reports	a	KD	of	4.5	±	1.4	mM.	Other	fast	
exchanging	residues	were	A155	(Fig.	4.v.c)	(KD	3.4	±	0.85	mM),	Q4	(Fig.	4.v.c)	(KD	1.6	±	0.55	mM)	
and	G78	(Fig.	4.v.a)	(KD	3.0	±	1.2	mM),	all	within	a	similar	weak	mM	binding	state.	The	binding	
was	not	uniform	however,	 as	A45	displayed	 a	 slow	exchange	pattern	 (Fig.	 4.v.e),	while	G118	
disappeared	completely,	suggesting	an	intermediate	exchange	process	(Fig.	4.v.b)	and	G87	was	
more	fast-intermediate	(Fig.	4.v.b).		
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To	 test	 whether	 the	 binding	 was	 linked	 to	 the	 active	 site,	 8.1	 mM	 EDTA	 was	 added	 to	 the	
sample	to	chelate	all	Ca2+	ions.	All	peaks	that	were	shifted	by	the	addition	of	dAMP	were	shifted	
back	 to	 their	 original	 EDTA	position,	 and	G118	 reappeared	 (Fig.	 4.v.a).	 This	 strongly	 suggests	
that	the	interaction	location	of	the	dAMP	is	 in	the	active	site	and	furthermore,	is	mediated	by	
the	divalent	cations	present	there.	Overall,	although	shifts	were	observed	for	various	residues	
upon	the	addition	of	nucleotides	and	FEN	 inhibitors,	none	of	 the	small	molecules	significantly	
improved	long-term	sample	stability	and	so	were	not	chosen	to	use	for	assignment	purposes.	
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Figure	4.v.	dAMP	titration	of	hFEN1.	(A)	A	1H-15N	TROSY	spectra	showing	wild	type	hFEN1	in	8	mM	CaCl2	
(red),	hFEN1	in	8mM	CaCl2	with	20.7	X	dAMP	added	(blue)	and	hFEN1	in	8.1	mM	EDTA	with	20.7	x	dAMP	
present	 (black).	 Below	 that	 are	 panels	 (B-E)	 highlighting	 specific	 residues	 during	 the	 dAMP	 titration.	
dAMP	concentraitons	are	0	mM	(red),	0.39	mM	(maroon),	0.78	mM	(orange),	1.6	mM	(green),	2.8	mM	
(cyan),	4.7	mM	(teal),	6.2	mM	(purple)	and	7.8	mM	(blue).	
Chapter	4:	NMR	optimisation	and	assignment		
	 75	
4.3c Protein mutation choices in order to enhance spectral quality and sample stability 
A	potential	target	for	mutation	was	one	of	the	six	cysteine	residues	in	hFEN1,	as	thiol	moieties	
are	known	to	oxidise	when	exposed	to	reactive	oxygen	or	reactive	nitrogen	species.112	Oxidation	
of	 the	 thiols	 could	 result	 in	 much	 bulkier	 hydrophilic	 groups,	 and	 might	 change	 the	
conformation	 of	 the	 protein,	 perhaps	 unfolding	 it.	 As	 the	 reducing	 agent	 βME	 enhanced	 the	
stability	of	samples,	it	was	decided	to	investigate	whether	removal	of	cysteine	side	chains	could	
improve	 the	 spectra.	Mutation	 of	 these	 residues	 to	 a	 threonine	 was	 selected,	 as	 this	 would	
mimic	a	hydrogen	bonded	buried	residue,	but	eliminate	the	potential	of	oxidation.	15N	labeled	
proteins	of	C163T,	C182T,	C235T	and	C311T	were	cloned,	expressed	and	prepared	by	Dr.	David	
Finger.	Comparing	the	1H-15N	TROSY	spectra	of	the	mutants	(Fig.	4.vi),	the	main	structure	of	the	
protein	 remained	 unchanged.	 However,	 individual	 mutations	 failed	 to	 stop	 aggregation.	
Attempts	to	express	a	triple	and	quadruple	cysteine	mutated	protein	resulted	in	the	formation	
of	 inclusion	 body	 at	 protein	 expression	 stages,	 perhaps	 due	 to	 incorrect	 protein	 folding	 or	
degradation.	
	
	
Figure	4.vi.	 1H-15N	TROSY	spectra	of	 four	cysteine	mutants.	Cysteine	mutants	show	very	similar	overall	
protein	architectures.	There	are	however,	 local	differences	present	at	or	near	mutated	 residues,	which	
Chapter	4:	NMR	optimisation	and	assignment		
	76	
are	 indicated	on	 the	 spectra.	C182	cannot	be	assigned,	but	G186	highlights	a	good	change	 in	 chemical	
shift	from	its	normal	position.	
	
Another	 potential	 choice	 for	mutation	was	 a	 proline	 residue,	 as	 it	 can	 help	 introduce	 a	 new	
peak	in	resonance-transferred	experiments.	A	second	reason	for	choosing	proline	is	its	ability	to	
isomerise	 its	ω-bond	between	cis	and	trans	 forms.	Prolyl	 isomerisation	has	been	known	to	be	
important	 in	 a	wide	 scope	of	biochemical	processes,	 including	protein	 folding	and	 stability.115	
Furthermore,	the	residue	S187,	which	 is	buried	 in	a	hydrophobic	pocket	has	been	reported	to	
be	phosphorylated	by	Cdk-Cyclin	complexes.116	One	possibility	 is	that	the	adjacent	proline	188	
might	exist	in	several	conformers,	allowing	the	kinase	to	access	the	serine	for	phosphorylation.	
The	 isomerisation	allows	for	conformational	change	 in	the	region	around	the	proline,	perhaps	
causing	 its	residues	to	be	 in	 intermediate	exchange,	hence	a	reduction	 in	signal.	Furthermore,	
due	to	the	week	timescales	of	aggregation,	a	prolyl	isomerisation	could	be	the	cause	of	such	a	
slow	forming	event.	Changing	the	residue	to	a	alanine,	which	will	only	reside	in	the	trans	form,	
would	abolish	prolyl-isomerisation,	aiding	the	S:N,	and	may	help	separate	out	peaks	in	crowded	
regions.	
	
4.4 Assignment of a novel mutant of hFEN1 
4.4a Assignment strategy of P188A mutant hFEN1. 
Triply	 labeled	 hFEN1P188A	 protein	 with	 15N,	 13C	 and	 2H	 was	 required	 to	 perform	 a	 fresh	
assignment.	hFEN1P188A	protein	was	prepared	from	plasmids	constructed	by	Dr.	David	Finger	in	
the	 same	method	as	 reported	 (Section	 2.1).	 The	purification	procedure	 allowed	 for	 sufficient	
back-exchange	 of	 amide	 deuterons	 to	 protons,	 as	 1H-15N	 TROSY	 spectra	 for	 both	 showed	 no	
change	 upon	 a	 triple-labeled	 sample	 preparation	 (Fig.	 4.viii).	 The	 yield	 of	 15N,	 13C,	 2H	 triply	
labeled	 protein	 from	 a	 500	 mL	 grow-up	 was	 1.4	 μmol,	 or	 approximately	 50	 mg	 of	 protein.	
Deuteration	of	non-labile	protons	in	the	protein	allowed	for	reduced	dipole-dipole	interactions	
between	 detected	 amide	 protons	 and	 adjacent	 C-H	 and	 N-H	 moieties,	 resulting	 in	 sharper	
peaks.	 Six	 TROSY	 triple-resonance	 experiments	 were	 performed:	 HNCO,	 HNCA,	 HNCACB,	
HN(CA)CO,	HN(CO)CA	and	HN(CO)CACB	as	described	in	Section	2.3c.	
	
4.4b Confirming the wild type hFEN1 assignment by using an independent hFEN1P188A 
assignment 
The	data	was	analysed	using	CCPNMR	analysis	 software.88	The	data	was	displayed	as	strips	of	
specific	15N	frequencies	(z-axis)	with	the	carbon	peaks	spread	vertically	(y-axis)	at	the	correlating	
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proton	 frequency	 (x-axis).	 Examining	 the	 directed	 experiments	 reveals	 what	 the	 carbon	
frequencies	for	i-1	would	be,	but	detected	on	i’s	amide	residue.	Links	were	found	by	searching	
the	spectra	for	non-directed	carbon	shifts,	which	match	up	with	the	directed	experiments	but	
on	a	different	amide	residue.	Using	unique	13C	chemical	shifts	(e.g.	alanine	or	glycine)	for	both	
Cα	and	Cβ,	it	was	possible	to	identify	unique	sequences	of	amino	acids	which	appear	only	once	
or	 twice	 in	 the	 hFEN1	 protein	 sequence	 (i.e.	 AAA,	 GA,	 AG).	 Using	 this	 technique	 73%	 of	 the	
theoretically	detectable	peaks	 in	 the	protein	were	assigned	 (Fig.	 4.vii)	 (BMRB	accession	code:	
27403,	Appendix	A1).	
	
Figure	 4.vii.	 Cartoon	 representation	 of	 the	 hFEN1P188A	 molecule	 to	 illustrate	 location	 of	 assigned	
residues.	 (A)	A	cartoon	showing	 the	3Q8K	structure	with	 important	 regions	highlighted,	 the	arch	 (red),	
the	α2-α3	 loop	 (blue),	 the	 saddle	 region	 (orange	 saddle),	 the	 positions	 of	 the	 two	 catalytic	metal	 ions	
(black	 spheres)	 and	 the	 potassium	 ion	 in	 the	 H2tH	 motif	 (purple	 sphere).	 (B)	 The	 assigned	 (red)	 and	
unassigned	 (grey)	 residues	 are	 coloured	 onto	 the	 product	 crystal	 structure	 3Q8K.	 Secondary	 structure	
elements	are	labeled	for	clarity.	
	
The	 hFEN1P188A	 protein	 assignment	 sought	 to	 confirm	 the	 links	 from	 the	 previous	 assignment	
done	on	WT	hFEN1,	as	well	as	improve	on	the	70%	assignment,	especially	in	regions	of	interest	
(bottom	of	 α4,	 and	 residues	 known	 to	 be	 in	 the	 active	 site	Fig.	 4.vii.a).	 A	 similar	 quantity	 of	
assignment	 was	 achieved	 (73%),	 but	 a	 higher	 degree	 of	 assignment	 confidence	 on	 the	 WT	
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hFEN1	protein	was	obtained.	New	residues	were	assigned	at	 the	middle	of	 the	α4	arch	 (E106	
and	 A105),	 but	 the	 bottom	 of	 the	 arch	 still	 remained	 unassignable.	 Additionally	 S210	 was	
assigned	at	the	top-left	of	the	spectrum	(Fig.	4.viii).	Some	peaks	have	been	shifted	so	that	they	
are	more	 dispersed	 and	 allow	 for	 easier	 and	 less	 ambiguous	 assignments.	 Conversely,	 other	
peaks	 like	 H276,	 upfield	 in	 proton,	 changed	 exchange	 regime	 and	 showed	 a	 reduced	 peak	
signal,	especially	in	the	triple	resonance	experiments.	
	
	
Figure	 4.viii.	 1H-15N	 TROSY	 spectra	 of	 hFEN1P188A	 and	 wild-type	 hFEN1.	 Wild	 type	 hFEN1	 protein	
spectrum	(blue)	overlaid	with	hFEN1P188A	protein	spectrum	(red).	The	two	tryptophans	are	highlighted	
in	the	top-left	panel	and	289L	is	highlighted	in	the	bottom-right	panel.	Both	proteins	are	perdeuterated.	
	
Overall	 the	 P188A	mutant	 helped	 confirm	 the	 assignment	 already	 achieved,	 identified	 some	
new	peaks	on	the	WT	spectrum,	as	well	as	 identifying	regions	of	 interest	 that	are	affected	by	
the	mutation.	Residues	 such	as	289L	or	 tryptophan	 side	chains	exhibit	distinct	 slow	exchange	
patterns,	 resulting	 in	differently	populated	peaks	between	WT	and	P188A	protein	 (Fig.	 4.viii).	
This	 shows	 signs	 of	 conformational	 motion	 that	 suggests	 these	 residues	 were	 sampling	 two	
rotameric	states	affected	by	flexibilities	elsewhere	in	the	protein.	Mutating	the	P188	residue	to	
alanine	mainly	resulted	in	a	change	of	the	local	conformations	of	residues	in	close	proximity	to	
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the	mutation	and	did	not	affect	the	remainder	of	the	protein	structure.	Similarly	it	did	not	allow	
for	 significantly	 new	 assignments	 to	 be	 found,	 yielding	 no	 new	 peak	 separations.	 Finally	 the	
hFEN1P188A	protein	has	 shown	 that	 the	proline	and	 the	 conformations	associated	with	 it	 have	
little	to	do	with	the	stability	of	the	protein,	as	it	remained	equally	prone	to	aggregation	as	the	
WT	 hFEN1	 protein.	 Despite	 the	 P188A	 mutant	 yielding	 a	 new	 assignment,	 it	 did	 not	 solve	
solubility	 issues.	 This	 fact,	 combined	 with	 the	 issue	 of	 unrepresentative	 conformational	
dynamics	means	that	the	WT	hFEN1	protein	was	chosen	for	further	studies.	
	
4.5 Chemical shift analyses of previously assigned wild type hFEN1 protein 
The	majority	of	unassigned	peaks	were	found	in	the	bottom	of	α4,	bottom	of	α5,	the	active	site,	
α2	 and	 α3.	 A	 peak	 height	 analysis	 showed	 that	 the	 interfaces	 between	 assignable	 and	
unassignable	regions	had	peaks	of	decreasing	intensity	(Fig.	4.ix).	This	implies	that	the	missing	
peaks	 were	 undergoing	 intermediate	 exchange,	 and	 hence	 could	 not	 be	 seen	 in	 the	 1H-15N	
TROSY	spectra.	The	mutation	P188A	had	no	 impact	on	these	dynamics,	and	 they	are	 likely	an	
intrinsic	property	of	 the	protein.	 In	contrast,	 residues	 in	the	α2-α3	 loop,	some	residues	 in	the	
arch	region	and	the	C-terminal	tail	had	greatly	increased	peak	heights.	This	suggests	that	these	
residues	are	moving	on	a	different	timescale	to	the	remaining	portion	of	the	protein.	
	
	
Figure	4.ix.	Relative	peak	height	versus	 residue	number.	Peak	height	 is	relative	to	the	lowest	 intensity	
assigned	 peak	 (E257)	 obtained	 from	 the	 wild	 type	 hFEN1	 protein	 1H-15N	 TROSY	 spectrum.	 Secondary	
structure	 from	 the	 3Q8K	 crystal	 structure	 is	 mapped	 below,	 with	 red	 regions	 displayed	 as	 areas	 of	
structural	heterogeneity	between	crystal	structures	3Q8K	and	1UL1.	Active	site	carboxylates	are	labeled	
on	 the	 top	of	 the	plot	 in	magenta,	 basic	 residues	 that	 contact	DNA	 in	 cyan,	 and	 the	H2tH	motif	 as	 an	
orange	box.	
	
Chemical	 shift	 analysis	 of	 all	 assigned	 backbone	 nuclei	 (15N,	 1HN,	 13Cα,	 13Cβ	 and	 13C')	 was	 also	
conducted	using	TALOS-N.89	The	algorithm	predicts	the	backbone	torsion	angles	ψ	and	φ	based	
on	 chemical	 shifts	 compared	 to	 a	database	of	 known	 tripeptide	 sequences	 and	 further	 filters	
using	an	artificial	neural	network.	Thus,	it	can	predict	where	the	residue	falls	in	a	Ramachandran	
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plot,	and	therefore	compute	a	probability	score	for	α-helix,	β-strand	or	absence	of	both	(loop).	
The	hFEN1	prediction	agreed	with	the	dsDNA	binding	region	(saddle	region)	in	crystal	structures	
for	 both	 product	 bound	 (3Q8K)	 and	 apo-hFEN1	 (1UL1_X)	 protein	 (Fig.	 4.x).	 This	 confirmed	
further	the	assignments	made	on	hFEN1	protein.	
	
	
Figure	4.x.	TALOS-N	predictions	of	secondary	structure.	TALOS-N	predictions	are	shown	in	(A)	with	the	
probability	 of	 the	 predictions	 being	 correct	 for	 α-helix	 in	 blue,	 β-strand	 in	 green	 and	 absence	 of	 both	
(loop)	 in	grey.	The	secondary	structure	mapping	of	crystal	structures	1UL1	(subunit	X)	 (B)	and	3Q8K	(C)	
are	 in	 the	 plots	 below.	 The	 secondary	 structure	 mapping	 below	 is	 from	 3Q8K	 with	 heterogeneous	
sections	highlighted	in	red.	
	
Differences	within	the	prediction	and	crystal	structures	were	however	present.	E295-S299	were	
predicted	by	TALOS-N	to	display	β-strand	ψ	and	φ	angles.	Upon	further	inspection	of	the	crystal	
structures	 (3Q8K	and	1UL1_X),	 the	dihedral	angles	do	 in	 fact	 loosely	agree	with	β-strand,	but	
crystal	structure	models	display	it	as	a	loop.	Likewise	the	β1-β2	loop	actually	contains	one	turn	
of	an	α-helix,	which	was	so	small	it	was	not	considered	to	be	of	helical	nature,	but	it	is	present	
in	 both	 the	 TALOS-N	 prediction	 and	 both	 crystal	 structures.	 The	 largest	 unanswered	
discrepancies	are	present	 in	the	arch	region	of	α4-α5.	 In	apo-hFEN1	protein,	there	 is	a	 lack	of	
density	in	this	arch	region,	whereas	in	complex	with	DNA,	there	is	distinct	α-helical	nature.	The	
TALOS-N	 prediction	 agrees	 with	 the	 DNA	 bound	 protein	 for	 residues	 A106-A111,	 with	 a	
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decreasing	 probability	 of	 α-helix	 for	 Q112-Q115.	 However,	 for	 the	 remaining	 A116-E124	 the	
TALOS-N	prediction	does	not	agree	with	the	DNA	bound	protein	X-ray	structure;	these	residues	
are	predicted	to	not	exist	in	any	secondary	structure.	Thus,	only	the	N-terminus	of	the	arch	was	
consistent	with	the	structure	of	DNA	bound	hFEN1,	whereas	the	C-terminal	portion	of	the	arch	
was	not.	
	
4.6 Discussion 
hFEN1	 protein,	 could	 be	 produced	 and	 purified	 in	 large	 quantities	 suitable	 for	 NMR	
spectroscopy,	but	is	a	very	unstable	enzyme,	especially	at	concentrations	higher	than	100	μM.	
Optimised	 purification	 procedures	 allowed	 highly	 pure	 samples	 devoid	 of	 nucleic	 acid	
contamination.	 Many	 procedures	 were	 tried	 in	 order	 to	 afford	 acceptable	 spectra	 while	
mitigating	protein	aggregation,	and	to	some	degree	these	were	successful.	Buffer	optimisation	
gave	ideal	conditions,	the	main	factors	being	addition	of	100	mM	βME,	at	around	100	mM	ionic	
strength,	at	pH	7.5,	which	allowed	samples	to	remain	in	solution	for	a	month	at	25	°C.	However,	
all	of	the	mutations	designed	to	give	greater	stability,	including	both	cysteine	mutants	and	the	
P188A	 mutant,	 failed	 to	 achieve	 this.	 Nevertheless,	 hFEN1P188A	 protein	 did	 help	 achieve	 a	
greater	confidence	in	the	assignment.	
	
The	assignment	of	the	protein,	both	WT	hFEN1	and	P188A,	were	achieved	to	a	large	degree	of	
confidence,	although	most	of	the	unassigned	regions	are	present	in	regions	of	interest	(arch	and	
active	site	residues).	This	could	be	due	to	an	intrinsic	property	of	the	enzyme,	as	suggested	by	
peak	 height	 analysis,	 whereby	 these	 residues	 are	 exchanging	 in	 the	 intermediate	 regime,	
resulting	 in	 poor	 S:N.	 Other	 peaks,	 especially	 residues	 in	 the	 arch,	 α2-α3	 loop	 and	 the	 C-
terminal	 tail	 are	 much	 higher	 compared	 to	 the	 average	 of	 the	 protein,	 indicating	 enhanced	
conformational	dynamics	in	these	regions.	The	TALOS-N	secondary	structure	prediction	further	
highlights	 the	arch	 region	of	 the	protein	as	a	 curious	 region.	While	 the	N-terminal	half	of	 the	
arch	 (top	 of	 the	 traditional	 α4)	 displayed	 α-helical	 nature,	 and	 thus	 agreed	with	 DNA	 bound	
crystal	structures	of	hFEN1	(3Q8K,	5UM9),	the	C-terminal	half	(the	traditional	α5)	did	not.	This	
brings	 into	question	 the	nature	of	 this	 region	of	 the	apo-protein	 in	 solution,	both	 structurally	
and	dynamically.	
	
Addition	of	active	site	probing	small	molecules,	such	as	hFEN1	inhibitors	or	dAMP	showed	that	
the	structure	of	the	protein	is	changed	upon	binding.	Regions	around	the	active	site,	such	as	the	
protein	 N-terminus	 and	 residues	 near	 active	 site	 carboxylates	 changed	 chemical	 shift	
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considerably.	More	interestingly	is	the	ability	of	dAMP	to	change	the	dynamics	of	the	top	of	the	
arch	(G118)	to	an	intermediate	exchange	regime,	but	only	when	divalent	ions	are	present	in	the	
active	site.	This	suggests	a	level	of	connectivity	between	the	active	site	and	the	top	of	the	arch,	
further	 adding	 to	 the	 question	 of	 how	 the	 arch	 is	 linked	 to	 catalysis,	 despite	 being	 quite	 far	
away	in	space.	
	
The	 arch	 is	 a	 striking	 feature	 of	 hFEN1.	 Its	 role	 in	 in	 terms	 of	 substrate	 recognition	 through	
threading,	 and	 the	 necessity	 for	 its	 structural	 integrity	 from	 the	 impact	 of	 proline	 scanning	
mutagenesis	are	well-documented.37	Establishing	what	structure	the	arch	adopts	in	solution,	or	
what	 dynamic	 movements	 it	 has	 are	 crucial	 to	 understanding	 the	 catalytic	 conformational	
change	involved	in	the	rate-limiting	stage	of	catalysis.	Equally,	the	elusive	α2-α3	loop	is	thought	
to	be	 involved	 in	recognition	of	a	1nt	3’	 flap	and	must	somehow	confer	this	 to	the	active	site	
when	in	the	correct	conformation.	While	predicted	to	be	in	the	correct	secondary	structure	by	
TALOS-N,	 the	 α2-α3	 loop	 is	 similar	 to	 the	 arch	 in	 terms	 of	 peak	 height	 and	 so	 may	 display	
analogous	 rapid	dynamics.	 This	might	 link	 the	 two	 regions	 together,	 allowing	 for	an	allosteric	
control	 of	 activity.	 In	 both	 cases	 however,	 a	 more	 rigorous	 NMR	 spectroscopic	 dynamic	
measurement	of	the	peaks	was	needed	to	elucidate	further	information.	
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Chapter 5: Nuclear spin relaxation and model-free analysis of 
hFEN1 
5.1 Protein Dynamics and Exchange using NMR spectroscopy 
The	 large	 peak	 height	 and	 the	 lack	 of	 predicted	 TALOS-N	 secondary	 structure	 present	 in	 the	
arch	region	and	the	α2-α3	loop	indicate	these	regions	of	FEN1	are	of	dynamic	interest	(Section	
4.5).	 Furthermore,	 crystal	 structures	 of	 both	 apo-hFEN1	 and	 DNA-bound	 hFEN1	 protein	
highlight	a	degree	of	structural	heterogeneity	in	these	two	regions	that	is	difficult	to	explain	by	
a	static	structure.	Looking	at	B-factors	of	each	crystal	structure	highlight	further	the	 increased	
root	mean	displacement	of	 the	α2-α3	 loop	and	arch	 region	 (Fig.	 5.i).	 Furthermore,	one	other	
region	involved	in	template	DNA	binding,	the	β-pin	(β6-β7)	is	also	seen	to	have	higher	B-factors,	
but	 does	 not	 seem	 to	 have	 higher-than-average	 peak	 heights.	 B-factors	 are	 not	 an	 adequate	
measure	of	protein	dynamics,	 as	 they	 could	be	 interpreted	not	only	by	 local	mobility	 in	 solid	
crystals,	but	also	by	errors	involved	in	fitting	the	X-ray	diffraction	pattern.	With	all	this	in	mind,	
a	more	rigorous	dynamic	analysis	of	hFEN1	protein	 in	solution	 is	necessary	 to	provide	 further	
information	 about	 a	 conformational	 change	 in	 the	 catalytic	 cycle.	 This	 chapter	will	 cover	 the	
experiments	performed	to	produce	order	parameters	 for	most	detectable	residues	and	hence	
measure	the	flexibility	of	most	residues	in	hFEN1.	
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Figure	5.i.	Plots	of	hFEN1	protein	sequence	highlighting	regions	of	higher	than	average	B-factors.	The	
secondary	structure	map	is	taken	from	the	crystal	structure	3Q8K,	α-helices	are	blue	cylinders,	β-strands	
are	green	arrows	and	loops	are	black	lines.	Regions	which	have	structural	heterogeneity	between	3Q8K	
and	1UL1	are	highlighted	by	red	lines	and	red	striped	cylinders.	The	B-factor	plots	are	of	(A)	5UM9,29	(B)	
3Q8K,27	 (C)	 1UL1x,	 (D)	 1UL1y,	 (E)	 1UL1z.110	 Regions	 of	 structural	 heterogeneity	 include	 the	α2-α3	 loop	
(blue),	the	arch	region	(red)	and	the	β-pin	(magenta).	A	B-factor	of	80	Å2	is	highlighted	as	a	dotted	line	to	
illustrate	a	root	mean	square	displacement	of	1	Å.		
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5.2 Nuclear spin relaxation of apo-hFEN1 protein 
5.2.a Relaxation measurements of R1, R2 and hNOE values 
Using	 nuclear	 spin	 relaxation	 (NSR)	 and	 subsequent	 model-free	 analysis	 NMR	 spectroscopy	
techniques,	 the	fast	picosecond-nanosecond	motions	of	backbone	amides	were	characterised.	
First,	 doubly	 labeled	 protein	 with	 2H	 and	 15N	 was	 expressed	 and	 purified	 using	 the	 same	
methodology	as	the	triply	labeled	protein	(Section	2.1).	TROSY	based	experiments	for	15N	spin	
lattice	 (R1)	and	 rotating	 frame	 (R1ρ)	 relaxation	 rates,	 as	well	 as	TROSY	 {1H}	heteroNOE	 (hNOE)	
were	performed	at	 two	 field	 strengths	 (600	MHz	and	800	MHz)	at	298	K.	The	R2	 values	were	
calculated	from	R1	and	R1ρ	 (Section	2.3d).	Out	of	251	residues	that	were	assigned	originally,	a	
full	set	of	R1,	R2	and	hNOE	values	were	obtained	for	203	peaks	at	600	MHz	and	197	peaks	at	800	
MHz.	The	reason	for	the	elimination	of	the	data	is	partially	due	to	the	complexity	of	the	hFEN1	
protein,	 and	 also	 its	 unique	 relaxation	 profile.	 Peaks	 that	 were	weak	 initially	 gave	 very	 poor	
exponential	fits,	likely	due	to	intermediate	exchange	broadening	and	some	peaks	were	merged	
with	other	peaks,	affording	ambiguous	and	mixed	relaxation	rates.	Therefore,	these	peaks	were	
eliminated	 from	 further	 analysis,	 as	 they	 were	 unrepresentative	 of	 their	 actual	 relaxation	
values.	Model-free	analysis	needs	all	three	values	of	R1	R2	and	hNOE	at	two	field	strengths,	and	
therefore	many	incomplete	datasets	were	rejected	from	the	analysis.	
	
The	data	however,	show	a	clear	pattern	(Fig.	5.ii).	Figures	from	the	600	MHz	data	showed	that	
there	is	an	average	relaxation	rate	or	hNOE	value,	which	is	shared	by	most	of	the	residues	of	the	
protein	(R1	≈	0.5	s-1,	R2	≈	30	s-1	and	hNOE	≈	+0.8).	Using	the	average	R2/R1	ratio	shared	by	most	
of	 the	 residues	of	 about	60,	 an	overall	 estimation	of	 the	 τc	was	 found	 to	be	around	25	ns,117	
which	is	consistent	with	a	protein	of	its	size	(38	kDa).118	Loops	like	the	β-pin	(β6-β7)	(46	–	38),	
α12-α13	(55	–	42),	α10-α11	(54	–	46)	and	the	large	α13-α14	loop	(52	–	27)	display	a	lower	than	
average	R2/R1	ratio.	The	lowest	R2/R1	ratios	were	found	in	the	arch	region	(24	–	3.7),	the	α2-α3	
loop	(41	–	8.4)	and	the	non-native	C-terminal	tail	(13	–	1.6).	While	the	values	were	different,	the	
exact	 same	 patterns	 were	 found	 in	 the	 800	 MHz	 data,	 although	 the	 data	 was	 noisier.	 The	
regions	with	 lowered	R2/R1	 ratios	and	more	negative	hNOE	values	correspond	to	 regions	with	
much	higher	B-factors,	or	missing	electron	density	 in	 crystal	 structures,	 and	 regions	of	higher	
peak	intensities	in	the	assignment.	
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Figure	5.ii.	Experimentally	determined	relaxation	values	and	hNOE	values	versus	residue	number	with	
secondary	structure	map	below.	(A)	Shows	the	data	from	600	MHz	and	(B)	the	data	from	800	MHz.	Spin-
lattice	(R1	in	red),	Spin-spin	(R2	in	blue)	and	
15N-{1H}	NOE	(hNOE)	values	are	plotted	at	the	two	different	
field	strengths.	Also	derived	from	the	data	are	the	R2/R1	values	below	in	black.	
	
5.2.b Model-free analysis using relax 
With	197	complete	relaxation	datasets,	the	data	was	subjected	to	model-free	analysis	using	the	
software	relax.119	The	software	calculates	the	diffusion	tensor	and	the	correlation	time	(τc)	 for	
the	whole	protein,	while	 in	parallel	also	calculating	the	effective	correlation	time	(τe)	 for	each	
residue.	 Both	 parameters	 are	 calculated	 together,	 and	 are	 then	 validated	 using	 statistical	
analysis,	resulting	in	a	more	reliable	and	accurate	calculation	of	model-free	parameters.	Model-
free	 parameters	 are	 fit	 to	 four	 different	 diffusion	 tensor	 models:	 isotropic	 spherical,	 prolate	
spheroid,	 oblate	 spheroid	 and	 ellipsoid.	 Since	 amide	 bond	 angles	 were	 needed	 for	 the	
spheroidal	 tensors,	 the	3D	coordinates	of	nitrogen	and	proton	were	provided	using	 the	3Q8K	
protein	structure.	Calculations	excluded	a	further	18	residues,	most	likely	due	to	high	errors	in	
the	data.	Initially,	the	calculations	ran	into	problems	and	the	predictions	failed	to	converge	to	a	
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solution.	This	was	proposed	to	be	due	to	the	fact	that	the	arch,	α2-α3	loop	and	C-terminal	tail	
were	 moving	 on	 a	 timescale	 so	 different	 from	 the	 bulk	 of	 the	 protein,	 the	 diffusion	 tensor	
model	failed	to	agree	on	a	unified	solution.		
	
With	this	in	mind,	the	16	residues	that	had	no	secondary	structure	in	the	1UL1	(x	subunit)	were	
omitted	from	calculations.	This	included	residues	in	the	arch	(109-129),	the	α2-α3	loop	(46-59),	
the	C-terminal	tail	(337-342)	and	the	β-pin	(199,	200).	Subsequently	relax	managed	to	converge	
on	all	diffusion	 tensors,	and	chose,	by	 the	 lowest	Akaike	 information	criteria	 (AIC),	 the	oblate	
spheroid	tensor	(Table	11,	Fig.	5.iii).	The	tensor	seems	to	fit	with	the	overall	shape	of	the	hFEN1	
molecule	 and	 best	 describes	 the	 tumbling	 of	 the	 molecule	 in	 solution.	 The	 remaining	 16	
residues	with	no	discernable	secondary	structure	were	run	through	relax	again,	with	both	the	
oblate	 spheroid	and	 spherical	diffusion	 tensors	 tested,	 and	 the	 spherical	diffusion	 tensor	was	
chosen	overwhelmingly	by	AIC	(Table	11).	This	hybrid	approach	allowed	all	179	residues	to	be	
analysed,	despite	the	wildly	different	dynamic	properties	of	certain	residues.		
	
Structured	Diffusion	Tensor	 AIC	Value	 Unstructured	Diffusion	Tensor	 AIC	Value	
Spherical	 1483.9	 Spherical	 182.15	
Prolate	Spheroid	 1508.3	 -	 -	
Oblate	Spheroid	 1479.2	 Oblate	Spheroid	 1535.3	
Ellipsoid	 1509.7	 -	 -	
Table	11.	Diffusion	 tensor	 statistical	 selection	process	using	AIC.	Analysis	 includes	the	163	residues	 in	
discernable	 structured	 regions	 of	 the	 1UL1-x	 subunit	 crystal	 structure	 (left),	 and	 the	 16	 remaining	
unstructured	residues	(right).	There	is	a	slight	preference	for	oblate	spheroid	over	complete	sphere	in	the	
structured	 region,	 whereas	 there	 is	 overwhelmingly	 a	 spherical	 selection	 for	 the	 16	 unstructured	
residues.	
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Figure	 5.iii.	 View	of	 the	 diffusion	 tensor	 overlaid	 upon	 the	 hFEN1	 crystal	 structure	 3Q8K.	The	 tensor	
shows	 good	 agreement	 with	 the	 structure	 of	 the	 protein,	 suggesting	 that	 the	 fast	 tumbling	 of	 the	
molecule	are	towards	the	X	and	Y-axes	(long	axes).	
	
5.1.c Analysis of Model-free parameters for the majority of the protein 
Order	parameters	(S2)	were	obtained	from	the	residues	and	showed	a	distinct	pattern	(Fig.	5.iv).	
Most	 backbone	 amides	were	well	 described	 by	 the	 overall	 tumbling	 of	 the	molecule	with	 S2	
values	of	around	0.8.	Loops,	especially	in	the	C-terminal	half	of	the	protein	(215-342)	displayed	
on	average	lower	S2	values.	There	were	minor	drops	to	around	0.7	for	example	in	α6-β4	and	the	
β-pin.	Much	 lower	and	noisier	S2	values	of	0.6-0.2	were	seen	 for	 loops	 like	α12-α13	and	α13-
α14.	The	errors	on	this	data	are	most	likely	due	to	errors	in	the	relax	fitting,	as	the	errors	on	the	
raw	data	are	no	worse	 for	 these	 residues.	 It	 should	be	noted	 that	 the	β-pin	displays	medium	
R2/R1	 values	 of	 65	 –	 39,	 but	 the	 model-free	 analysis	 indicates	 it	 is	 not	 moving	 on	 a	 ps-ns	
timescale.	Furthermore	a	large	number	of	residues	have	Rex	terms,	which	account	for	71%	of	all	
fitted	 residues	 (Fig.	 5.v,	 Table	 12).	 The	 Rex	 parameters	 are	 designed	 to	 account	 for	 chemical	
exchange	in	the	model-free	analysis	and	offset	larger	than	expected	R2	values.	Thus,	for	71%	of	
the	analysed	residues,	some	kind	of	chemical	exchange	is	expected,	and	probably	accounts	for	
some	 kind	 of	 relatively	 slow	 motion	 occurring	 in	 the	 protein	 on	 the	 millisecond	 timescale.	
Overall,	 this	 implies	 that	 hFEN1	 has	 a	 much	 more	 complicated	 dynamic	 dsDNA	 interacting	
region,	with	millisecond	motions	present	in	loops.	
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Figure	5.iv.	Model-free	analysis	of	the	relaxation	data	of	hFEN1	showing	regions	of	increased	flexibility.	
(A)	The	order	parameter	(S2)	values	versus	residue	number	with	a	secondary	structure	map	below	as	seen	
in	 previous	 figures.	 Black	 circles	 represent	 residues	 analysed	 fully	 by	 relax,	 while	 pink	 triangles	 are	
residues	analysed	by	an	isotropic	spherical	diffusion	tensor.	The	purple	line	represents	predicted	S2	values	
from	the	TALOS-N	random	coil	index	prediction.89	(B)	S2	values	plotted	on	the	backbone	amide	nitrogens	
of	the	hFEN1	crystal	structure	(3Q8K).	The	spectrum	bar	on	the	left	represents	the	colour	and	size	of	each	
residue	as	determined	by	the	S2	value.	
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Figure	 5.v.	 Model-free	 chemical	 exchange	 parameters	 (Rex).	 (A)	 The	 chemical	 exchange	 (Rex)	 values	
versus	 residue	number	with	a	 secondary	 structure	map	below	as	 seen	 in	previous	 figures.	Black	 circles	
represent	 residues	 analysed	 fully	 by	 relax,	 while	 pink	 triangles	 are	 residues	 analysed	 by	 an	 isotropic	
spherical	 diffusion	 tensor.	 (B)	 S2	 values	 plotted	on	 the	backbone	 amide	nitrogens	 of	 the	hFEN1	 crystal	
structure	 (3Q8K).	 The	 spectrum	 bar	 on	 the	 left	 represents	 the	 colour	 and	 size	 of	 each	 residue	 as	
determined	by	the	Rex	value.	70%	of	all	analysed	residues	had	a	Rex	value	assigned	to	them.	The	highest	
values	were	present	in	the	saddle	region	of	the	protein	indicating	a	slow	millisecond	timescale	of	motion	
for	the	majority	of	residues.	
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Model-Free	Models	 Number	of	Residues	Selected	for	Each	Model	
m1	=	{S2}	 21	
m2	=	{S2,	τe}	 11	
m3	=	{S2,	Rex}	 62	
m4	=	{S2,	τe,	Rex}	 24	
m5	=	{S2,	S2f,	τs}	 18	
m6	=	{S2,	τf,	S2f,	τs}	 2	
m7	=	{S2,	S2f,	τs,	Rex}	 28	
m8	=	{S2,	τf,	S2f,	τs,	Rex}	 13	
TOTAL	 179	
Table	12.	Model-free	model	selection	for	all	179	analysed	residues.	70%	of	all	residues	were	fitted	with	
a	Rex	term	present,	and	roughly	one	third	of	all	residues	were	in	the	m3	model.	
	
5.2.d Intrinsically Disordered Regions in arch, α2-α3 loop and C-terminal tail 
The	lowest	reliable	S2	parameters	however	are	present	in	the	α2-α3	loop,	the	top	of	α4	and	α5	
and	 the	 C-terminal	 tail.	 These	 regions	 display	 a	 noticeable	 difference	 in	 the	 timescales	 of	
motion	from	the	majority	of	the	protein,	consistent	with	the	relaxation	data.	The	mobility	of	the	
C-terminus	of	 the	protein	 (339-342)	 can	be	 rationalised	by	 the	 fact	 that	 it	 is	 a	non-native	 tail	
region,	devoid	of	secondary	structure	and	exposed	to	solvent.	There	are	only	three	data	points	
for	the	loop,	but	they	are	all	indicate	a	S2	value	of	~	0.2.	It	could	be	that	a	large,	solvent	exposed	
loop	 could	 result	 in	 faster	 motions	 for	 these	 residues.	 Finally	 the	 S2	 values	 in	 α4	 drastically	
decrease	 from	about	0.6	 to	>	0.1	and	 is	at	 its	 lowest	at	 the	small	 loop	at	 the	top	of	 the	arch,	
then	 further	 increases	 to	 0.2	 at	 the	 top	 of	 α5.	 Having	 such	 low	 S2	 values	 means	 that	 these	
residues	 are	 very	 poorly	 described	 by	 the	 motion	 of	 the	 molecule	 and	 are	 much	 better	
described	 by	 the	 fast	 picosecond-nanosecond	 internal	 motions.	 These	 regions	 are	 therefore	
postulated	to	be	disordered	regions	in	apo-hFEN1	in	solution.		
	
To	 confirm	 the	 experimental	 data,	 chemical	 shift	 analysis	 using	Random	Coil	 Index-S2	 (RCI-S2)	
values	 were	 predicted	 using	 TALOS-N.89	 There	 was	 good	 agreement	 with	 the	 model-free	
analysis,	 although	 the	 prediction	 underestimates	 the	 lower	 S2	 values	 (Fig.	 5.iv).	 This	 further	
confirms	 the	 theory	 that	 these	 are	 intrinsically	 disordered	 regions,	 as	 coded	 by	 the	 primary	
sequence	of	the	protein.		
	
5.2.e Classification of Intrinsically Disordered Regions (IDR) 
To	 further	 classify	 the	 intrinsic	 disorder	 present	 in	 these	 regions,	 the	 differences	 between	
experimental	 chemical	 shift	 values	 and	 predictions	 using	 the	 neighbor	 corrected	 random	 coil	
chemical	shift	library	for	intrinsically	disordered	proteins	(ncIDP)	was	investigated.120	The	ncIDP	
predictions	 of	 the	 entire	 of	 hFEN1	 protein	 for	 15N	 and	 Cα,	 show,	 for	most	 of	 the	 structured	
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region	 of	 the	 protein,	 a	 large	 discrepancy	 from	 the	 experimental	 values.	 However,	 the	 C-
terminal	tail,	arch	region	and	the	α2-α3	loop	have	chemical	shifts	close	in	value	ncIDP	predicted	
chemical	shifts,	which	is	a	further	indication	that	these	loops	are	disordered	in	the	absence	of	
substrate.	 Although	 disordered,	 a	 closer	 look	 at	 15N	 and	 Cα	 resonances	 can	 be	 a	 powerful	
indicator	of	 local	dynamic	preferences	for	certain	secondary	structures.	Figure	5.vi	shows	that	
the	 residues	 in	 the	 α2-α3	 loop	 and	 the	 C-terminus	 are	 different	 between	 experimental	 and	
predicted	values	of	≥1,	indicating	a	good	agreement	with	an	extended	conformation.	However,	
the	 arch	 region	 is	 more	 complex.	 The	 N-terminal	 α	 portion	 of	 α4,	 from	 residue	 A107-Q113	
exhibits	differences	of	≤1,	which	indicates	that	this	region	prefers	α-helical	ϕ-ψ	space.	There	is	a	
gradual	decrease	in	α-helical	propensity	from	Q110-A114,	and	from	residues	A114-A120	there	is	
a	switch	to	extended	conformation.	Furthermore	AGADIR	predictions	of	percent	helicity	using	
primary	 amino	 acid	 sequences	 (Fig.	 5.vi.c)121	 and	 the	 TALOS-N	 data	 (Fig.	 4.x)	 of	 secondary	
structure	prediction	both	agree	with	this	data.	This	suggests	that	α4	is	poised	to	form	α-helical	
structure,	whereas	α5	is	not.	
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Figure	 5.vi.	 Chemical	 shift	 analyses	 and	 AGADIR	 predictions	 for	 predicted	 disordered	 regions.	
Differences	between	neighbour	corrected	random	coil	and	experimental	chemical	 shifts	 for	 15N	 (A)	and	
13Cα	 (B).	 Values	 of	 less	 than	 one	 are	 in	 good	 agreement	 of	 extended	 unstructured	 regions,	 whereas	
negative	values	 for	15N	and	positive	values	 for	13Cα	 indicate	helical	structure.	C)	An	AGADIR	prediction	
using	protein	primary	structure	to	determine	%	helicity.121	Hollow	bars	indicate	information	where	there	
is	 no	 NMR	 data	 present.	 α2	 dramatically	 decreases	 its	 helical	 propensity	 as	 it	 reaches	 the	 C-terminal	
portion,	whereas	α4	starts	with	much	higher	propensity	then	decreases	equally	quickly.	Both	α5	and	the	
final	C-terminal	tail	have	no	α-helical	nature.	
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Further	 analysis	 of	 the	 arch	 region	 was	 done	 using	 an	 algorithm	 called	 the	 classification	 of	
intrinsically	disordered	ensemble	regions	(CIDER).	The	software	uses	charge	distribution	of	the	
primary	sequence	to	predict	how	extended	or	collapsed	the	disordered	region	is.122	Analysis	of	
residues	P90-L130	using	CIDER	showed	that	this	region	was	a	polyampholytic	coil	or	hairpin.	The	
linear	sequence	distribution	of	charged	residues	is	assessed	by	a	value	of	self-assembly	κ,	with	a	
value	of	1	 indicating	 full	 collapse	and	0	 indicating	no	self-assembly.	The	arch	 region	of	hFEN1	
has	 a	 very	 low	 κ	 value	 of	 0.12,	 suggesting	 that	 the	 loop	 prefers	 to	 exist	 in	 an	 extended	
conformation	in	solution.		
	
5.2.f Implications of having intrinsically disordered regions 
The	arch	and	the	α2-α3	loop	are	moving	on	timescales	completely	separated	from	the	tumbling	
of	 the	 protein.	 At	 first	 glance	 it	 seems	 counterintuitive	 to	 have	 disordered	 sections	 of	 an	
enzyme	involved	in	catalysis.	The	structure	of	the	enzyme	when	bound	to	DNA	would	indicate	
that	active	site	 residues	 in	 the	arch,	such	as	R100	and	K93,	have	to	be	positioned	correctly	 in	
order	for	reaction	to	occur.	In	other	words	the	structure	of	the	enzyme	relates	to	its	function	as	
a	 nuclease.	 Positional	 ambiguity	 for	 these	 essential	 catalytic	 residues	 should	 slow	 down	 the	
reaction,	as	seen	with	mutants	where	these	key	catalytic	residues	are	mutated	to	alanines.37,38	
However,	there	may	be	benefits	to	having	such	disordered	regions	present	in	the	protein.	
	
Firstly,	 since	 the	 arch	 most	 likely	 exists	 in	 an	 extended	 conformation,	 it	 allows	 for	 a	 large	
capture	area	of	any	potential	5’	flaps.	It	is	difficult	to	envision	a	5’	ssDNA	flap	going	through	the	
small	 gap	 presented	 in	 the	 ordered	 crystal	 structure	 in	 the	 absence	 of	 an	 energy	 source.	 By	
having	the	gap	much	 larger,	and	disordered	there	 is	a	higher	chance	of	 the	threading	process	
happening	 spontaneously.	 Thus,	 when	 the	 DNA	 is	 bound,	 a	 disordered	 arch	 increases	 the	
probability	 of	 a	 successful	 threading	 event	 occurring	 thereby	 hastening	 the	 reaction.	
Furthermore,	 it	 allows	 for	 accommodation	 of	DNA	with	 some	degree	 of	 secondary	 structure,	
which	 is	 consistent	with	kinetic	 studies	with	a	gapped	 substrate.22,38	 This	might	be	vital	 in	 for	
DNA	replication,	as	it	allows	for	a	degree	of	flexibility	in	the	type	of	flap	substrate	processed	by	
hFEN1.	
	
Once	 the	DNA	 is	captured	an	ordering	event	must	occur	 to	place	active	site	 residues	 into	 the	
correct	position,	as	well	as	forcing	the	DNA	to	adopt	a	conformer	amenable	for	hydrolysis	(i.e.	
conformational	 change).	 A	 disadvantage	 of	 having	 a	 disorder-to-order	 transition	 into	 a	
catalytically	active	state	is	that	this	has	a	high	entropic	penalty.	Thus,	the	assembly	of	the	entire	
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arch	would	be	expected	to	have	a	high	energy	cost	(large	energy	barrier),	therefore	it	would	be	
expected	to	be	a	slow	process.	However,	this	would	be	inconsistent	with	the	speed	of	the	single	
turnover	 rate	of	hFEN1	 (milliseconds).	The	entropic	cost	of	ordering	 the	entire	arch	would	be	
very	high;	however	having	α4	already	transiently	sampling	α-helical	conformations	reduces	the	
penalty.	 This	 allows	 for	 a	 much	 smaller	 conformational	 shift	 of	 ensembles	 with	 low	 energy	
barriers,	 allowing	 for	 rapid	 folding.	 Such	 triggers	 for	 a	 conformational	 shift	 could	 be	 the	
formation	of	the	mini-hydrophobic	core	at	the	top	of	the	arch,	and	contacts	with	the	template	
DNA	with	residues	like	R104.	The	α5	is	much	smaller	and	can	be	potentially	induced	to	form	a	α-
helix	when	 then	 entropic	 penalty	 is	 balanced	by	 enthalpic	 gains	 from	external	 contacts.	 Such	
contacts	 could	 include	 interactions	 from	 the	ordered	α2-α3	 loop	 (R47)	 and	 contacts	with	 the	
template	DNA	 (K125,	K128	and	R129).	 Thus	using	a	 combination	of	 conformational	 ensemble	
shifts	 (α4)	 and	 induced	 helix	 formation	 (α5),	 a	 finely	 tuned	 fast	 ordering	 process	 with	 low	
energy	barriers	can	be	achieved.	
	
Finally,	there	is	the	question	of	specificity.	The	induction	of	α5	is	only	energetically	favourable	
when	the	cues	from	the	correct	substrate	are	present.	The	positioning	of	the	1nt	3’	flap	into	α2-
α3	forms	an	omega	loop	(Ω-loop)	formation.	This	non-regular	secondary	structure,	is	frequently	
involved	 in	 catalysis,	 folding	 and	 stability,	 just	 like	 in	 the	 example	 of	 TIM	 (Section1.5e).39	
Positioning	of	the	template	portion	of	the	DNA	and	the	5’	 flap	forms	contacts	 in	the	arch	and	
help	 induce	 a	 change	 in	α5.	Having	 the	whole	 system	as	 an	 induced	 fit	would	 result	 in	 great	
specificity,	 but	 the	 energetic	 penalties	 would	 result	 in	 very	 slow	 folding.	 Adopting	 a	 dual	
conformational	ensemble	 change	and	 induced	 fit	 system	allows	 the	 specificity	 to	 remain	high	
enough,	 while	 keeping	 the	 energetics	 of	 folding	 as	 flat	 as	 possible.	 It	 also	 allows	 for	 rapid	
unfolding	and	release	of	substrate	that	 is	non-ideal.	Furthermore,	 it	would	have	a	 low	affinity	
for	the	catalytically-active	conformation	which	would	allow	for	fast	dissociation	of	product	DNA,	
and	hence	aid	catalytic	turnover.		
	
5.2.g Reasons that relaxation dispersion of hFEN1 is currently unattainable. 
One	of	the	aims	was	to	analyse	the	rates	of	motion	between	a	potential	ordered	and	disordered	
state	 of	 the	 protein,	 and	 to	 link	 this	 rate	 to	 the	 single	 turnover	 rate	 of	 hFEN1.	 Model-free	
analysis	identified	regions	of	disorder,	but	cannot	provide	rates	of	motion	between	an	ordered	
and	disordered	state.	Rex	 terms	 for	70%	of	 the	protein	 indicate	 that	some	kind	of	exchange	 is	
taking	 place,	 so	 relaxation	 dispersion	 was	 thought	 to	 be	 a	 valid	 experiment	 to	 quantify	 the	
exchange	processes	 taking	place.	Therefore	 to	 screen	 for	any	 residues	undergoing	a	potential	
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two	state	exchange	process,	differences	 in	 15N	chemical	 shift	were	measured	using	HSQC	and	
HMQC	 experiments	 at	 600	 MHz	 and	 800	 MHz.	 This	 procedure	 can	 be	 applied	 to	 ascertain	
residues	 undergoing	 exchange.123	 However	 the	 experiments	 were	 inconclusive	 showing	
difference	in	the	signs	of	chemical	shift	difference	between	the	two	field	strengths.	This	could	
be	due	to	poor	spectral	 resolution.	Furthermore,	measuring	relaxation	dispersion	by	CPMG	or	
R1ρ	 is	 time-consuming,	 during	 which	 the	 hFEN1	 protein	 was	 liable	 to	 precipitate.	 These	 two	
factors	combined	prevented	acquisition	of	relaxation	dispersion	profiles.	
	
5.3 Discussion 
The	arch	 region	and	the	α2-α3	 loop	were	both	confirmed	as	 regions	of	 intrinsic	disorder.	The	
intrinsic	disorder	is	though	to	aid	in	capture	of	a	5’	ssDNA	flap	and	hence	aid	threading.	Analysis	
of	the	disordered	arch	shows	that	the	α4	portion	is	transiently	forming	α-helix,	while	α5	is	not.	
This	allows	for	a	mix	of	a	conformational	selection	of	helix	in	α4	combined	with	an	induced	fit	of	
helix	 in	 α5.	 These	 ordering	 processes	 are	 both	 made	 energetically	 favorable	 by	 the	 correct	
substrate.	These	both	help	explain	the	catastrophic	rate	reductions	 in	arch	proline	mutants	of	
hFEN1	protein.37	Another	induced	fit	event	potentially	accounts	for	the	molding	of	the	α2-α3	Ω-
loop	around	a	3’	flap.	It	is	known	that	the	3’	flap	enhances	the	reaction	rate	considerably.22	The	
disorder	provides	 low-energy	barriers	 to	 folding,	hence	expediting	catalysis	whilst	maintaining	
the	ability	to	fold	only	when	bound	to	a	correct	substrate,	hence	enhancing	specificity.	Finally,	
having	disorder	as	the	default	state	of	the	hFEN1	protein	would	allow	easier	unfolding	and	thus	
dissociation	from	the	bound	dsDNA,	hence	assisting	turnover.	The	utility	of	intrinsic	disorder	for	
the	highly	structure	specific	nuclease	hFEN1	protein	can	therefore	be	seen.	
	
Direct	evidence	of	the	timescales	of	motion	for	the	arch	and	α2-α3	loop	could	not	be	obtained	
through	relaxation	dispersion.	The	residues	in	question	simply	do	not	display	adequate	spectra	
in	order	 to	obtain	 the	data.	There	 is	also	 the	 lack	of	data	 for	 residues	of	 interest	 flanking	 the	
disordered	regions,	presumably	due	to	 intermediate	exchange,	which	prevents	analysis	of	key	
regions	of	interest.	The	dsDNA	binding	region	of	the	protein	is	exhibiting	millisecond	timescale	
motions,	 as	 is	 seen	with	 the	 ubiquity	 of	 Rex	terms.	 It	 is	 unknown	what	 effect	 this	 has	 on	 the	
protein	 but	 it	 is	 consistent	 with	 the	 tendency	 to	 precipitate	 and	 the	 very	 uncooperative	
unfolding	of	hFEN1	in	urea.37	For	the	moment	however	it	can	be	assumed	that	the	arch	and	α2-
α3	loop	are	the	main	regions	that	are	linked	to	the	proposed	conformational	change	involved	in	
catalysis.	
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There	 are	 several	 other	 factors	 involved	 in	 hFEN1	 catalysis,	 including	 the	 addition	of	 divalent	
cations	and	the	DNA	conformational	changes	that	must	occur.	While	unable	to	inspect	potential	
exchange	 states	 using	 relaxation	 dispersion,	 looking	 directly	 at	 a	 DNA-hFEN1	 bound	 complex	
will	 highlight	dynamics	when	bound	 to	 the	 substrate.	 Furthermore,	 all	NSR	experiments	have	
been	conducted	in	the	presence	of	0.1	mM	EDTA.	However,	there	are	chemical	shift	changes	in	
1H-15N	TROSY	spectra	upon	binding	of	either	Mg2+	or	Ca2+	ions,	which	are	essential	for	catalysis	
and	DNA	conformational	 changes.28	By	 looking	 further	at	hFEN1-DNA	complexes	and	 the	 role	
that	divalent	cations	play	in	the	whole	of	the	protein,	further	information	can	be	gained	about	
the	dynamical	tuning	of	hFEN1	protein.	
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Chapter 6: Investigation of substrate bound hFEN1 complexes 
by NMR spectroscopy. 
6.1 Analysing changes in dynamics upon binding DNA. 
The	 ordering	 of	 the	 highly	 flexible	 arch	 and	 the	 α2-	 α3	 loop	 are	 thought	 to	 occur	 when	 all	
substrate	feature	selection	steps	are	passed.	The	main	questions	are	therefore,	how	fast	does	
this	 ordering	 occur,	 and	 at	 which	 timescale	 are	 the	 residues	 moving	 when	 bound	 to	 the	
substrate?	 In	 an	 attempt	 to	 answer	 these	 questions	 a	 protein-DNA	 complex	was	 analysed	by	
NMR	 spectroscopy.	 In	particular,	 a	DNA	 titration	of	 hFEN1	was	desirable	 in	order	 to	pinpoint	
residues	that	are	affected	by	binding	of	substrate.	Of	particular	interest	are	the	arch	region	and	
the	 α2-	 α3	 loop.	 Do	 they	 change	 timescales	 in	 the	 presence	 of	 substrate	 DNA?	 If	 so	 then	 it	
might	 become	 apparent	 by	 chemical	 shift	 perturbation	 mapping	 the	 DNA	 titration.	
Furthermore,	 if	 a	 stable	 complex	 can	be	made,	 then	 the	protein	 could	be	assigned	 to	 further	
studies.	A	subsequent	nuclear	spin	relaxation	(NSR)	analysis	could	be	performed	on	the	hFEN1-
DNA	complex,	assessing	the	fast	flexibilities	of	the	entire	protein.	This	could	be	compared	to	the	
flexibilities	 of	 apo-hFEN1,	 in	 particular	 the	 outcomes	 of	 the	 arch	 and	 α2-α3	 loop.	 Although	
untenable	 for	 the	 apo-protein,	 relaxation	 dispersion	 might	 be	 able	 to	 be	 used	 in	 order	 to	
quantify	 μs-ms	motions	 of	 exchange	 for	 residues	 on	 a	 protein-DNA	 complex.	 In	 this	 chapter,	
necessary	 conditions	 to	 form	 a	 DNA-protein	 complex	 will	 be	 discussed,	 as	 well	 as	 the	
implications	of	dynamics	of	the	arch	and	α2-	α3	loop	when	bound	to	DNA.	
	
6.2 Assignment and chemical exchange dynamics of a substrate bound 
hFEN1 complex. 
6.2a hFEN1 K93A mutant and DNA titration in the presence of EDTA. 
To	study	DNA	binding	to	hFEN1	protein,	it	was	necessary	to	form	catalytically	inert	complexes.	
hFEN1	 is	 notoriously	 promiscuous	 when	 it	 comes	 to	 DNA	 hydrolysis,	 and	 over	 NMR	
experimental	 timescales	would	 probably	 hydrolyse	 even	 non-ideal	 DNA	 samples.	 Therefore	 a	
mutant	 of	 hFEN1	 protein	 was	 chosen	 to	 hinder	 hydrolysis,	 while	 keeping	 the	 structure	 and	
function	of	the	protein	the	same	as	wild	type.	Lysine	93	(K93)	is	an	essential	amino	acid	present	
in	the	bottom	of	α4,	and	has	been	observed	to	interact	with	the	scissile	phosphate	of	the	duplex	
in	 the	active	site.	Mutated	 to	an	alanine,	 the	protein	hFEN1K93A	 shows	a	dramatic	decrease	 in	
both	single-	and	multiple-turnover	reactions.37,38	The	protein	however	shows	little	change	in	its	
interaction	with	DNA.	 FRET	 experiments	 to	 detect	 DNA	 bending	 report	minor	 changes	 in	 the	
Chapter	6:	hFEN1-DNA	complexes	
	 99	
KBend	of	hFEN1K93A	compared	to	wild	type	protein	(KBend	of	8	±	1	for	K93A	vs	7	±	1	for	wild	type).	
Equally,	 exciton	 coupled	 circular	 dicrhoism	 (ECCD)	 experiments	 that	 measure	 DNA	
conformational	 change	 on	 addition	 of	 metal	 ions	 report	 similar	 signals	 to	 that	 of	 wild	 type,	
suggesting	that	the	protein	can	deform	the	DNA	into	the	active	site.28	A	1H-15N	TROSY	spectrum	
of	hFEN1K93A	 in	 the	presence	of	0.1	mM	EDTA	 (Fig.	 6.i)	was	 taken	 that	 shows	minor	 chemical	
shift	changes	in	residues	proximal	to	Lysine	93,	for	example,	residues	like	K88	and	C235.	Leucine	
289,	which	is	in	slow	exchange	in	wild	type	hFEN1,	moves	predominantly	to	one	conformer.	The	
remainder	 of	 the	 protein	 is	 unchanged	 compared	 to	 wild	 type.	 Due	 to	 its	 similar	 ability	 to	
accommodate	 DNA	 conformational	 changes	 but	 single-turnover	 rate	 of	 almost	 2000	 times	
lower	than	wild	type,	hFEN1K93A	was	chosen	for	all	protein-DNA	complex	experiments.	
	
	
Figure	6.i.	1H-15N	TROSY	spectra	highlighting	differences	between	wild-type	hFEN1	and	hFEN1K93A.	Wild-
type	protein	is	shown	in	grey	and	hFEN1K93A	is	shown	in	red.	Both	spectra	were	recorded	in	the	presence	
of	 0.1	mM	EDTA.	A	 selection	of	more	dispersed	peaks	 are	displayed	on	 the	 spectrum	of	 the	wild-type	
protein.	It	should	be	noted	that	the	grey	spectra	is	taken	with	perdeuterated	protein.	
	
A	 DNA	 titration	 was	 performed	 with	 hFEN1K93A	 to	 see	 structural	 and	 dynamic	 changes	 upon	
substrate	binding.	The	DNA	chosen	to	bind	to	hFEN1K93A	was	an	ideal	double-flapped	substrate	
Chapter	6:	hFEN1-DNA	complexes	
	100	
with	two	hairpins	on	the	upstream	and	downstream	regions	(dual	hairpin	substrate:	DHPS1,	Fig.	
6.ii).	A	unimolecular	substrate	construction	ensured	the	protein-DNA	interactions	were	limited	
to	 the	 bent	 junction,	 as	 there	 is	 only	 one	 5’	 terminus	 and	 3’	 flap	 present.	 The	 15N-labeled	
hFEN1K93A	protein	was	prepared	and	purified	as	described	in	section	2.1.	From	1	L	of	media	the	
yield	of	15N	hFEN1K93A	protein	was	1.4	μmol	or	approximately	53	mg.	DHPS1	was	titrated	into	a	
500	 μM	 15N-labeled	 hFEN1K93A	 protein	 sample	 in	 the	 presence	 of	 0.1	 mM	 EDTA	 and	 1H-15N	
TROSY	spectra	were	taken	at	each	titration	point.	The	overall	DHPS1	concentration	went	from	0	
μM	to	500	μM	(0,	50,	100,	200,	250	and	500	μM).	Peak	chemical	shift	changes	were	observed	
for	a	 large	portion	of	the	protein,	with	most	of	 the	peaks	undergoing	a	 fast	exchange	regime.	
Further	 addition	 of	 DHPS1	 caused	 rapid	 precipitation	 of	 the	 sample	 and	 the	 spectra	
deteriorated	 in	quality	as	500	μM	DNA	was	 reached.	This	 is	could	be	due	 to	 the	 formation	of	
large	bodies	of	protein-DNA	aggregates	with	multiple	proteins	binding	to	one	DHPS1	molecule.	
The	 precipitation	 of	 the	 protein	 prevented	 fitting	 of	 KD	 values	 and	 also	 prevented	 confident	
transfer	of	the	assignment	from	the	apo-protein	to	a	DNA	complex	spectrum.		
	
	
Figure	6.ii.	Cartoon	representation	of	the	dual	hairpin	substrate	(DHPS1).	A	unimolecular	DNA	construct	
with	two	hairpins	present	and	mismatches	on	the	5’	and	3’	ends	to	produce	flaps.	
	
Peaks	 associated	 with	 the	 arch,	 α2-	 α3	 loop	 and	 β-pin	 disappeared	 after	 the	 first	 or	 second	
addition	of	sub-stoichiometric	DNA	(50-100	μM)	(i.e.,	A45,	A196	Fig.	6.iii.b,	G118	Fig.	6.iii.c	and	
53L	 Fig.	 6.iii.d)	 indicating	 that	 these	 peaks	 are	 undergoing	 fast-intermediate	 exchange.	 The	
addition	of	DHPS1	therefore	changes	the	dynamics	of	certain	flexible	DNA	binding	regions	from	
a	very	fast	ps-ns	timescale	to	a	much	slower	μs-ms	timescale.	The	peaks	from	the	α2-	α3	loop	
and	 arch	 region	 did	 not	 re-appear	 after	 further	 addition	 of	 DHPS1,	 suggesting	 that	 these	
residues	stay	in	an	intermediate	regime.	The	timescales	of	motion	are	likely	to	be	10	–	1000	s-1,	
which	is	typical	of	intermediate	exchange	at	600	MHz.	This	change	of	exchange	regime	further	
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confirmed	the	conformational	change	of	dynamics	upon	binding	of	substrate,	but	cannot	place	
a	definitive	number	on	the	timescale.	
	
Figure	 6.iii.	 Titration	 of	 substrate	 DNA	 into	 a	 hFEN1K93A	 protein	 sample	 in	 the	 absence	 of	 divalent	
cations.	 (A)	 1H-15N	 TROSY	 spectra	 highlighting	 differences	 between	 hFEN1K93A	 bound	 and	 unbound	 to	
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substrate	 DNA.	 hFEN1K93A	 protein	 unbound	 is	 shown	 in	 red	 and	 the	 stable	 hFEN1K93A-DHPS1	 complex	
shown	 in	 black	 (see	 section	 6.2b).	 Both	 spectra	 were	 recorded	 in	 the	 presence	 of	 0.1	 mM	 EDTA.	 A	
selection	of	more	dispersed	peaks	are	displayed	on	 the	spectrum	of	 the	unbound	protein.	 (B-D)	 1H-15N	
TROSY	spectra	taken	during	the	titration	of	DNA	into	a	hFEN1K93A	sample	with	specific	regions	highlighted.	
DHPS1	DNA	concentrations	are	0	μM	(red),	50	μM	(maroon),	100	μM	(orange),	200	μM	(green),	250	μM	
(teal)	and	500	μM	(black).	The	quality	of	the	spectra	deteriorated	rapidly	during	the	later	concentration	
points,	so	later	chemical	shifts	are	not	accurate.	
	
6.2b hFEN1K93A-DNA stable complex formation and assignment 
A	method	to	produce	a	stable	hFEN1K93A-DHPS1	complex	in	order	to	produce	an	assignment	and	
measure	 NSR	 on	 a	 complex	 was	 optimised.	 13C,	 15N,	 2H	 triply	 labeled	 hFEN1K93A	 protein	 was	
produced	and	grown	using	the	method	described	before	in	Section	2.1.	A	growup	in	500	mL	of	
media	yielded	0.6	μmol	or	23	mg	of	protein.	A	1:1.1,	protein:DNA	complex	was	pre-made	under	
dilute	 conditions	 (1-10	μM)	 at	 lower	 salt	 (6	mM	KCl)	 concentrations	 in	 the	presence	of	 EDTA	
(Section	2.3h).	This	sample	was	then	concentrated	to	500	μM	protein.	Once	made,	the	sample	
was	significantly	more	stable	than	the	apo-protein	and	it	would	remain	in	solution	for	longer	(>	
1	month)	 (Fig.	 6.iii.a).	 This	 could	be	due	 to	 the	 stability	of	 the	protein	being	enhanced	by	 its	
substrate	bound	in	a	preferential	location.	The	number	of	observable	peaks	was	230,	lower	than	
the	 292	 in	 the	 wild	 type	 hFEN1	 spectrum.	 This	 suggests	 a	 loss	 of	 peaks	 to	 intermediate	
exchange	or	an	 increased	R2.	Assignment	of	 the	protein	complex	was	performed	by	 the	same	
methodology	as	apo-hFEN1	protein,	using	triply	labeled	13C,	15N,	2H	protein	in	the	presence	of	8	
mM	CaCl2.	 The	assignment	was	hampered	by	poor	 correlation	 in	 the	 13C	dimension,	 and	only	
132	peaks	were	assigned	by	 this	methodology,	which	 is	around	40%	of	 theoretical	peaks,	and	
57%	of	detectable	peaks	(Fig.	6.iv.b)	(BMRB	accession	code:	27404,	Appendix	A2).	
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Figure	 6.iv.	 Cartoon	 representation	 of	 the	 hFEN1K93A	 molecule	 to	 illustrate	 location	 of	 assigned	
residues.	 (A)	A	cartoon	showing	 the	3Q8K	structure	with	 important	 regions	highlighted,	 the	arch	 (red),	
the	α2-α3	 loop	 (blue),	 the	 saddle	 region	 (orange	 saddle),	 the	 positions	 of	 the	 two	 catalytic	metal	 ions	
(black	 spheres)	 and	 the	 potassium	 ion	 in	 the	 H2tH	 motif	 (purple	 sphere).	 (B)	 The	 assigned	 (red)	 and	
unassigned	 (grey)	 residues	 are	 coloured	 onto	 the	 product	 crystal	 structure	 3Q8K.	 Secondary	 structure	
elements	are	labeled	for	clarity.	Substrate	DNA	is	present	on	the	protein	during	assignment,	but	omitted	
on	the	figure	for	clarity.		
	
Chemical	 shift	 differences	 between	 apo-hFEN1K93A	 protein	 and	 the	 hFEN1K93A-DNA	 complex	
were	 plotted	 for	 known	 residues	 (Fig.	 6.v).	 Regions	 that	 displayed	 high	 chemical	 shift	
differences	 included	 the	 H2tH	motif	 (e.g.,	 G231,	 I238,	 R245,	 and	 D248),	 the	 active	 site	 (e.g.,	
G87,	 K88,	 A175	 and	 R192),	 the	 3’-flap	 binding	 pocket	 (e.g.,	 S317,	 E318	 and	 G324)	 and	 the	
hydrophobic	 wedge	 (e.g.,	 G66).	 These	 chemical	 shift	 differences	 were	 mostly	 localised	 in	
regions	 known	 to	 interact	 with	 the	 DNA	 as	 seen	 from	 previous	 crystal	 structures	 bound	 to	
substrate	and	product	(5UM9	and	3Q8K	respectively).		
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Figure	6.v.	Differences	in	chemical	shift	between	protein	bound	and	unbound	to	DNA.	(A)	1H-15N	TROSY	
spectra	 highlighting	 differences	 between	 hFEN1K93A	 bound	 and	 unbound	 to	 substrate	 DNA.	 hFEN1K93A	
protein	 unbound	 is	 shown	 in	 blue	 and	 hFEN1K93A-DHPS1	 complex	 shown	 in	 orange.	 Both	 spectra	were	
recorded	 in	 the	 presence	 of	 8	 mM	 CaCl2.	 A	 selection	 of	 more	 dispersed	 peaks	 are	 displayed	 on	 the	
spectrum	of	 the	unbound	protein.	Small	arrows	highlight	clear	chemical	 shift	differences.	Front	 (B)	and	
rear	(C)	views	of	chemical	shift	differences	represented	on	the	protein	product	structure	3Q8K.	For	every	
traceable	peak	pair	there	is	a	sphere	represented	on	the	amide	residue.	The	magnitude	of	chemical	shift	
difference	 is	 represented	 by	 color	 on	 each	 sphere	 as	 seen	 by	 the	 spectrum-bar.	 Secondary	 structure	
elements,	 and	 key	 residues	 are	 labeled.	 Active	 site	 carboxylates	 are	 represented	 in	 magenta	 and	 the	
positioning	 of	 the	 divalent	 cations	 in	 black	mesh.	 (D)	 A	 graph	 showing	 chemical	 shift	 perturbation	 (ω)	
measured	 in	 ppm	 plotted	 versus	 residue	 number	with	 secondary	 structure	 elements	 shown	 below	 for	
clarity.	
	
Relaxation	 experiments	 were	 performed	 on	 this	 hFEN1K93A-DHPS1	 complex	 using	 the	 same	
methodology	as	before	(Section	5.2a,	Section	2.3d).	Relaxation	data	had	low	signal-to-noise	and	
was	missing	important	residues	in	the	arch	and	α2-α3	loop.	A	particular	problem	was	the	quality	
of	the	1H-15N	HSQC	spectrum,	hindering	the	ability	to	convert	R1ρ	values	to	R2	reliably.	Despite	
this,	 some	 preliminary	 R1	 data	 was	 obtained	 at	 600	 MHz	 (Fig.	 6.vi).	 The	 R1	 values	 show	 a	
decrease	from	the	apo-protein,	consistent	with	the	 increase	 in	molecular	weight	compared	to	
apo-hFEN1K93A	(52	kDa	from	38	kDa).	The	majority	of	the	residues	were	relaxing	around	0.4	s-1,	
with	the	C-terminus	of	the	protein	displaying	much	higher	values,	which	is	consistent	with	the	
apo-protein.	Other	than	the	C-terminus	of	the	protein	there	are	no	anomalously	high	R1	values.	
The	arch,	α2-α3	 loop	and	β-pin	 remain	unassigned	due	 to	being	 in	an	 intermediate	exchange	
regime	and	so	there	is	no	information	on	these	key	regions.	
	
	
Figure	 6.vi.	 Comparison	 of	 spin-lattice	 (R1)	 values	 of	 apo-hFEN1	 and	 hFEN1K93A-DHPS1	 complex.	 The	
apo-hFEN1	protein	R1	values	average	around	0.5	s-1	(left	in	red),	whereas	the	hFEN1K93A-DNA	complex	R1	
values	 average	 around	 0.4	 s-1	 (right	 in	 orange).	 Secondary	 structure	mapping	 are	 displayed	 below	 the	
plots.		
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6.3 Influence of calcium ions on both apo-hFEN1K93A protein and hFEN1K93A-
DHPS1 complexes 
6.3a Catalytically inert calcium ions are a good replacement for natural magnesium. 
An	 essential	 co-factor	 for	 hFEN1	 to	 perform	 hydrolysis	 and	 facilitate	 DNA	 conformational	
change	is	Mg2+	 ions.124,125	An	analogous	replacement	for	Mg2+	 ions	is	Ca2+	 ions,	which	facilitate	
the	same	DNA	conformational	change,	but	do	not	allow	for	hydrolysis.28,126	In	section	1.5c,	the	
effect	 of	 divalent	 cations	 was	 noted	 on	 hFEN1	 in	 terms	 of	 both	 quality	 of	 NMR	 spectra	 and	
stability	 of	 the	 sample.	 It	 concluded	 that	Mg2+	 and	 Ca2+	 had	 no	 effect	 on	 stability	 and	minor	
chemical	 shift	 perturbations	 of	 peaks	 next	 to	 the	 active	 site	 occurred.	 Differences	 between	
samples	 containing	Mg2+	 and	Ca2+	 showed	 localised	 changes	near	 the	active	 site,	 in	particular	
the	N-terminus	of	the	protein.	This	is	likely	due	to	the	differences	in	ionic	radii	and	differences	
in	coordination	geometry.	Therefore	Ca2+	ions	are	suitable	for	studies	with	DNA,	as	they	do	not	
allow	for	hydrolysis,	while	mimicking	the	protein	structural	changes	that	Mg2+	 ions	produce	 in	
vivo.	 Therefore	 the	 role	 of	 Ca2+,	 both	 in	 apo-hFEN1K93A	 and	 DNA	 bound	 hFEN1K93A,	 can	 be	
studied.	 Ca2+	 ions	 are	 similar	 in	 function	 but	 catalytically	 inert,	 hence	 can	 be	 used	 to	 reveal	
structural	changes	throughout	the	hFEN1K93A	protein	when	substrate	DNA	is	bound.	
	
6.2b Calcium ions in Apo-hFEN1K93A 
Comparison	of	1H-15N	TROSY	spectra	with	substrate-free	hFEN1K93A	in	the	absence	and	presence	
of	8	mM	Ca2+	 showed	 several	 chemical	 shift	differences	 (Fig.	 6.vii.a).	 The	main	differences	of	
chemical	 shift	were	 located	 in	 regions	next	 to	active	 site	 carboxylates	 (D34,	D86,	E158,	E160,	
D179,	 E181,	 D233)	 and	 the	 N-terminus	 of	 the	 protein	 (Fig.	 6.vii.b,c).	 Minor	 changes	 were	
present	in	the	β5,	α3,	α7,	β4-α7	loop,	the	β3-α4	loop	and	the	βpin,	which	are	all	regions	near	
the	 active	 site	 residues.	 There	 were	 also	 slight	 chemical	 shift	 perturbations	 present	 in	 the	 β	
strands,	perhaps	propagated	structural	changes	from	the	active	site.	Furthermore,	the	addition	
of	Ca2+	 ions	did	not	change	peak	heights	associated	with	 the	arch	and	α2-α3	 loop,	 suggesting	
that	 it	does	not	change	dynamics.	Overall	 the	changes	 in	chemical	shift	are	minor	but	 located	
mainly	in	regions	next	to	active	site	carboxylates.	
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Figure	6.vii.	Chemical	shift	differences	between	hFEN1K93A	in	the	absence	and	presence	of	Ca
2+	ions.	(A)	
1H-15N	TROSY	 spectra	of	both	hFEN1K93A	in	 the	presence	of	0.1	mM	EDTA	 (red)	 and	8	mM	CaCl2	 (blue).	
Clearly	 dispersed	 peaks	 are	 labeled.	 (B)	 Chemical	 shift	 difference	 represented	 on	 the	 protein	 product	
structure	3Q8K.	For	every	 traceable	peak	pair	 there	 is	a	sphere	represented	on	the	amide	residue.	The	
magnitude	of	chemical	shift	difference	is	represented	by	color	on	each	sphere	as	seen	by	the	spectrum-
bar.	Secondary	structure	elements,	and	key	residues	are	labeled.	Active	site	carboxylates	are	represented	
in	magenta	 and	 the	 positioning	 of	 the	 divalent	 cations	 in	 black	mesh.	 (C)	 A	 close-up	 of	 the	 active	 site	
region	within	the	dotted	rectangle	in	(B).	(D)	A	graph	showing	chemical	shift	perturbation	(ω)	measured	
in	ppm	plotted	versus	residue	number	with	secondary	structure	elements	shown	below	for	clarity.	
	
6.2c Calcium ions in the hFEN1K93A-DHPS1 complex 
A	 titration	 of	 0-8	 mM	 CaCl2	 was	 added	 to	 a	 500	 mM	 hFEN1K93A-DHPS1	 complex	 and	 known	
peaks	 were	 monitored.	 The	 peaks	 that	 changed	 chemical	 shift	 were	 similar	 to	 those	 that	
changed	upon	addition	of	Ca2+	ions	to	the	hFEN1K93A	protein	sample,	and	included	peaks	around	
the	active	site.	This	suggests	that	the	Ca2+	ions	were	bound	in	a	similar	location.	However,	the	
N-terminal	 residues	Q4,	G5	 and	 L6	 all	 disappeared	 upon	 addition	 of	 Ca2+	when	 the	DNA	was	
present	 (Fig.	 6.viii,	 Fig.	 6.ix.c).	 Q4	 for	 example,	 broadened	 out	 greatly	 and	 shifted	 slightly	
upfield	 in	 1H	 after	 the	 first	 addition	 of	 Ca2+,	 and	 subsequent	 titrations	 broadened	 it	 until	 it	
eventually	disappeared.	This	shows	that	N-terminal	peaks	were	changing	their	exchange	regime	
to	 intermediate	when	 Ca2+	 was	 added	 to	 the	 hFEN1K93A-DNA	 complex.	 The	 residue	 S317	was	
assigned	 in	 the	 hFEN1K93A-DHPS1	 complex	 in	 the	 presence	 of	 Ca2+	 but	 at	 lower	 Ca2+	
concentrations	 the	 peak	 disappears	 (Fig.	 6.ix.e).	 Therefore	 suggesting	 that	 it	 changed	 to	 an	
intermediate	 exchange	 regime	 in	 the	 absence	 of	 Ca2+.	 Comparing	 hFEN1K93A	 and	 hFEN1K93A-
DHPS1	 complex,	 the	 weighted	 1H-15N	 chemical	 shift	 perturbations	 (ω)	 value	 for	 S317	 is	 0.68	
ppm	(Fig.	6.v.d).	This	 is	consistent	with	the	backbone	amide	of	S317	making	a	hydrogen	bond	
with	 a	 phosphate	 group	 on	 the	 upstream	 DNA,	 as	 observed	 in	 the	 3Q8K	 crystal	 structure.	
Regardless	of	the	presence	or	absence	of	Ca2+	ions,	the	arch	residues	and	the	α2-α3	loop	do	not	
reappear,	suggesting	that	they	are	still	 in	an	 intermediate	exchange	regime.	Overall,	dynamics	
of	the	protein	changed	when	Ca2+	was	added	to	a	hFEN1K93A-DNA	complex,	suggesting	a	change	
in	conformation	of	N-terminal	residues	and	S317,	but	not	the	arch	or	α2-α3	loop.	
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Figure	 6.viii.	 1H-15N	TROSY	 spectra	highlighting	differences	between	hFEN1K93A-DHPS1	 complex	 in	 the	
presence	and	absence	of	Ca2+	ions.	hFEN1K93A-DHPS1	in	the	presence	of	0.1	mM	EDTA	is	shown	in	black.	
The	hFEN1K93A-DHPS1	 complex	 in	 the	presence	of	8	mM	CaCl2	 is	 shown	 in	orange.	A	 selection	of	more	
dispersed	 peaks	 are	 displayed	 on	 the	 spectrum	 of	 the	 unbound	 protein.	 Small	 arrows	 highlight	 clear	
chemical	shift	differences.	
	
The	 chemical	 shift	 values	 of	 a	 large	 number	 of	 peaks	 removed	 from	 the	 active	 site	 changed	
when	Ca2+	was	titrated	into	the	hFEN1K93A-DNA	complex.	An	example	is	G87	(Fig.	6.viii),	which	is	
next	to	the	active	site	carboxylate	D86,	and	has	a	large	increase	in	chemical	shift	perturbation	
(ω)	when	Ca2+	ions	are	added	in	the	hFEN1K93A-DNA	complex	(0.22	ppm	in	the	presence	of	DNA	
compared	 to	 0.07	 ppm	 without).	 In	 the	 5UM9	 hFEN1-substrate	 crystal	 structure	 the	 5’	 flap	
passes	through	the	arch	near	to	G87,	suggesting	the	Ca2+	ions	mediate	contact	with	it.	Indeed,	
the	 presence	 of	 divalent	 metal	 ions	 has	 been	 shown	 to	 be	 required	 for	 efficient	 DNA	
threading.126	 Large	 chemical	 shift	perturbations	were	also	 found	at	G231	and	R239	 (Fig.	 6.viii	
and	Fig.	6.ix.d,c)	when	Ca2+	ions	were	added	to	the	hFEN1K93A-DHPS1	complex.	G231	is	present	
at	 the	 N-terminal	 end	 of	 the	 H2tH	motif	 and	 R239	 is	 also	 in	 the	 H2tH	motif	 contacting	 the	
template	DNA.	When	Ca2+	ions	are	added	in	the	absence	of	DNA,	G231	has	an	ω	value	of	0.022	
ppm,	however	 in	 the	presence	of	DNA,	 the	chemical	 shift	difference	was	greatly	enhanced	 to	
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0.39	ppm.	Likewise,	addition	of	Ca2+	ions	causes	a	shift	for	R239,	which	goes	from	an	ω	value	of	
0.013	 ppm	 in	 the	 absence	 of	 DNA,	 to	 0.17	 ppm	 in	 the	 presence	 of	 DNA.	 Residues	 in	 the	
upstream	binding	pocket	(α14-α15	loop	and	α6)	also	showed	greater	chemical	shift	differences	
than	in	apo-hFEN1K93A.	This	shows	that	the	H2tH	motif,	which	is	around	20	Å	from	the	active	site	
and	distant	residues	in	the	upstream	binding	region	responded	to	the	Ca2+	metal	occupancy	of	
the	active	site.	
	
	
Figure	 6.ix.	 Chemical	 shift	 differences	 between	 the	 hFEN1K93A-DHPS1	 complex	 in	 the	 absence	 and	
presence	 of	 Ca2+	 ions.	 (A)	 Front	 and	 (B)	 rear	 views	 of	 chemical	 shift	 differences	 represented	 on	 the	
protein	product	structure	3Q8K.	For	every	traceable	peak	pair	there	is	a	sphere	represented	on	the	amide	
residue.	The	magnitude	of	chemical	shift	difference	is	represented	by	color	on	each	sphere	as	seen	by	the	
spectrum-bar.	 Secondary	 structure	elements,	and	key	 residues	are	 labeled.	Active	 site	 carboxylates	are	
represented	in	magenta	and	the	positioning	of	the	divalent	cations	in	black	mesh.	(C-E)	Show	highlighted	
regions	from	Fig.6.viii	with	extra	1H-15N	TROSY	spectra	of	the	Ca2+	titration	of	hFEN1K93A-DHPS1.	The	Ca
2+	
concentrations	are	0	mM	(black),	0.5	mM	(cyan),	1mM	(olive),	2	mM	(magenta),	4	mM	(yellow),	6	mM	
(green)	 and	 8	 mM	 (orange).	 The	 panels	 represent	 disappearance	 through	 intermediate	 exchange	
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broadening	of	 the	N-terminal	residue	Q4	(C)	and	 large	chemical	shift	changes	by	fast	exchange	 in	R239	
and	R322	 (E).	 L190	undergoes	 slow	exchange	 (C),	while	G231	 (D)	and	D86	 (E)	undergo	 intermediate	 to	
slow	 exchanges.	 Panel	 (E)	 shows	 the	 reappearance	 of	 S317	 at	 higher	 Ca2+	 concentrations.	 (F)	 A	 graph	
showing	chemical	shift	perturbation	(ω)	measured	in	ppm	plotted	versus	residue	number	with	secondary	
structure	elements	shown	below	for	clarity.	
	
Overall	the	magnitude	of	chemical	shift	perturbation	was	greater	in	response	to	addition	of	Ca2+	
in	the	presence	of	DNA	than	in	the	absence	of	DNA	(Fig	6.ix.a,b,f).	Chemical	shift	changes	from	
Ca2+	 ion	addition	in	the	β3-α4	loop	where	the	5’	flap	exits,	the	whole	H2tH	motif,	β	strands	in	
the	 saddle	 region	 and	 α6,	 α14	 and	 α15	 are	 all	 larger	 in	 the	 hFEN1K93A-DNA	 complex	 than	
hFEN1K93A	 alone.	 These	 observables	 point	 towards	 DNA	 binding	 regions	 of	 the	 protein	 being	
sensitive	to	local	changes	in	the	Ca2+	bound	active	site,	even	if	they	are	removed	in	space	to	the	
active	site.		
	
6.4 Discussion 
From	chapter	 5,	 it	was	shown	that	 the	arch	region	and	α2-α3	 loop	were	disordered	 in	hFEN1	
protein	in	the	absence	of	ligand	DNA.	These	regions	are	involved	in	crucial	DNA	selection	steps	
in	catalysis,	the	threading	of	the	5’	flap	(arch	region)	and	3’	flap	recognition	(α2-α3	loop).	The	
addition	of	substrate	DNA	to	the	protein	changes	the	timescale	of	motion	of	the	arch	region	and	
α2-α3	loop	from	around	1010	s-1	to	10	–	1000	s-1.	This	reduction	in	rate	implies	that	these	regions	
are	 undergoing	 a	 conformational	 change	 at	 a	 different	 dynamic	 timescale.	 This	might	 be	 the	
same	 conformational	 change	 that	 was	 responsible	 for	 the	 unexpectedly	 large	 influence	 of	
viscogen	on	rate	constants.	The	single	turnover	rate	of	hFEN1	(15-30	s-1)	is	within	the	estimate	
of	 the	slower	motion,22	 so	 it	 could	be	 that	 the	conformational	change	 that	occurs	 is	 linked	 to	
the	rate-limiting	step	of	reaction.	
	
In	 the	hFEN1K93A-DNA	complex,	 there	are	many	 chemical	 shift	 changes	 in	 residues	distal	 from	
the	 active	 site	 upon	 addition	 of	 Ca2+.	 The	magnitude	 of	 the	 chemical	 shift	 changes	 was	 also	
greater	than	addition	of	Ca2+	to	apo-hFEN1K93A.	The	DNA	on	the	protein	is	proposed	to	undergo	
conformational	 changes,	mainly	 an	 untwisting	 of	 the	 5’	 reacting	 strand	 into	 the	 active	 site.29	
Having	metal	ions	present	in	the	active	site	may	distort	the	5’	flap	and	causes	structural	changes	
on	 the	 protein	 as	 far	 away	 as	 the	 H2tH	 motif	 or	 the	 upstream	 binding	 region	 (α14-α15).	
Furthermore	 residues	 in	 the	 N-terminus	 change	 dynamic	 regime	when	 Ca2+	 is	 titrated	 in	 the	
presence	of	DNA,	but	not	in	the	absence.	The	G2	and	the	N-terminal	amine	have	been	proposed	
to	 aid	 in	 hydrolysis	 facilitating	 the	 formation	 of	 hydroxide.	 The	 change	 in	 dynamics	 of	 these	
residues	 strongly	 suggests	 that	 these	 residues	 are	 involved	 in	 the	 catalytic	 process,	 but	 only	
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when	DNA	is	present.	Thus	preparation	of	the	nucleophile	may	be	controlled	by	access	of	DNA	
to	the	active	site,	linking	reactivity	to	selectivity.	Furthermore,	the	reappearance	of	S317	when	
Ca2+	 is	added	 indicates	 that	 the	3’	 flap	duplex	 region	 is	 coordinating	with	 the	protein.	Overall	
this	 shows	 that	 hFEN1	 protein	 has	 a	 level	 of	 DNA-mediated	 allostery	 linking	 both	 3’	 flap	
recognition	and	downstream	duplex	interactions	to	active	site	metals	and	catalysis.	
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Chapter 7: Conclusions 
7.1 Summary 
The	work	described	in	this	thesis	has	used	several	approaches	to	study	the	reaction	mechanism	
of	human	flap	endonuclease.	This	structure-specific	nuclease	is	an	essential	enzyme	involved	in	
lagging	 strand	 DNA	 replication	 and	 DNA	 repair	 mechanisms.	 Previous	 studies	 in	 the	 Grasby	
laboratory	 on	 hFEN1	 highlighted	 the	 importance	 of	 a	 conformational	 change	 in	 the	 catalytic	
step.	In	chapter	3	the	purpose	was	to	further	confirm	the	presence	of	a	conformational	change	
in	the	catalytic	cycle	of	hFEN1.	Dr.	Blanka	Séngerova	in	her	PhD	thesis	postulated	that	for	the	T5	
bacteriophage	 FEN	 some	 non-chemical	 step	 is	 likely	 to	 be	 involved	 in	 the	 conversion	 of	 the	
enzyme-substrate	 complex	 (ES)	 to	 product	 (EQ).42	 The	work	 in	 this	 thesis	 attempts	 to	 extend	
these	studies	to	the	human	endonuclease	to	determine	if	the	same	process	is	present.	Indeed	
similar	 results	 for	 hFEN1	were	 found	under	kcat/KM	 conditions	 and	 single-turnover	 conditions.	
The	rates	were	both	insensitive	to	the	pKa	of	the	leaving	group,	consistent	with	a	non-chemical	
step	 being	 involved	 with	 the	 conversion	 of	 enzyme-substrate	 complex	 to	 enzyme-product	
complex	(i.e.,	 𝐸𝑆 → [𝐸𝑄])	for	hFEN1.		
	
However	 hFEN1	 and	 T5	 FEN	 differ	 in	 their	 responses	 to	 viscosity,	 with	 hFEN1	 displaying	 an	
abnormally	 high	 viscosity	 dependence	 at	 relative	 viscosities	 higher	 than	 2.	 This	 was	 likely	
attributable	to	the	viscogen	retarding	two	kinetic	steps,	firstly	the	bimolecular	association	rate	
and	secondly,	a	conformational	rearrangement.	In	order	to	separate	the	two	processes,	it	would	
be	 necessary	 to	 perform	 these	 experiments	 under	 single-turnover	 conditions.	 This	 would	 be	
challenging	under	 rapid-quench	 conditions	due	 to	 the	need	of	 instantaneous	mixing,	which	 is	
slowed	by	viscous	solutions.	The	only	 information	at	present	 is	single-molecule	FRET	apparent	
single	 turnover	 ‘rates’	 that	show	a	dependence	with	 the	microviscogens	glycerol	and	sucrose,	
but	not	with	the	macroviscogen	polyethelyne	glycol-8000.40	
	
An	 attempt	 to	 quantify	 the	 rate	 of	 this	 conformational	 change	 was	 made	 by	 using	 NMR	
spectroscopy.	In	chapter	4	the	challenges	of	studying	a	novel	protein	system	are	highlighted.	Of	
particular	concern	was	the	stability	of	the	sample,	which	directed	much	of	the	earlier	work	done	
by	 Dr.	 David	 Finger,	 and	 indeed	 was	 an	 ongoing	 problem	 throughout	 all	 experiments.	 The	
mutation	of	cysteine	residues	and	the	mutation	of	P188	failed	to	stop	short	term	aggregation.	
Neither	 did	 the	 addition	 of	 various	 small	 hFEN1	 ligands,	 such	 as	 mono-	 or	 di-nucleotides	 or	
known	inhibitors	aid	in	stability.	While	the	addition	of	large	excess	of	βME	did	aid	stability	in	the	
short	 term,	 it	 should	 be	 noted	 that	 no	 one	mutation	 or	 addition	 of	 small	 molecule	 stopped	
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aggregation	 of	 the	 protein	 over	 extended	 periods	 of	 time,	 a	 testament	 to	 instability	 of	 the	
protein.	Nevertheless,	samples	were	made	that	were	amenable	for	assignment	and	relaxation	
experiments.	 Investigation	 of	 the	 peak	 heights	 showed	 the	 arch	 region	 and	 α2-α3	 loop	 had	
much	greater	peak	heights	 than	would	be	expected	 for	 internal	 residues.	These	 regions	were	
key	to	the	catalytic	machinery,	and	displayed	structural	heterogeneity	between	DNA-bound27,29	
and	 non-DNA	 bound24	 hFEN1	 X-ray	 crystal	 structures.	 Thus	 these	 two	 regions	 were	 likely	
candidates	for	sites	of	conformational	change	linked	to	catalysis.	
	
In	chapter	5	NMR	relaxation	rates	were	measured	to	quantify	the	motions	the	protein,	and	in	
particular	 the	 arch	 region	 and	 α2-α3	 loop.	 Indeed	 these	 regions	 displayed	much	 lower	 R2/R1	
ratios	and	much	more	negative	hNOE	values	than	the	other	residues	of	the	protein.	Model	free	
analysis	further	confirmed	that	the	arch	and	α2-α3	loop	were	regions	of	intrinsic	disorder	within	
the	protein.	The	fact	that	the	arch	is	disordered	in	an	extended	conformation	in	solution	in	the	
absence	of	DNA	means	it	can	accommodate	a	wide	variety	of	5’	flaps.	It	has	been	shown	that	5’	
flaps	with	bulky	streptavidin	can	pass	through	the	arch,	as	well	as	even	small	regions	of	5’	DNA	
with	 secondary	 structure.38	 This	 lends	 weight	 to	 the	 arch	 undergoing	 a	 disorder-to-order	
transition	to	allow	the	reacting	5’	flap	strand	to	pass	through	or	‘thread’.		
	
Having	 disorder	 present	 in	 the	 protein	 could	 actually	 allow	 for	 a	 larger	 capture	 radius	 of	 the	
reacting	 flap	 and	 the	 1nt	 3’	 flap,	 aiding	 affinity.	 Furthermore,	 using	 chemical	 shift	 databases	
(ncIDP,	TALOS-N)	 the	arch	displayed	an	 interesting	dual	property,	with	 the	N-terminal	portion	
sampling	 α-helical	 torsion	 angles	 while	 the	 C-terminal	 portion	 displaying	 fully	 extended	
conformations.	 Thus	 the	 proposed	 model	 is	 that	 the	 N-terminal	 portion	 of	 the	 arch	 is	
conformationally	 selected	 while	 the	 C-terminal	 portion	 and	 the	 α2-α3	 loop	 are	 induced	 by	
presence	of	substrate.	This	makes	sense	from	an	energetic	standpoint,	as	the	so-called	α4	is	a	
large	helix	and	for	it	to	be	induced	would	be	a	large	energy	barrier.	Having	the	dual	induced-fit	
and	 conformational	 selection	 of	 an	 ordered	 state	 allows	 for	 relatively	 low	 energy	 barriers	 of	
folding,	while	also	allowing	for	a	degree	of	specificity	depending	on	what	substrate	is	presented.	
	
In	 chapter	 6	 the	 effect	 of	 adding	 DNA	 to	 hFEN1	was	 investigated.	 Adding	 sub-stoichiometric	
DNA	was	 found	 to	 change	 the	 rate	of	motion	of	 the	arch	and	α2-α3	 loop	 to	 an	 intermediate	
exchange	regime.	The	intermediate	exchange	regime	is	usually	found	around	10-1000	s-1,	which	
places	 it	 close	 to	 the	 single	 turnover	 rate	 of	 hFEN1	 catalysis	 (15-30	 s-1).22	 It	 is	 therefore	 a	
possibility	 that	 the	 movement	 of	 these	 regions	 when	 DNA	 is	 bound	 is	 the	 rate-limiting	
conformational	 change	during	 catalysis.	 Furthermore,	addition	of	Ca2+	 ions	 to	 the	hFEN1-DNA	
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complex	 causes	widespread	 chemical	 shift	 perturbations	 in	 regions	 far	 away	 from	 the	metal-
binding	 active	 site.	 They	 also	 cause	 a	 change	 in	 dynamics	 of	 the	 N-terminus	 of	 the	 protein,	
which	 is	 facing	 into	 the	 active	 site.	 These	 widespread	 chemical	 shift	 changes	 and	 dynamic	
changes	are	not	evident	 in	hFEN1	 in	the	absence	of	DNA.	The	regions	of	major	perturbations,	
such	as	the	H2tH	motif	and	the	3’	flap	binding	pocket	are	responsible	for	selectively	binding	a	
suitable	 substrate,	 hence	 aiding	 specificity.	 Thus	 the	 protein	 has	 a	 level	 of	 DNA-mediated	
allostery,	which	links	DNA	recognition	regions	to	the	active	site.	
	
7.2 Future Work 
While	the	site	of	disorder-to-order	 in	 the	protein	has	been	 located	 in	a	solution	state	system,	
the	DNA	dynamics	are	still	relatively	unknown.	In	chapter	1	it	was	proposed	that	two	steps	were	
required	for	DNA	to	position	on	hFEN1	in	order	for	hydrolysis	to	occur.	These	were	bending	of	
the	 duplex,	 and	 twisting	 of	 the	 reacting	 strand	 into	 contact	 with	 the	 metals.28	 The	 ongoing	
question	is	whether	the	flapped	substrate	follows	an	induced	fit,40	or	conformational	selection	
model,41	with	 respect	 to	 bending.	 In	 other	words,	whether	 the	protein	 completely	molds	 the	
DNA	into	a	bent	conformation,	or	whether	the	DNA	exhibits	the	ability	to	bend	in	solution.	The	
studies	so	far	have	focused	on	using	single-molecule	FRET	techniques,	which	are	limited	in	how	
fast	detectors	can	measure	photons,	giving	a	millisecond	limit	on	temporal	resolution.		
	
Using	NMR	 spectroscopy	 it	might	 be	 possible	 to	 study	 the	 ps-ns	 dynamics	 of	 sugar	 and	 base	
atoms	by	using	model	free	analysis,	similar	to	the	technique	applied	for	hFEN1.	Special	care	is	
needed	 to	 decouple	 the	 tumbling	 of	 the	molecule	 from	 the	 local	 librations	 of	 15N-H	 or	 13C-H	
bonds.	 A	 small	 construct	 can	 be	 made	 in	 vitro	 using	 15N,	 13C	 uniformly	 labeled	 nucleoside	
triphosphates.127	Then	an	unlabeled	RNA	sequence	is	polymerised	onto	the	end	of	the	labeled	
domain	of	interest.	This	has	shown	to	be	a	good	way	of	analysing	dynamics	of	small	structural	
portions	of	RNA,	such	as	regulatory	RNAs	in	HIV-1.128	Furthermore,	atomic	resolution	relaxation	
dispersion	 can	 also	 be	performed	 to	 see	 if	 any	 lowly	 populated	 excited	 states	 are	 present.129	
Measuring	 the	 dynamics	 in	 the	 presence	 and	 absence	 of	 hFEN1	 should	 reveal	 any	 potential	
conformers	in	solution,	highlighting	any	transiently	sampled	bent	states.	Thus	information	could	
be	 gained	 about	 a	 dynamic	 conformational	 selection	 by	 hFEN1	 or	 whether	 the	 protein	 truly	
induces	a	bend	in	the	DNA.	
	
The	 lack	of	 protein	 stability	was	 a	 constant	problem	 for	hFEN1,	however	 FENs	 are	present	 in	
many	other	organisms.	Of	particular	interest	are	the	FENs	from	hyperthermophilic	archaea,	like	
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Pyrococcus	furiosus31	and	Archaeoglobus	fulgidus.25	While	the	sequences	of	these	enzymes	are	
different,	 their	 activity	 and	 substrate	 specificity	 remains	 similar.130	 The	 interest	 of	 studying	
thermophilic	 species	 lies	 in	 the	 dynamics	 of	 the	 arch	 at	 temperatures	 that	 are	 lower	 than	
optimal	for	them.	Firstly	the	stability	of	the	protein	is	likely	to	be	higher	at	lower	temperatures.	
Secondly,	by	speeding	up	the	molecular	tumbling	at	higher	temperatures,	higher	signal	to	noise	
ratios	 may	 be	 obtained.	 Furthermore,	 a	 link	 could	 be	 found	 between	 kinetic	 activities	 at	
different	temperatures	and	the	flexibility	of	arch	and	α2-α3	loop	residues.	
References	
	 117	
References 
(1)		 Hershey,	A.	D.	J.	Gen.	Physiol.	1952,	36,	39.	
(2)		 McCarty,	M.	J.	Exp.	Med.	1946,	83,	89.	
(3)		 Nakamura,	J.;	Swenberg,	J.	A.	Cancer	Res.	1999,	59,	2522.	
(4)		 Fisher,	L.	M.	Nature	1982,	299,	105.	
(5)		 Gerlt,	J.	A.;	Coderre,	J.	A.;	Mehdi,	S.	Adv.	Enzymol.	Relat.	Areas	Mol.	Biol.	1983,	55,	291.	
(6)		 Williams,	N.	H.;	Wyman,	P.	Chem.	Commun.	2001,	1268.	
(7)		 Yang,	W.	Q.	Rev.	Biophys.	2011,	44,	1.	
(8)		 Finger,	 L.	 D.;	 Atack,	 J.	 M.;	 Tsutakawa,	 S.;	 Classen,	 S.;	 Tainer,	 J.;	 Grasby,	 J.;	 Shen,	 B.	
Eukaryot.	Replisome	A	Guid.	to	Protein	Struct.	Funct.	2012,	62,	301.	
(9)		 Szankasi,	P.;	Smith,	G.	R.	Science	1995,	267,	1166.	
(10)		 Genschel,	J.;	Bazemore,	L.	R.;	Modrich,	P.	J.	Biol.	Chem.	2002,	277,	13302.	
(11)		 Sun,	M.;	Schwalb,	B.;	Pirkl,	N.;	Maier,	K.	C.;	Schenk,	A.;	Failmezger,	H.;	Tresch,	A.;	Cramer,	
P.	Mol.	Cell	2013,	52,	52.	
(12)		 Balakrishnan,	L.;	Bambara,	R.	A.	Annu.	Rev.	Biochem.	2013,	82,	119.	
(13)		 MacNeill,	S.	Subcell.	Biochem.	2012,	62,	1.	
(14)		 Blow,	J.	J.;	Dutta,	A.	Nat.	Rev.	Mol.	Cell	Biol.	2005,	6,	476.	
(15)		 Burgers,	P.	M.	J.	Chromosoma	1998,	107,	218.	
(16)		 Pellegrini,	L.	Eukaryot.	Replisome	a	Guid.	to	Protein	Struct.	Funct.	2012,	62,	135.	
(17)		 Burgers,	P.	M.	J.	J.	Biol.	Chem.	2009,	284,	4041.	
(18)		 Ceska,	T.	A.;	Sayers,	J.	R.;	Stier,	G.;	Suck,	D.	Nature	1996,	382,	90.	
(19)		 Larsen,	E.;	Gran,	C.;	Saether,	B.	E.;	Seeberg,	E.;	Klungland,	A.	Mol	Cell	Biol	2003,	23,	5346.	
(20)		 Tishkoff,	D.	X.;	Filosi,	N.;	Gaida,	G.	M.;	Kolodner,	R.	D.	Cell	1997,	88,	253.	
(21)		 Zheng,	L.;	Jia,	J.;	Finger,	L.	D.;	Guo,	Z.;	Zer,	C.;	Shen,	B.	Nucleic	Acids	Res.	2011,	39,	781.	
(22)		 Finger,	L.	D.;	Blanchard,	M.	S.;	Theimer,	C.	A.;	Sengerová,	B.;	Singh,	P.;	Chavez,	V.;	Liu,	F.;	
Grasby,	J.	A.;	Shen,	B.	J.	Biol.	Chem.	2009,	284,	22184.	
(23)		 Yang,	W.;	Lee,	J.	Y.;	Nowotny,	M.	Mol.	Cell	2006,	22,	5.	
(24)		 Sakurai,	 S.;	 Kitano,	 K.;	 Yamaguchi,	 H.;	 Hamada,	 K.;	 Okada,	 K.;	 Fukuda,	 K.;	 Uchida,	M.;	
Ohtsuka,	E.;	Morioka,	H.;	Hakoshima,	T.	EMBO	J.	2005,	24,	683.	
(25)		 Chapados,	B.	R.;	Hosfield,	D.	J.;	Han,	S.;	Qiu,	J.;	Yelent,	B.;	Shen,	B.;	Tainer,	J.	A.	Cell	2004,	
116,	39.	
(26)		 Exell,	 J.	 C.;	 Thompson,	 M.	 J.;	 Finger,	 L.	 D.;	 Shaw,	 S.	 J.;	 Debreczeni,	 J.;	 Ward,	 T.	 A.;	
McWhirter,	C.;	Siöberg,	C.	L.	B.;	Molina,	D.	M.;	Abbott,	W.	M.;	Jones,	C.	D.;	Nissink,	J.	W.	
M.;	Durant,	S.	T.;	Grasby,	J.	A.	Nat.	Chem.	Biol.	2016,	12,	815.	
References	
	118	
(27)		 Tsutakawa,	 S.	 E.;	 Classen,	 S.;	 Chapados,	 B.	 R.;	 Arvai,	 A.	 S.;	 Finger,	 L.	 D.;	 Guenther,	 G.;	
Tomlinson,	 C.	 G.;	 Thompson,	 P.;	 Sarker,	 A.	 H.;	 Shen,	 B.;	 Cooper,	 P.	 K.;	 Grasby,	 J.	 A.;	
Tainer,	J.	A.	Cell	2011,	145,	198.	
(28)		 Algasaier,	S.	 I.;	Exell,	 J.	C.;	Bennet,	 I.	A.;	Thompson,	M.	 J.;	Gotham,	V.	 J.	B.;	Shaw,	S.	 J.;	
Craggs,	T.	D.;	Finger,	L.	D.;	Grasby,	J.	A.	J.	Biol.	Chem.	2016,	291,	8258.	
(29)		 Tsutakawa,	S.	E.;	Thompson,	M.	J.;	Arvai,	A.	S.;	Neil,	A.	J.;	Shaw,	S.	J.;	Algasaier,	S.	I.;	Kim,	
J.	 C.;	 Finger,	 L.	 D.;	 Jardine,	 E.;	 Gotham,	 V.	 J.	 B.;	 Sarker,	 A.	 H.;	 Her,	 M.	 Z.;	 Rashid,	 F.;	
Hamdan,	S.	M.;	Mirkin,	S.	M.;	Grasby,	J.	A.;	Tainer,	J.	A.	Nat.	Commun.	2017,	8,	15855.	
(30)		 Mase,	 T.;	 Kubota,	 K.;	Miyazono,	 K.	 I.;	 Kawarabayasi,	 Y.;	 Tanokura,	M.	Acta	 Crystallogr.	
Sect.	F	Struct.	Biol.	Cryst.	Commun.	2011,	67,	209.	
(31)		 Hosfield,	D.	J.;	Mol,	C.	D.;	Shen,	B.;	Tainer,	J.	A.	Cell	1998,	95,	135.	
(32)		 AlMalki,	F.	A.;	Flemming,	C.	S.;	Zhang,	J.;	Feng,	M.;	Sedelnikova,	S.	E.;	Ceska,	T.;	Rafferty,	
J.	B.;	Sayers,	J.	R.;	Artymiuk,	P.	J.	Nat.	Struct.	Mol.	Biol.	2016,	23,	640.	
(33)		 Matsui,	E.;	Musti,	K.	V.;	Abe,	 J.;	Yamasaki,	K.;	Matsui,	 I.;	Harata,	K.	 J.	Biol.	Chem.	2002,	
277,	37840.	
(34)		 Hwang,	K.	Y.;	Baek,	K.;	Kim,	H.-Y.	Y.;	Cho,	Y.	Nat.	Struct.	Biol.	1998,	5,	707.	
(35)		 Shah,	 S.;	 Dunten,	 P.;	 Stiteler,	 A.;	 Park,	 C.	 K.;	 Horton,	 N.	 C.	 Proteins	 Struct.	 Funct.	
Bioinforma.	2015,	83,	188.	
(36)		 Garforth,	S.	J.;	Ceska,	T.	A.;	Suck,	D.;	Sayers,	J.	R.	Proc.	Natl.	Acad.	Sci.	U.	S.	A.	1999,	96,	
38.	
(37)		 Patel,	N.;	Exell,	 J.	C.;	 Jardine,	E.;	Ombler,	B.;	Finger,	L.	D.;	Ciani,	B.;	Grasby,	 J.	A.	 J.	Biol.	
Chem.	2013,	288,	34239.	
(38)		 Patel,	N.;	Atack,	J.	M.;	Finger,	L.	D.;	Exell,	J.	C.;	Thompson,	P.;	Tsutakawa,	S.;	Tainer,	J.	A.;	
Williams,	D.	M.;	Grasby,	J.	A.	Nucleic	Acids	Res.	2012,	40,	4507.	
(39)		 Fetrow,	J.	S.	FASEB	J.	1995,	9,	708.	
(40)		 Rashid,	 F.;	Harris,	 P.	D.;	 Zaher,	M.	 S.;	 Sobhy,	M.	A.;	 Joudeh,	 L.	 I.;	 Yan,	C.;	 Piwonski,	H.;	
Tsutakawa,	S.	E.;	Ivanov,	I.;	Tainer,	J.	A.;	Habuchi,	S.;	Hamdan,	S.	M.	Elife	2017,	6.	
(41)		 Craggs,	 T.	 D.;	 Hutton,	 R.	 D.;	 Brenlla,	 A.;	White,	M.	 F.;	 Penedo,	 J.	 C.	Nucleic	 Acids	 Res.	
2014,	42,	1857.	
(42)		 Sengerová,	 B.;	 Tomlinson,	 C.;	 Atack,	 J.	 M.;	 Williams,	 R.;	 Sayers,	 J.	 R.;	 Williams,	 N.	 H.;	
Grasby,	J.	A.	Biochemistry	2010,	49,	8085.	
(43)		 Tom,	S.;	Henricksen,	L.	A.;	Bambara,	R.	A.	J.	Biol.	Chem.	2000,	275,	10498.	
(44)		 Beattie,	T.	R.;	Bell,	S.	D.	Biochem.	Soc.	Trans.	2011,	39,	70.	
(45)		 Loria,	J.	P.;	Berlow,	R.	B.;	Watt,	E.	D.	Acc.	Chem.	Res.	2008,	41,	214.	
(46)		 Schwartz,	S.	D.;	Schramm,	V.	L.	Nat.	Chem.	Biol.	2009,	5,	551.	
References	
	 119	
(47)		 Smock,	R.	G.;	Gierasch,	L.	M.	Science	(80-.	).	2009,	324,	198.	
(48)		 Kamerzell,	T.	J.;	Middaugh,	C.	R.	J.	Pharm.	Sci.	2008,	97,	3494.	
(49)		 Neudecker,	P.;	Lundström,	P.;	Kay,	L.	E.	Biophys.	J.	2009,	96,	2045.	
(50)		 Dyson,	H.	J.;	Wright,	P.	E.	Methods	Enzymol.	2005,	394,	299.	
(51)		 Kleckner,	 I.	 R.;	 Foster,	M.	 P.	Biochim.	 Biophys.	 Acta	 -	 Proteins	 Proteomics	2011,	1814,	
942.	
(52)		 Kempf,	J.	G.;	Loria,	J.	P.	Cell	Biochem.	Biophys.	2003,	37,	187.	
(53)		 Palmer,	A.	G.;	Grey,	M.	J.;	Wang,	C.	Methods	Enzymol.	2005,	394,	430.	
(54)		 Massi,	F.;	 Johnson,	E.;	Wang,	C.;	Rance,	M.;	Palmer,	A.	G.	J.	Am.	Chem.	Soc.	2004,	126,	
2247.	
(55)		 Pervushin,	K.;	Riek,	R.;	Wider,	G.;	Wuthrich,	K.	Proc.	Natl.	Acad.	Sci.	1997,	94,	12366.	
(56)		 Pervushin,	 K.	 D.;	 Riek,	 R.;	 Wider,	 G.	 D.;	 Wüthrich,	 K.	 P.	 D.	 Transverse	 relaxation-
optimized	NMR	spectroscopy	(TROSY),	May	19,	1999.	
(57)		 Reed,	M.	A.	C.;	Hounslow,	A.	M.;	Sze,	K.	H.;	Barsukov,	I.	G.;	Hosszu,	L.	L.	P.;	Clarke,	A.	R.;	
Craven,	C.	J.;	Waltho,	J.	P.	J.	Mol.	Biol.	2003,	330,	1189.	
(58)		 Raines,	R.	T.	Chem.	Rev.	1998,	98,	1045.	
(59)		 Wlodawer,	A.;	Borkakoti,	N.;	Moss,	D.	 S.;	Howlin,	B.	Acta	Crystallogr.	 Sect.	B	1986,	42,	
379.	
(60)		 Hammes,	G.	G.	Biochemistry	2002,	41,	8221.	
(61)		 Rico,	M.;	Santoro,	J.;	González,	C.;	Bruix,	M.;	Neira,	J.	L.;	Nieto,	J.	L.;	Herranz,	J.	J.	Biomol.	
NMR	1991,	1,	283.	
(62)		 Toiron,	C.;	González,	C.;	Bruix,	M.;	Rico,	M.	Protein	Sci.	1996,	5,	1633.	
(63)		 Cole,	R.;	Loria,	J.	P.	Biochemistry	2002,	41,	6072.	
(64)		 Beach,	H.;	Cole,	R.;	Gill,	M.	L.;	Loria,	J.	P.	J.	Am.	Chem.	Soc.	2005,	127,	9167.	
(65)		 Zegers,	I.;	Maes,	D.;	Dao-Thi,	M.	-H;	Wyns,	L.;	Poortmans,	F.;	Palmer,	R.	Protein	Sci.	1994,	
3,	2322.	
(66)		 Kovrigin,	E.	L.;	Loria,	J.	P.	J.	Am.	Chem.	Soc.	2006,	128,	7724.	
(67)		 Watt,	E.	D.;	Shimada,	H.;	Kovrigin,	E.	L.;	Loria,	J.	P.	Proc.	Natl.	Acad.	Sci.	2007,	104,	11981.	
(68)		 Kempf,	J.	G.;	Jung,	J.	Y.;	Sampson,	N.	S.;	Loria,	J.	P.	J.	Am.	Chem.	Soc.	2003,	125,	12064.	
(69)		 Igumenova,	T.	I.;	Palmer,	A.	G.	J.	Am.	Chem.	Soc.	2006,	128,	8110.	
(70)		 Lolis,	E.;	Alber,	T.;	Davenport,	R.	C.;	Rose,	D.;	Hartman,	F.	C.;	Petsko,	G.	A.	Biochemistry	
1990,	29,	6609.	
(71)		 Lolis,	E.;	Petsko,	G.	A.	Biochemistry	1990,	29,	6619.	
(72)		 Guallar,	V.;	Jacobson,	M.;	McDermott,	A.;	Friesner,	R.	A.	J.	Mol.	Biol.	2004,	337,	227.	
(73)		 Jogl,	G.;	Rozovsky,	S.;	McDermott,	A.	E.;	Tong,	L.	Proc.	Natl.	Acad.	Sci.	U.	S.	A.	2003,	100,	
References	
	120	
50.	
(74)		 Pompliano,	D.	L.;	Peyman,	A.;	Knowles,	J.	R.	Biochemistry	1990,	29,	3186.	
(75)		 Kempf,	J.	G.;	Jung,	J.	yeon;	Ragain,	C.;	Sampson,	N.	S.;	Loria,	J.	P.	J.	Mol.	Biol.	2007,	368,	
131.	
(76)		 Sampson,	N.	S.;	Knowles,	J.	R.	Biochemistry	1992,	31,	8482.	
(77)		 Berlow,	R.	B.;	Igumenova,	T.	I.;	Loria,	J.	P.	Biochemistry	2007,	46,	6001.	
(78)		 Studier,	F.	W.	Protein	Expr.	Purif.	2005,	41,	207.	
(79)		 Sivashanmugam,	A.;	Murray,	V.;	Cui,	C.;	Zhang,	Y.;	Wang,	J.;	Li,	Q.	Protein	Sci.	2009,	18,	
936.	
(80)		 Gasteiger,	E.;	Gattiker,	A.;	Hoogland,	C.;	Ivanyi,	I.;	Appel,	R.	D.;	Bairoch,	A.	Nucleic	Acids	
Res.	2003,	31,	3784.	
(81)		 Cavaluzzi,	M.	J.	Nucleic	Acids	Res.	2004,	32,	13e.	
(82)		 Åström,	H.;	Limén,	E.;	Strömberg,	R.	J.	Am.	Chem.	Soc.	2004,	126,	14710.	
(83)		 Williams,	R.;	Sengerová,	B.;	Osborne,	S.;	Syson,	K.;	Ault,	S.;	Kilgour,	A.;	Chapados,	B.	R.;	
Tainer,	J.	A.;	Sayers,	J.	R.;	Grasby,	J.	A.	J.	Mol.	Biol.	2007,	371,	34.	
(84)		 Exell,	 J.	 C.	 Spectroscopic	 evidence	 for	 catalytically-required	 FEN-1	 mediated	 DNA	
conformational	 change;	 a	 novel	 strategy	 for	 FEN1	 inhibition,	 University	 of	 Sheffield,	
2015.	
(85)		 Cheng,	N.	S.	Ind.	Eng.	Chem.	Res.	2008,	47,	3285.	
(86)		 Brouwer,	A.	C.;	Kirsch,	J.	F.	Biochemistry	1982,	21,	1302.	
(87)		 Cavanagh,	 J.;	 Fairbrother,	 W.;	 Palmer	 III,	 A.;	 Rance,	 M.;	 Skelton,	 N.	 Protein	 NMR	
spectroscopy.	Principles	and	Practice.;	2007;	Vol.	2nd.	
(88)		 Vranken,	W.	F.;	Boucher,	W.;	Stevens,	T.	J.;	Fogh,	R.	H.;	Pajon,	A.;	Llinas,	M.;	Ulrich,	E.	L.;	
Markley,	J.	L.;	Ionides,	J.;	Laue,	E.	D.	Proteins	Struct.	Funct.	Genet.	2005,	59,	687.	
(89)		 Shen,	Y.;	Bax,	A.	J.	Biomol.	NMR	2013,	56,	227.	
(90)		 Lakomek,	N.	A.;	Ying,	J.;	Bax,	A.	J.	Biomol.	NMR	2012,	53,	209.	
(91)		 d’Auvergne,	E.	J.;	Gooley,	P.	R.	J.	Biomol.	NMR	2003,	25,	25.	
(92)		 d’Auvergne,	E.	J.;	Gooley,	P.	R.	J.	Biomol.	NMR	2006,	35,	117.	
(93)		 d’Auvergne,	E.	J.;	Gooley,	P.	R.	Mol.	Biosyst.	2007,	3,	483.	
(94)		 d’Auvergne,	E.	J.;	Gooley,	P.	R.	J.	Biomol.	NMR	2008,	40,	107.	
(95)		 d’Auvergne,	E.	J.;	Gooley,	P.	R.	J.	Biomol.	NMR	2008,	40,	121.	
(96)		 Williamson,	M.	P.	Prog.	Nucl.	Magn.	Reson.	Spectrosc.	2013,	73,	1.	
(97)		 Patel,	D.;	Tock,	M.	R.;	Frary,	E.;	Feng,	M.;	Pickering,	T.	J.;	Grasby,	J.	A.;	Sayers,	J.	R.	J.	Mol.	
Biol.	2002,	320,	1025.	
(98)		 Tock,	M.	R.;	Frary,	E.;	Sayers,	J.	R.;	Grasby,	J.	A.	EMBO	J.	2003,	22,	995.	
References	
	 121	
(99)		 Briggs,	G.	E.;	Haldane,	J.	B.	S.	Biochem.	J.	1925,	19,	1037.	
(100)		 Van	Slyke,	D.	D.;	Cullen,	G.	E.	J.	Biol.	Chem.	1914,	19,	141.	
(101)		 Berg,	O.	G.;	von	Hippel,	P.	H.	Annu.	Rev.	Biophys.	Biophys.	Chem.	1985,	14,	131.	
(102)		 Zalatan,	J.	G.;	Herschlag,	D.	J.	Am.	Chem.	Soc.	2006,	128,	1293.	
(103)		 Mihai,	C.;	Kravchuk,	A.	V.;	Tsai,	M.	D.;	Bruzik,	K.	S.	J.	Am.	Chem.	Soc.	2003,	125,	3236.	
(104)		 O’Brien,	P.	J.;	Herschlag,	D.	Biochemistry	2002,	41,	3207.	
(105)		 Zheng,	L.;	Dai,	H.;	Zhou,	M.;	Li,	M.;	Singh,	P.;	Qiu,	J.;	Tsark,	W.;	Huang,	Q.;	Kernstine,	K.;	
Zhang,	X.;	Lin,	D.;	Shen,	B.	Nat.	Med.	2007,	13,	812.	
(106)		 Zheng,	L.;	Shen,	B.	J.	Mol.	Cell	Biol.	2011,	3,	23.	
(107)		 Rogers,	J.	M.;	Steward,	A.;	Clarke,	J.	J.	Am.	Chem.	Soc.	2013,	135,	1415.	
(108)		 Sekhar,	A.;	Latham,	M.	P.;	Vallurupalli,	P.;	Kay,	L.	E.	J.	Phys.	Chem.	B	2014,	118,	4546.	
(109)		 Rauscher,	A.;	Derényi,	I.;	Gráf,	L.;	Málnási-Csizmadia,	A.	IUBMB	Life	2013,	65,	35.	
(110)		 Sakurai,	 S.;	 Kitano,	 K.;	 Yamaguchi,	 H.;	 Hamada,	 K.;	 Okada,	 K.;	 Fukuda,	 K.;	 Uchida,	M.;	
Ohtsuka,	E.;	Morioka,	H.;	Hakoshima,	T.	EMBO	J.	2005,	24,	683.	
(111)		 Guo,	Z.;	Chavez,	V.;	Singh,	P.;	Finger,	L.	D.;	Hang,	H.;	Hegde,	M.	L.;	Shen,	B.	J.	Mol.	Biol.	
2008,	377,	679.	
(112)		 Conte,	 M.	 Lo;	 Carroll,	 K.	 S.	 In	 Oxidative	 Stress	 and	 Redox	 Regulation;	 Jakob,	 U.;	
Reichmann,	D.,	Eds.;	Springer	Netherlands,	2013;	Vol.	9789400757,	pp.	1–42.	
(113)		 Golovanov,	A.	 P.;	Hautbergue,	G.	M.;	Wilson,	 S.	 A.;	 Lian,	 L.	 Y.	 J.	 Am.	 Chem.	 Soc.	2004,	
126,	8933.	
(114)		 Tumey,	L.	N.;	Bom,	D.;	Huck,	B.;	Gleason,	E.;	Wang,	J.;	Silver,	D.;	Brunden,	K.;	Boozer,	S.;	
Rundlett,	 S.;	 Sherf,	 B.;	 Murphy,	 S.;	 Dent,	 T.;	 Leventhal,	 C.;	 Bailey,	 A.;	 Harrington,	 J.;	
Bennani,	Y.	L.	Bioorganic	Med.	Chem.	Lett.	2005,	15,	277.	
(115)		 Hunter,	T.	Cell	1998,	92,	141.	
(116)		 Henneke,	G.;	Koundrioukoff,	S.;	Hübscher,	U.	Oncogene	2003,	22,	4301.	
(117)		 Kay,	L.	E.;	Torchia,	D.	A.;	Bax,	A.	Biochemistry	1989,	28,	8972.	
(118)		 Rossi,	P.;	Swapna,	G.	V.	T.;	Huang,	Y.	J.;	Aramini,	J.	M.;	Anklin,	C.;	Conover,	K.;	Hamilton,	
K.;	Xiao,	R.;	Acton,	T.	B.;	Ertekin,	A.;	Everett,	J.	K.;	Montelione,	G.	T.	J.	Biomol.	NMR	2010,	
46,	11.	
(119)		 Bieri,	M.;	d’Auvergne,	E.	J.;	Gooley,	P.	R.	J.	Biomol.	NMR	2011,	50,	147.	
(120)		 Tamiola,	K.;	Acar,	B.;	Mulder,	F.	A.	A.	J.	Am.	Chem.	Soc.	2010,	132,	18000.	
(121)		 Lacroix,	E.;	Viguera,	A.	R.;	Serrano,	L.	J.	Mol.	Biol.	1998,	284,	173.	
(122)		 Das,	R.	K.;	Ruff,	K.	M.;	Pappu,	R.	V.	Curr.	Opin.	Struct.	Biol.	2015,	32,	102.	
(123)		 Skrynnikov,	N.	R.;	Dahlquist,	F.	W.;	Kay,	L.	E.	J.	Am.	Chem.	Soc.	2002,	124,	12352.	
(124)		 Lyamichev,	V.;	Brow,	M.;	Dahlberg,	J.	Science.	1993,	260,	778.	
References	
	122	
(125)		 Harrington,	J.	J.;	Lieber,	M.	R.	EMBO	J.	1994,	13,	1235.	
(126)		 Finger,	L.	D.;	Patel,	N.;	Beddows,	A.;	Ma,	L.;	Exell,	J.	C.;	Jardine,	E.;	Jones,	A.	C.;	Grasby,	J.	
A.	Nucleic	Acids	Res.	2013,	41,	9839.	
(127)		 Alvarado,	L.	J.;	Longhini,	A.	P.;	LeBlanc,	R.	M.;	Chen,	B.;	Kreutz,	C.;	Dayie,	T.	K.	Methods	
Enzymol.	2014,	549,	133.	
(128)		 Zhang,	Q.;	Xiaoyan,	S.;	Watt,	E.	D.;	Al-Hashimi,	H.	M.	Science.	2006,	311,	653.	
(129)		 Xue,	 Y.;	 Kellogg,	 D.;	 Kimsey,	 I.	 J.;	 Sathyamoorthy,	 B.;	 Stein,	 Z.	 W.;	 McBrairty,	 M.;	 Al-
Hashimi,	H.	M.	In	Methods	in	Enzymology;	2015;	Vol.	558,	pp.	39–73.	
(130)		 Kaiser,	M.	W.;	Lyamicheva,	N.;	Ma,	W.;	Miller,	C.;	Neri,	B.;	Fors,	L.;	Lyamichev,	V.	I.	J.	Biol.	
Chem.	1999,	274,	21387.	
Appendices	
	 123	
Appendices  
	
Residue	
Number	
Residue	
Name	 H	 N	 C	 CA	 CB	
1	 Met	 -	 -	 -	 -	 -	
2	 Gly	 -	 -	 170.41	 43.74	 -	
3	 Ile	 7.99	 122.22	 176.64	 57.16	 35.46	
4	 Gln	 8.75	 129.11	 176.58	 57.09	 27.2	
5	 Gly	 8.73	 110.27	 176.12	 45.73	 -	
6	 Leu	 7.15	 121.99	 176.82	 57.54	 39.74	
7	 Ala	 8.5	 121.5	 180.25	 56.41	 16.48	
8	 Lys	 7.95	 119.33	 177.66	 58.18	 31.24	
9	 Leu	 7.76	 119.97	 179.18	 57.59	 41.19	
10	 Ile	 8.37	 117.53	 177.11	 64.07	 35.92	
11	 Ala	 7.4	 120.09	 178.29	 54.87	 17.02	
12	 Asp	 7.74	 115.76	 178.47	 56.29	 41.18	
13	 Val	 8.37	 111.51	 175.34	 61.37	 32.22	
14	 Ala	 8.79	 125.51	 -	 49.82	 18.24	
15	 Pro	 -	 -	 179.27	 64.99	 29.87	
16	 Ser	 8.12	 113.28	 175.3	 59.83	 61.81	
17	 Ala	 8.19	 123.64	 174.64	 52.21	 20.16	
18	 Ile	 7.22	 117.47	 175.86	 59.3	 38.51	
19	 Arg	 8.68	 125.7	 174.64	 53.57	 32.22	
20	 Glu	 8.38	 122.62	 175.8	 54.39	 30.73	
21	 Asn	 8.85	 121.56	 173.81	 51.46	 42.83	
22	 Asp	 8.58	 120.4	 177.88	 53.69	 42.47	
23	 Ile	 8.65	 127.01	 175.05	 64.72	 37.27	
24	 Lys	 8.22	 120.25	 178.97	 57.86	 31.1	
25	 Ser	 7.9	 115	 174.48	 59.83	 62.42	
26	 Tyr	 7.46	 119.23	 172.94	 58.31	 36.99	
27	 Phe	 6.96	 120.21	 177.18	 60.26	 38.32	
28	 Gly	 8.17	 117.07	 174.3	 44.61	 -	
29	 Arg	 7.88	 119.04	 175	 54.03	 29.57	
30	 Lys	 8.35	 121.64	 177.38	 -	 34.08	
31	 Val	 -	 -	 173.22	 59.34	 35.31	
32	 Ala	 8.2	 125.44	 174.77	 49.45	 19.83	
33	 Ile	 8.84	 124.27	 -	 59.18	 39.35	
34	 Asp	 -	 -	 -	 -	 -	
35	 Ala	 -	 -	 -	 -	 -	
36	 Ser	 -	 -	 -	 -	 -	
37	 Met	 -	 -	 -	 -	 -	
38	 Ser	 -	 -	 -	 -	 -	
39	 Ile	 -	 -	 -	 -	 -	
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40	 Tyr	 -	 -	 -	 -	 -	
41	 Gln	 -	 -	 -	 -	 -	
42	 Phe	 -	 -	 178.5	 -	 -	
43	 Leu	 8.04	 119.04	 179.8	 56.99	 41.39	
44	 Ile	 7.66	 114.75	 177.03	 61.91	 37	
45	 Ala	 7.28	 124.51	 178.41	 53.02	 18.23	
46	 Val	 7.5	 117.1	 176.56	 62.41	 31.41	
47	 Arg	 8.09	 123.73	 -	 55.79	 29.55	
48	 Gln	 -	 -	 -	 -	 -	
49	 Gly	 -	 -	 -	 -	 -	
50	 Gly	 -	 -	 173.95	 44.92	 -	
51	 Asp	 8.19	 120.86	 176.3	 53.96	 40.67	
52	 Val	 7.88	 119.77	 176.29	 62.2	 31.6	
53	 Leu	 8.2	 124.82	 177.45	 54.77	 40.93	
54	 Gln	 8.18	 120.44	 175.84	 55.65	 28.45	
55	 Asn	 -	 -	 -	 -	 -	
56	 Glu	 -	 -	 -	 -	 -	
57	 Glu	 -	 -	 -	 -	 -	
58	 Gly	 -	 -	 -	 -	 -	
59	 Glu	 -	 -	 -	 -	 -	
60	 Thr	 -	 -	 -	 -	 -	
61	 Thr	 -	 -	 -	 -	 -	
62	 Ser	 -	 -	 -	 -	 -	
63	 His	 -	 -	 -	 -	 -	
64	 Leu	 -	 -	 -	 -	 -	
65	 Met	 -	 -	 178.1	 -	 -	
66	 Gly	 7.83	 104.6	 174.9	 46.08	 -	
67	 Met	 7.14	 120.33	 178.71	 58.28	 -	
68	 Phe	 8.22	 120.94	 175.84	 60.78	 39.27	
69	 Tyr	 8.12	 115.29	 180.24	 62.9	 36.76	
70	 Arg	 8.87	 118.41	 -	 58.32	 27.79	
71	 Thr	 -	 -	 176.26	 -	 -	
72	 Ile	 7.81	 122.85	 176.52	 65.85	 36.99	
73	 Arg	 7.48	 118.65	 179.05	 58.68	 28.26	
74	 Met	 7.36	 116.76	 178.03	 60.37	 31.94	
75	 Met	 -	 -	 181.27	 57.88	 31.43	
76	 Glu	 9.14	 121.46	 177.02	 58.17	 28.47	
77	 Asn	 7.17	 117.08	 173.44	 53.84	 40.16	
78	 Gly	 7.75	 105.75	 174.34	 46.04	 -	
79	 Ile	 7.76	 124.84	 174.23	 60.51	 37.77	
80	 Lys	 7.92	 126.92	 -	 51.92	 31.38	
81	 Pro	 -	 -	 176.84	 61.37	 32.69	
82	 Val	 8.59	 118.13	 174.15	 58.76	 33.59	
83	 Tyr	 7.94	 127.43	 174.64	 58.36	 40	
84	 Val	 9.11	 123.1	 174.91	 60.68	 32.4	
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85	 Phe	 9.29	 128.24	 175.8	 57.36	 40.37	
86	 Asp	 8.84	 121.1	 177.41	 55.64	 41.87	
87	 Gly	 8.76	 113.19	 173.95	 44.32	 -	
88	 Lys	 7.62	 127.98	 -	 53.94	 31.38	
89	 Pro	 -	 -	 -	 -	 -	
90	 Pro	 -	 -	 -	 -	 -	
91	 Gln	 -	 -	 -	 -	 -	
92	 Leu	 -	 -	 -	 -	 -	
93	 Lys	 -	 -	 -	 -	 -	
94	 Ser	 -	 -	 -	 -	 -	
95	 Gly	 -	 -	 -	 -	 -	
96	 Glu	 -	 -	 -	 -	 -	
97	 Leu	 -	 -	 -	 -	 -	
98	 Ala	 -	 -	 -	 -	 -	
99	 Lys	 -	 -	 -	 -	 -	
100	 Arg	 -	 -	 -	 -	 -	
101	 Ser	 -	 -	 -	 -	 -	
102	 Glu	 -	 -	 -	 -	 -	
103	 Arg	 -	 -	 -	 -	 -	
104	 Arg	 -	 -	 178.8	 56.56	 -	
105	 Ala	 7.89	 123.14	 179.39	 53.42	 17.72	
106	 Glu	 8.13	 119.61	 177.74	 57.52	 28.75	
107	 Ala	 7.97	 123.32	 179.4	 53.42	 17.78	
108	 Glu	 8.11	 119	 177.86	 57.51	 28.8	
109	 Lys	 7.86	 120.96	 177.77	 57.4	 31.49	
110	 Gln	 7.99	 119.51	 177.18	 56.47	 27.83	
111	 Leu	 7.93	 122.14	 178.07	 55.81	 41.02	
112	 Gln	 8.07	 120	 176.98	 56.39	 28.04	
113	 Gln	 8.12	 120.48	 176.42	 56.15	 28.33	
114	 Ala	 8.09	 124.37	 178.21	 52.67	 18.09	
115	 Gln	 8.13	 119.04	 176.32	 55.66	 28.3	
116	 Ala	 8.09	 124.92	 177.7	 52.25	 18.21	
117	 Ala	 8.1	 123.04	 178.41	 52.23	 18.28	
118	 Gly	 8.22	 108.81	 174.25	 45.05	 -	
119	 Ala	 8	 123.97	 178.05	 52.17	 18.35	
120	 Glu	 8.42	 120.23	 176.91	 56.79	 28.99	
121	 Gln	 8.23	 120.63	 176.37	 55.76	 28.49	
122	 Glu	 8.25	 122.3	 176.91	 56.49	 29.05	
123	 Val	 8	 120.9	 176.84	 62.75	 31.5	
124	 Glu	 8.28	 123.74	 177.32	 56.82	 28.96	
125	 Lys	 -	 -	 -	 -	 -	
126	 Phe	 -	 -	 -	 -	 -	
127	 Thr	 -	 -	 -	 -	 -	
128	 Lys	 -	 -	 -	 -	 -	
129	 Arg	 -	 -	 -	 -	 -	
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130	 Leu	 -	 -	 -	 -	 -	
131	 Val	 -	 -	 -	 -	 -	
132	 Lys	 -	 -	 -	 -	 -	
133	 Val	 -	 -	 -	 -	 -	
134	 Thr	 -	 -	 -	 -	 -	
135	 Lys	 -	 -	 177.59	 59.37	 31.54	
136	 Gln	 7.8	 117.79	 178.35	 59.01	 26.7	
137	 His	 7.4	 118.06	 178.99	 60.41	 31.24	
138	 Asn	 7.7	 117.37	 177.09	 56.57	 38.31	
139	 Asp	 9.04	 120.94	 180.26	 57.21	 39.09	
140	 Glu	 8.63	 120.63	 178.76	 59.25	 29.18	
141	 Cys	 8.1	 117.2	 176.35	 65.08	 26.95	
142	 Lys	 8.31	 120.48	 177.62	 60.26	 31.44	
143	 His	 7.63	 119.39	 177.41	 58.52	 29.45	
144	 Leu	 7.94	 118.48	 178.22	 58.08	 41.07	
145	 Leu	 8.46	 118.51	 179.6	 58.01	 39.47	
146	 Ser	 8.33	 115.16	 178.5	 61.31	 62.27	
147	 Leu	 7.79	 122.75	 178.09	 57.07	 41.3	
148	 Met	 8.15	 116.38	 173.98	 57.42	 34.99	
149	 Gly	 7.54	 106.17	 173.98	 45.36	 -	
150	 Ile	 7.98	 122.17	 -	 54.16	 37.4	
151	 Pro	 -	 -	 175.38	 62.18	 31.49	
152	 Tyr	 7.34	 112.84	 173.91	 54.56	 41.62	
153	 Leu	 9.09	 119.36	 175.19	 52.46	 46.02	
154	 Asp	 8.74	 123	 174.94	 53.62	 41.07	
155	 Ala	 8.88	 127.12	 175.7	 49.55	 16.98	
156	 Pro	 -	 -	 178.24	 63.31	 29.98	
157	 Ser	 6.39	 113.52	 173.76	 55.81	 61.6	
158	 Glu	 8.61	 124.06	 179.96	 56.77	 28.15	
159	 Ala	 10.52	 134.14	 181.02	 55.85	 17.75	
160	 Glu	 -	 -	 -	 -	 -	
161	 Ala	 -	 -	 180.16	 54.52	 17.22	
162	 Ser	 7.01	 115.74	 175.8	 64.47	 63.35	
163	 Cys	 8.76	 120.92	 175.93	 64.54	 25.65	
164	 Ala	 7.4	 119.3	 178.65	 54.86	 17.86	
165	 Ala	 7.71	 120.25	 180.26	 54.83	 16.5	
166	 Leu	 7.54	 117.73	 178.33	 57.9	 41.65	
167	 Val	 7.34	 121.77	 180.99	 64.95	 30.75	
168	 Lys	 8.63	 123.49	 178.65	 59.42	 32.2	
169	 Ala	 7.41	 116.56	 177.5	 51.42	 19.31	
170	 Gly	 8.06	 107.61	 175.13	 45.48	 -	
171	 Lys	 8.04	 116.38	 176.57	 55.47	 31.73	
172	 Val	 6.94	 104.55	 173.8	 57.79	 33.34	
173	 Tyr	 8.62	 120.63	 173.53	 58.72	 39.36	
174	 Ala	 6.74	 110.3	 174.6	 50.18	 24.04	
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175	 Ala	 6.95	 121.68	 175.34	 49.21	 21.14	
176	 Ala	 8.99	 126.37	 174.91	 50.38	 20.7	
177	 Thr	 7.55	 116.5	 -	 58.81	 67.7	
178	 Glu	 -	 -	 -	 -	 -	
179	 Asp	 -	 -	 -	 -	 -	
180	 Met	 -	 -	 -	 -	 -	
181	 Asp	 -	 -	 -	 -	 -	
182	 Cys	 -	 -	 -	 -	 -	
183	 Leu	 -	 -	 -	 -	 -	
184	 Thr	 -	 -	 176	 -	 -	
185	 Phe	 7.76	 114.9	 175.04	 59.72	 39.76	
186	 Gly	 7.76	 106.6	 174.84	 44.87	 -	
187	 Ser	 8.26	 116.16	 174.57	 58.57	 64.09	
188	 Ala	 7.74	 127.81	 178.43,174.57	 54.61	 18.77	
189	 Val	 6.59	 111.86	 175.25	 60.06	 34.44	
190	 Leu	 8.44	 131.63	 175.02	 52.75	 46.02	
191	 Met	 9.34	 125.23	 174.36	 54.01	 36.25	
192	 Arg	 9.38	 123.98	 175.51	 55.16	 31.59	
193	 His	 9.2	 112.73	 177.51	 55.96	 26.71	
194	 Leu	 9.11	 124.58	 -	 57.02	 41.6	
195	 Thr	 -	 -	 173.86	 59.93	 67.67	
196	 Ala	 6.69	 124.42	 -	 51.56	 18.87	
197	 Ser	 -	 -	 -	 -	 -	
198	 Glu	 -	 -	 -	 -	 -	
199	 Ala	 -	 -	 178.77	 53.47	 17.7	
200	 Lys	 7.27	 115.12	 175.87	 56.21	 31.45	
201	 Lys	 7.54	 115.32	 175.87	 56.23	 28.88	
202	 Leu	 8.44	 121.81	 -	 52.03	 40.73	
203	 Pro	 -	 -	 175.42	 62	 30.86	
204	 Ile	 8.4	 120.95	 175.99	 59.43	 34.7	
205	 Gln	 7.79	 126.12	 174.17	 53.82	 31.53	
206	 Glu	 9.3	 126.41	 174.85	 53.75	 31.97	
207	 Phe	 9.37	 122.12	 175.64	 56.14	 42.05	
208	 His	 8.55	 121.63	 176.04	 54.82	 31.64	
209	 Leu	 8.05	 128.35	 177.87	 57.9	 41.93	
210	 Ser	 9.53	 112.69	 177.28	 61.14	 -	
211	 Arg	 6.8	 120.47	 177.8	 56.64	 28.6	
212	 Ile	 7.49	 121.2	 177	 65.94	 36.98	
213	 Leu	 7.88	 116.03	 179.93	 58.02	 37.98	
214	 Gln	 7.77	 117.23	 179.43	 58.44	 28.1	
215	 Glu	 8.25	 118.65	 179.07	 58.84	 28.77	
216	 Leu	 7.79	 114.51	 176.72	 54.67	 41.73	
217	 Gly	 7.65	 110.75	 174.71	 46.47	 -	
218	 Leu	 7.85	 117.53	 176.15	 52.52	 44.88	
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219	 Asn	 7.49	 116.1	 176.24	 50.13	 38.59	
220	 Gln	 8.54	 119.1	 177.94	 59.03	 26.71	
221	 Glu	 8.52	 118.59	 178.53	 60.97	 28.25	
222	 Gln	 8.2	 118.68	 178.41	 57.77	 28.54	
223	 Phe	 8.45	 120.91	 177.47	 60.38	 38.67	
224	 Val	 8.62	 122.92	 177.22	 67.06	 29.85	
225	 Asp	 7.33	 120.15	 178.75	 57.14	 40.3	
226	 Leu	 8.41	 120.93	 177.58	 57.78	 39.71	
227	 Cys	 7.62	 116.15	 176.26	 63.68	 25.63	
228	 Ile	 7.84	 120.74	 178.73	 64.61	 36.65	
229	 Leu	 7.85	 118.99	 179.75	 56.23	 40.9	
230	 Leu	 8.12	 121.55	 177.49	 57	 39.19	
231	 Gly	 7.24	 106.33	 171.5	 46.05	 -	
232	 Ser	 9.93	 128.82	 173.9	 57.25	 67.79	
233	 Asp	 9.16	 117.06	 177.98	 54.8	 40.16	
234	 Tyr	 7.31	 113.1	 174.77	 60.28	 39.67	
235	 Cys	 7.17	 108.57	 -	 55.74	 29	
236	 Glu	 -	 -	 175.36	 57.16	 30.06	
237	 Ser	 8.03	 115.23	 172.91	 56.21	 63.68	
238	 Ile	 8.3	 119.05	 176.83	 60.71	 37.14	
239	 Arg	 8.61	 131.02	 177.1	 57.48	 28.82	
240	 Gly	 8.59	 110.33	 174.18	 44.87	 -	
241	 Ile	 7.24	 120.87	 175.3	 59.47	 35.63	
242	 Gly	 8.29	 116.1	 171.66	 44.27	 -	
243	 Pro	 -	 -	 177.84	 65.75	 32	
244	 Lys	 7.95	 114.53	 179.56	 59.11	 30.43	
245	 Arg	 7.59	 121.82	 177.56	 57.22	 28.12	
246	 Ala	 8.51	 121.92	 178.66	 55.38	 16.99	
247	 Val	 7.39	 115.69	 176.75	 66.45	 30.56	
248	 Asp	 7.27	 119.31	 178.64	 57.29	 41.14	
249	 Leu	 8.5	 117.1	 179.4	 57.28	 -	
250	 Ile	 8.19	 121.11	 178.82	 60.7	 34.74	
251	 Gln	 8.52	 120.89	 178.67	 58.97	 27.44	
252	 Lys	 7.69	 116.23	 178.39	 58.44	 32.23	
253	 His	 8.22	 114.84	 177.64	 56.05	 31.06	
254	 Lys	 8.05	 113.91	 175.69	 59.79	 29.3	
255	 Ser	 8.01	 112.82	 174.59	 55.56	 66.12	
256	 Ile	 8.37	 122.26	 176.82	 66.04	 36.45	
257	 Glu	 8.92	 119.57	 178.46	 59.69	 28.91	
258	 Glu	 7.33	 117.86	 178.48	 57.68	 28.46	
259	 Ile	 7.79	 120.96	 178.38	 65.8	 37.07	
260	 Val	 8.51	 116.62	 178.06	 66.19	 30.59	
261	 Arg	 7.05	 117.18	 177.63	 58.27	 29.77	
262	 Arg	 7.33	 116.39	 176.29	 54.82	 29.91	
263	 Leu	 7.31	 121.44	 176.99	 53.99	 42.12	
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264	 Asp	 8.41	 124.84	 175.69	 51.37	 40.97	
265	 Pro	 -	 -	 177.52	 63.76	 31.07	
266	 Asn	 8.26	 115.75	 175.86	 54.31	 38.2	
267	 Lys	 7.34	 118.86	 175.54	 56.47	 33.91	
268	 Tyr	 7.75	 116.94	 -	 54.11	 38.53	
269	 Pro	 -	 -	 -	 -	 -	
270	 Val	 -	 -	 -	 -	 -	
271	 Pro	 -	 -	 175.91	 62.58	 30.82	
272	 Glu	 8.38	 122.67	 177.14	 56.63	 29.12	
273	 Asn	 8.95	 121.09	 -	 53.24	 -	
274	 Trp	 7.81	 118.55	 -	 -	 28.99	
275	 Leu	 -	 -	 -	 -	 -	
276	 His	 -	 -	 -	 -	 -	
277	 Lys	 -	 -	 179.43	 58.32	 -	
278	 Glu	 8.81	 123.03	 179.48	 59.82	 26.91	
279	 Ala	 7.81	 123.19	 177.15	 54.43	 18.39	
280	 His	 8.31	 117.95	 176.47	 59.04	 28.15	
281	 Gln	 7.6	 116.57	 177.53	 58.25	 27.64	
282	 Leu	 7.48	 121.51	 -	 57.76	 -	
283	 Phe	 -	 -	 -	 -	 -	
284	 Leu	 -	 -	 -	 -	 -	
285	 Glu	 -	 -	 -	 -	 -	
286	 Pro	 -	 -	 176.66	 62.44	 31.05	
287	 Glu	 8.51	 120.65	 176.94	 56.24	 28.6	
288	 Val	 8.59	 120.98	 175.02	 58.95	 36.89	
289	 Leu	 6.94	 118.99	 174.31	 53.6	 40.8	
290	 Asp	 8.28	 119.85	 176.75	 50.35	 40.13	
291	 Pro	 -	 -	 176.95	 63.89	 32.31	
292	 Glu	 7.94	 113.93	 177.73	 56.45	 27.96	
293	 Ser	 7.55	 112.81	 174.08	 58.25	 63.91	
294	 Val	 6.77	 118.36	 174.47	 60.79	 32.17	
295	 Glu	 8.42	 127.39	 175.12	 54.53	 29.68	
296	 Leu	 8.46	 126.22	 174.97	 53.76	 41.22	
297	 Lys	 7.17	 122.73	 173.36	 54.84	 34.46	
298	 Trp	 8.73	 126.63	 176.25	 58.89	 30.04	
299	 Ser	 9.2	 120.58	 172.81	 56.62	 64.57	
300	 Glu	 8.41	 121.25	 174.76	 54.48	 28.44	
301	 Pro	 -	 -	 175.64	 62.08	 31.56	
302	 Asn	 8.52	 121.23	 174.74	 50.82	 36.56	
303	 Glu	 8.3	 124.1	 177.38	 61.01	 29.2	
304	 Glu	 8.74	 116.27	 180.42	 59.28	 28	
305	 Glu	 7.52	 117.92	 179.11	 57.79	 28.66	
306	 Leu	 8.5	 122.89	 178.78	 58.73	 40.95	
307	 Ile	 8.06	 120.36	 178.64	 63.62	 35.78	
308	 Lys	 7.75	 121.8	 178.53	 60.04	 31.35	
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309	 Phe	 8.04	 117.07	 176.36	 59.12	 39.59	
310	 Met	 8.73	 114.47	 176.34	 56.59	 32.07	
311	 Cys	 8.36	 116.42	 177.13	 58.81	 27.5	
312	 Gly	 7.63	 109.5	 175.16	 47.35	 -	
313	 Glu	 7.56	 118.89	 173.76	 57.97	 28.69	
314	 Lys	 7.2	 113.81	 175.62	 53.66	 29.9	
315	 Gln	 6.77	 109.62	 175.87	 57.21	 24.73	
316	 Phe	 8.58	 118.92	 176.8	 58.47	 38.5	
317	 Ser	 8.72	 116.68	 176.09	 57.47	 62.94	
318	 Glu	 8.98	 130.68	 178.37	 59.96	 28.51	
319	 Glu	 8.51	 118.92	 179.81	 59.31	 28.25	
320	 Arg	 7.29	 118.14	 179.87	 58.2	 29.37	
321	 Ile	 7.93	 120.42	 178.73	 61.08	 33.88	
322	 Arg	 9.07	 120.18	 179.54	 60.68	 28.51	
323	 Ser	 7.86	 113.93	 177.52	 61.43	 -	
324	 Gly	 7.91	 109.88	 174.66	 47.36	 -	
325	 Val	 8.59	 121.41	 178.19	 66.44	 30.25	
326	 Lys	 7.98	 120.86	 179.51	 58.81	 30.78	
327	 Arg	 7.41	 118.72	 178.99	 58.81	 29.98	
328	 Leu	 7.82	 119.29	 178.8	 56.51	 40.85	
329	 Ser	 8.31	 115.43	 176.5	 60.32	 62.53	
330	 Lys	 8.05	 122.05	 178.1	 57.6	 31.3	
331	 Ser	 7.85	 115.04	 174.97	 59.66	 62.77	
332	 Arg	 7.67	 121.94	 176.79	 56.26	 29.39	
333	 Gln	 -	 -	 -	 -	 -	
334	 Gly	 -	 -	 -	 -	 -	
335	 Ser	 -	 -	 -	 -	 -	
336	 Thr	 -	 -	 174.45	 61.66	 69.2	
337	 Leu	 8.05	 124.21	 177.2	 54.96	 41.21	
338	 Glu	 8.17	 122.05	 176.27	 56.22	 29.33	
339	 Val	 7.92	 121.54	 175.75	 61.87	 31.63	
340	 Leu	 8.04	 125.56	 176.8	 54.55	 41.44	
341	 Phe	 8.02	 121.01	 174.69	 57.14	 38.59	
342	 Gln	 7.68	 126.4	 180.28	 56.88	 29.66	
	
A1.	1H,	15N	and	13C	chemical	shifts	from	the	assignment	of	hFEN1P188A.	Also	found	in	the	BMRB	
under	accession	code	27403.	
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Residue	
Number	
Residue	
Name	 H	 N	 C	 CA	 CB	
8	 Lys	 8.07	 120.5	 -	 58.35	 31.07	
9	 Leu	 7.87	 120.64	 -	 57.87	 41.36	
10	 Ile	 8.54	 118.52	 -	 64.62	 36.77	
11	 Ala	 7.64	 120.37	 178.34	 54.85	 17.17	
12	 Asp	 7.86	 116.42	 -	 56.34	 41.55	
13	 Val	 8.5	 112.34	 -	 61.54	 -	
14	 Ala	 8.83	 125.49	 -	 49.76	 18.75	
16	 Ser	 8.13	 113.24	 -	 59.8	 61.98	
17	 Ala	 8.34	 124.24	 -	 52.31	 20.44	
18	 Ile	 7.31	 117.73	 -	 59.39	 38.64	
19	 Arg	 8.85	 126.23	 174.64	 53.51	 32.16	
20	 Glu	 8.36	 123.14	 175.83	 54.37	 30.26	
21	 Asn	 8.8	 122.13	 173.9	 51.37	 43.14	
22	 Asp	 8.49	 120	 -	 53.07	 42.89	
25	 Ser	 7.81	 115.27	 -	 60.34	 62.65	
26	 Tyr	 7.67	 119.16	 -	 58.28	 37.32	
27	 Phe	 7.04	 120.97	 177.18	 60.54	 38.33	
28	 Gly	 8.41	 117.88	 174.31	 44.61	 -	
29	 Arg	 7.93	 119.23	 175.02	 54.06	 29.7	
30	 Lys	 8.47	 121.6	 -	 54.19	 34.19	
86	 Asp	 9.04	 122.23	 -	 55.25	 42.26	
87	 Gly	 8.6	 112.72	 173.73	 44.18	 -	
88	 Lys	 7.64	 128.13	 174.29	 53.94	 31.57	
107	 Ala	 7.95	 123.07	 -	 54.66	 17.18	
108	 Glu	 8.31	 119.11	 -	 -	 -	
146	 Ser	 8.3	 114.89	 -	 61.14	 62.42	
149	 Gly	 7.56	 105.98	 173.88	 45.17	 -	
152	 Tyr	 7.37	 113.47	 173.61	 54.62	 41.78	
153	 Leu	 9.12	 119.85	 -	 52.35	 -	
154	 Asp	 8.77	 123.75	 -	 53.5	 41.07	
155	 Ala	 8.95	 127.58	 -	 49.6	 17.42	
157	 Ser	 6.51	 114.06	 -	 55.68	 61.7	
158	 Glu	 8.19	 124.36	 -	 56.02	 -	
164	 Ala	 7.42	 119.89	 178.78	 54.85	 17.69	
165	 Ala	 7.49	 120.02	 180.19	 54.79	 16.95	
166	 Leu	 7.74	 118.1	 -	 57.9	 -	
167	 Val	 7.54	 120.74	 -	 64.35	 -	
168	 Lys	 8.61	 122.69	 -	 59.93	 32.27	
169	 Ala	 7.4	 116.19	 -	 51.47	 19.48	
170	 Gly	 8	 107.54	 175.08	 45.35	 -	
171	 Lys	 8.08	 116.64	 -	 55.41	 31.92	
172	 Val	 6.97	 104.68	 -	 57.84	 33.38	
173	 Tyr	 8.76	 120.94	 -	 59.54	 39.35	
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174	 Ala	 6.84	 109.9	 -	 50.82	 -	
175	 Ala	 6.8	 122.32	 -	 49.01	 21.87	
176	 Ala	 9.35	 127.1	 -	 50.21	 19.87	
189	 Val	 6.56	 110.92	 -	 60.62	 34.73	
190	 Leu	 8.59	 132.82	 -	 52.68	 46.16	
191	 Met	 9.54	 126.38	 -	 54.13	 35.89	
192	 Arg	 9.42	 123.42	 -	 54.93	 31.32	
208	 His	 8.71	 121.9	 -	 54.66	 31.4	
209	 Leu	 8.07	 128.77	 -	 57.83	 42.06	
210	 Ser	 9.52	 113.04	 -	 61.22	 -	
211	 Arg	 6.92	 120.9	 -	 56.69	 28.96	
214	 Gln	 7.81	 117.56	 -	 58.4	 28.31	
215	 Glu	 8.24	 118.77	 -	 58.67	 28.61	
216	 Leu	 7.85	 115.48	 -	 54.88	 -	
217	 Gly	 7.75	 110.83	 -	 46.37	 -	
218	 Leu	 7.92	 118	 176.17	 52.55	 45.16	
219	 Asn	 7.57	 116.43	 -	 50.19	 38.57	
220	 Gln	 8.6	 119.45	 -	 58.98	 26.61	
221	 Glu	 8.56	 119.08	 -	 60.81	 -	
222	 Gln	 8.2	 119.09	 -	 57.73	 28.37	
223	 Phe	 8.59	 121.22	 -	 60.43	 38.89	
224	 Val	 8.74	 123.47	 -	 67.32	 29.92	
225	 Asp	 7.41	 120.87	 -	 57.35	 40.52	
226	 Leu	 8.44	 121.6	 -	 57.94	 39.84	
227	 Cys	 7.82	 116.57	 -	 63.56	 -	
237	 Ser	 8.35	 116.78	 -	 56.94	 63.65	
238	 Ile	 8.91	 119.94	 -	 60.7	 37.39	
239	 Arg	 8.81	 132.98	 -	 57.82	 28.55	
244	 Lys	 7.9	 120.85	 174.38	 59.07	 30.7	
245	 Arg	 7.63	 116.59	 -	 58.69	 32.26	
246	 Ala	 9.11	 120.91	 -	 55.39	 18.59	
247	 Val	 7.43	 115.73	 -	 66.3	 31.19	
248	 Asp	 6.86	 119.03	 -	 57.32	 41.49	
249	 Leu	 8.45	 117.14	 -	 57.37	 41.13	
253	 His	 8.24	 115.11	 -	 56.28	 31.75	
254	 Lys	 8.13	 113.99	 -	 59.75	 29.46	
255	 Ser	 8.02	 112.89	 174.57	 55.73	 66.21	
256	 Ile	 8.5	 122.72	 -	 65.85	 36.61	
257	 Glu	 8.85	 118.63	 -	 59.99	 28.59	
258	 Glu	 7.44	 118.38	 -	 57.6	 28.58	
259	 Ile	 7.99	 121.39	 -	 65.95	 37.41	
260	 Val	 8.59	 116.64	 -	 66.11	 30.51	
261	 Arg	 7.08	 117.39	 -	 58.17	 29.8	
262	 Arg	 7.4	 116.85	 -	 54.68	 30.07	
263	 Leu	 7.43	 121.84	 -	 54.24	 42.29	
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264	 Asp	 8.62	 125.61	 175.65	 51.31	 41.09	
272	 Glu	 8.44	 122.89	 177.19	 56.6	 29.31	
273	 Asn	 9	 120.89	 -	 53.38	 36.99	
274	 Trp	 7.84	 118.69	 -	 55.53	 -	
287	 Glu	 8.38	 120.65	 -	 -	 28.48	
288	 Val	 8.57	 121.2	 174.95	 58.76	 36.94	
289	 Leu	 7.03	 119.59	 174.48	 53.57	 40.96	
290	 Asp	 8.33	 120.31	 176.77	 50.42	 40.67	
292	 Glu	 8	 114.21	 -	 56.58	 28.09	
293	 Ser	 7.6	 113.05	 174.07	 58.2	 64.03	
294	 Val	 6.82	 118.87	 174.53	 60.97	 32.33	
295	 Glu	 8.48	 127.82	 175.1	 54.5	 29.93	
296	 Leu	 8.55	 126.32	 -	 53.75	 41.35	
297	 Lys	 7.33	 123.11	 173.3	 54.89	 34.53	
298	 Trp	 8.82	 127.51	 -	 58.91	 29.63	
299	 Ser	 9.26	 121.42	 172.62	 56.81	 64.72	
300	 Glu	 8.49	 121.52	 174.63	 54.54	 28.58	
302	 Asn	 8.53	 121.14	 -	 50.77	 36.61	
303	 Glu	 8.29	 124.86	 -	 61.01	 29.44	
304	 Glu	 8.81	 116.65	 -	 59.42	 28.17	
305	 Glu	 7.55	 117.88	 -	 57.78	 -	
306	 Leu	 8.57	 123.04	 -	 58.52	 41.14	
307	 Ile	 8.2	 120.72	 -	 63.76	 35.78	
308	 Lys	 7.75	 121.97	 -	 60.11	 31.52	
309	 Phe	 7.99	 116.64	 -	 59.14	 40.05	
317	 Ser	 9.39	 119.57	 176.42	 57.36	 62.96	
318	 Glu	 9.07	 132.47	 -	 60.11	 28.43	
319	 Glu	 8.54	 119.03	 179.92	 59.25	 28.45	
320	 Arg	 7.34	 118.88	 -	 58.84	 29.27	
321	 Ile	 8.21	 121.09	 -	 61.19	 33.78	
322	 Arg	 9.01	 120.15	 179.81	 60.83	 28.48	
323	 Ser	 8	 115.22	 -	 61.33	 -	
324	 Gly	 8.31	 110.51	 174.78	 47.28	 -	
325	 Val	 8.85	 122.43	 -	 66.88	 30.34	
332	 Arg	 7.52	 121.77	 176.96	 56.57	 29.44	
333	 Gln	 7.87	 120.02	 176.72	 56.13	 -	
334	 Gly	 8.25	 109.64	 -	 45.17	 -	
336	 Thr	 8.13	 116.42	 -	 61.74	 69.27	
337	 Leu	 8.1	 124.45	 177.21	 54.96	 41.28	
338	 Glu	 8.22	 122.34	 176.25	 56.2	 29.42	
339	 Val	 7.98	 121.94	 175.73	 61.85	 31.74	
340	 Leu	 8.1	 125.97	 176.79	 54.54	 41.55	
341	 Phe	 8.09	 121.41	 174.69	 57.15	 38.68	
342	 Gln	 7.74	 126.75	 180.27	 56.89	 29.85	
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A2:	1H,	15N	and	13C	chemical	shifts	from	the	hFEN1K93A-DHPS1	protein	complex.	Also	found	in	
the	BMRB	under	accession	code	27404.	
	
